Δημοσιεύσεις
Δημοσιεύσεις 1996
G. Fountzilas, P. Kosmidis, K.S. Shridhar, A. Kalogera-Fountzila, K. Banis, A. Dimitriadis, V. Avramidis, A. Nikolaou, T. Zaramboukas, D. Skarlos, A. Vritsios, I. Daniilidis
Cancer Invest 1996;14(3):189-96
A PHASE II STUDY OF PACLITAXEL IN ADVANCED BREAST CANCER RESISTANT TO ANTHRACYCLINES
G. Fountzilas, A. Athanassiadis, T. Giannakakis, D. Bafaloukos, K. Karakousis, N. Dombros, P. Kosmidis, D. Skarlos
Eur J Cancer 1996 Jan;32A(1):47-51
G. Fountzilas, K. Gossios, A. Zisiadis, E. Svarna, D. Skarlos, N. Pavlidis
Med Pediatr Oncol 1996 May;26(5):305-17
D.V.Skarlos, G. Aravantinos, P. Kosmidis, N. Pavlidis, K. Gennatas, M. Beer, N. Mylonakis, P. Makrantonakis, G. Klouvas, S. Karpathios, H. Linardou, C. Konstantaras, G. Fountzilas
Eur J Cancer 1996 Mar;32A(3):421-8
D. Bafaloukos, N. Pavlidis, G. Fountzilas, D. Skarlos, G. Klouvas, P. Makrantonakis, T. Giannakakis, N. Tsavaris, P. Kosmidis
Am J Clin Oncol 1996 Jun;19(3):296-300
PACLITAXEL AND CARBOPLATIN IN NON-OPERABLE NON-SMALL CELL LUNG CANCER
P. Kosmidis, N. Mylonakis, G. Fountzilas, E. Samantas, A. Athanasiadis, D. Skarlos
Semin Oncol 1996 Dec;23(6 Suppl 16):68-70
P. Kosmidis, N. Mylonakis, G. Fountzilas, N. Pavlidis, E. Samantas, A. Karabelis, K. Kattis, D. Skarlos
Ann Oncol 1996 Jul;7(5):517-20
D. Pectasides, N. Pavlidis, L. Gogou, F. Antoniou, C. Nicolaides, D. Tsikalakis, G. Fountzilas
Am J Clin Oncol 1996 Oct;19(5):459-64
G. Fountzilas, A. Polichronis, K. Katsohis, K. Gennatas, D. Toussis, D. Skarlos, P. Kosmidis, S. Vassilaros, C. Semoglou, T. Giannakakis, E. Fahantidis, G. Klouvas, N. Tsavaris, C. Konstantaras, P. Makrantonakis, C. Kolotas, N. Zamboglou, S. Tsiliakos, D. Hainoglou, N. Mylonakis, N. Pavlidis
Oncology 1996 Mar-Apr;53(2):137-46
PHASE II STUDY OF 5-FLUOROURACIL AND INTERFERON-GAMMA IN PATIENTS WITH METASTATIC COLORECTAL CANCER
N. Pavlidis, C. Nicolaides, A. Athanassiades, K. Beriatou, D. Skarlos, Th. Giannakakis, P. Kosmidis, N. Karvounis, G. Fountzilas
Oncology 1996 Mar-Apr;53(2):159-62
SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMA
N. Pavlidis, C. Nikolaides, E. Bairaktari, J. Kalef-Ezra, A. Athanassiadis, C. Seferiadis, G. Fountzilas
Int J Biol Markers 1996 Jan-Mar;11(1):6-1
WIDESPREAD CASTLEMAN DISEASE: CT FINDINGS
K. Gossios, C. Nicolaides, M. Bai, G. Fountzilas
Eur Radiol 1996;6(1):95-8
P.A. Kosmidis, N. Tsavaris, D. Skarlos, D. Theocharis, E. Samantas, N. Pavlidis, E. Briassoulis, G. Fountzilas
J Clinl Oncol 1996 Oct;14(10):2682-7
M. Elisaf, E. Bairaktari, C. Nicolaides, G. Fountzilas, C. Tzallas, K. Siamopoulos, O. Tsolas, N. Pavlidis
Anticancer Res 1996 Sep-Oct;16(5A):2725-8
Lancet 1996 Nov 2;348(9036):1189-96
Δημοσιεύσεις 1997
D.V.Skarlos, G. Aravantinos, E. Linardou, C. A. Kostakopoulos, I. Kastriotis, C. Christodoulou, D. Picramenos, Th. Giannakakis, K. Dimopoulos, G. Fountzilas
Eur Urol 1997; 31:420-427
PACLITAXEL AND CARBOPLATIN IN INOPERABLE NON- SMALL CELL LUNG CANCER: A PHASE II STUDY
P.A. Kosmidis, N.Mylonakis, G. Fountzilas, E. Samantas, A. Athanasiadis, E. Andreopoulou, N. Pavlidis, D. Skarlos
Annals of Oncology 1997 Jul;8(7):697-9
P. Kosmidis, C.Bacoyiannis, G. Fountzilas, G. Aravantinos, N. Tsavaris, C. Milathianakis, D. Skarlos
Annals of Oncology 1997 Apr;8(4):373-8
G. Aravantinos, D.V.Skarlos, P. Kosmidis, A. Athanassiades, D. Bafaloukos, T. Giannakakis, S. Karpathios, G. Fountzilas
European Journal of Cancer 1997 Jan;33(1):160-3
P. Kosmidis, N. Mylonakis, G. Fountzilas, E. Samantas, A. Athanassiades, N. Pavlidis, D. Skarlos
Seminars in Oncology 1997 Aug;24(4 Suppl 12):S12-30-S12-33
PACLITAXEL AND CARBOPLATIN IN RECURRENT OR METASTATIC HEAD AND NECK CANCER: A PHASE II STUDY
G. Fountzilas, A. Athanassiadis, E. Samantas, D. Skarlos, A. Kalogera-Fountzila, A. Nikolaou, H. Bacoyiannis, G. Stathopoulos, P. Kosmidis, J. Daniilidis
Seminars in Oncology 1997 Feb;24(1 Suppl 2):S2-65-S2-67
D.V.Skarlos, G. Aravantinos, P. Kosmidis, A. Athanassiadis, G.P. Stathopoulos, N. Pavlidis, D. Bafaloukos, S. Karpathios, P. Papakostas, C. Bamia, G. Fountzilas
Seminars in Oncology 1997 Oct;24(5 Suppl 15):S15-57-S15-61
G. Fountzilas, A. Athanassiades, T. Giannakakis, E. Briasoulis, D. Bafaloukos, A. Kalogera-Fountzila, A. Onienaoum, H. Kalofonos, D. Pectasides, E. Andreopoulou, C. Bamia, P. Kosmidis, N. Pavlidis, D. Skarlos
Annals of Oncology 1997 Dec;8(12):1213-20
G. Fountzilas, A. Athanassiadis, A. Kalogera-Fountzila, G. Aravantinos, D. Bafaloukos, E. Briasoulis, N. Dombros, I. Ioannidis, N. Pavlidis, P. Kosmidis, D. Skarlos
European Journal of Cancer 1997 Oct;33(11):1893-5
G. Fountzilas, S. Vasilaros, D. Koukouras, N. Malamos, D. Pectasides, A. Adamou, E. Nenopoulou, K. Kiriakou, I. Zouvani, K. Katsohis, A. Kappas, C. Skopa, C. Semoglou, E. Fahantidis, C. Konstantaras, E. Vasilaki, T. Economopoulos, H. Bacoyiannis, D. Bafaloukos, E. Razi, A. Polichronis, G. Androulakis, T. Papaioannou, N. Pavlidis, D. Skarlos, D. Skarlos, P. Kosmidis
Anticancer research 1997 Nov-Dec;17(6D):4681-9
G. Fountzilas, A. Athanassiadis, A. Nikolaou, A. Kalogera-Fountzila, J. Tzitzikas, E. Samantas, D. Skarlos, N. Zamboglou, J. Daniilidis
Tumori 1997 Jul-Aug;83(4):735-9
G. Fountzilas, P. Kosmidis, V. Avramidis, A. Nikolaou, A. Kalogera-Fountzila, P. Makrantonakis, C. Bacoyiannis, E. Samantas, D. Skarlos, J. Daniilidis
Medical and Pediatric Oncology 1997 Jun;28(6):401-10
G. Fountzilas, D. Skarlos, A. Athanassiades, A. Kalogera-Fountzila, E. Samantas, C. Bacoyiannis, N. Nicolaou, N. Dombros, E. Briasoulis, M. Dinopoulou, G. Stathopoulos, N. Pavlidis, P. Kosmidis, J. Daniilidis
Annals of Oncology 1997 May;8(5):451-5
C. Nicolaides, G. Klouvas, G. Fountzilas, A. Athanassiadis, D. Skarlos, E. Samantas, P. Kosmidis, N. Mylonakis, N. Pavlidis
Journal of Experimental & Clinical Cancer Research 1997 Mar;16(1):91-4
G. P. Stathopoulos, S. Rigatos, P. Papakostas, G. Fountzilas
European Journal of Cancer 1997 Oct;33(11):1780-3
HAPLOTYPES OF HUMAN LEUKOCYTE ANTIGENS AMONG PATIENTS WITH NASOPHARYNGEAL CANCER IN GREECE
M. Daniilidis, G. Fountzilas, A. Fleva, J. Daniilidis, A. Tourkantonis
Oncology 1997 May-Jun;54(3):185-92
CONCURRENT RADIATION AND INTRACAROTID CISPLATIN INFUSION IN MALIGNANT GLIOMAS: A FEASIBILITY STUDY
G. Fountzilas, A. Karavelis, P. Makrantonakis, P. Selviaridis, J. Tzitzikas, A. Kalogera-Fountzila, A. Hatzibaloglou, G. Karkavelas, G. Foroglou, A. Tourkantonis
American Journal ofClinical Oncology 1997 Apr;20(2):138-42
Δημοσιεύσεις 1998
CONCURRENT PACLITAXEL AND RADIOTHERAPY. TREATMENT FEASIBILITY STUDIES
H.G. Vogt, T. Martin, A. Capizzello, C. Kolotas, S. Hey, L. Schneider, W. Dornoff, G. Fountzilas, T. Templin, H. Kettner, N. Zamboglou
Strahlentherapie und Onkologie. 1998;174:1: 24-8
TAMOXIFEN FOR EARLY BREAST CANCER: AN OVERVIEW OF THE RANDOMISED TRIALS
Early Breast Cancer Trialists’ Collaborative Group
POLYCHEMOTHERAPY FOR EARLY BREAST CANCER: AN OVERVIEW OF THE RANDOMISED TRIALS
Early Breast Cancer Trialists’ Collaborative Group
M. Elisaf, E. Bairaktari, C. Nicolaides, G. Fountzilas, C. Tzallas, O. Tsolas, K. Siamopoulos, N. Pavlidis
Nutr Metab Cardiovasc Dis 1998 ; 8 : 101-105
G. Fountzilas, A.M. Dimopoulos, C. Papadimitriou, A. Kalogera-Fountzila, G. Aravantinos, D. Bafaloukos, A. Athanassiades, C. Nicolaides, A. Keramopoulos, N. Pavlidis, P. Kosmidis, D. Skarlos
Ann. Oncol. 1998 Sep;9(9):1031-4
PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED BREAST CANCER
G. Fountzilas, A. Athanassiades, V. Papadimitriou, M.A Dimopoulos, D. Bafaloukos, G. Aravantinos, C. Nicolaides, H. Kalofonos, P. Papakostas, N. Xiros, E. Razi
Oncology. 1998 Jan;12(1 Suppl 1):45-8
Al. Giatromanolaki, G. Fountzilas, M.I. Koukourakis, P. Arapantoni, V. Theologi, S. Kakolyris, V. Georgoulias, A.L. Harris, K.C. Gatter.
Clin Exp Metastasis. 1998 Oct;16(7):665-72
TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH DOSE EPIRUBICIN
C. Nicolaides, T. Giannakakis, D. Skarlos, A. Athanassiadis, G. Fountzilas, D. Damigos, N. Pavlidis
J Exp Clin Cancer Res. 1998 Mar;17(1):71-5
PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER
An. Kalogera-Fountzila, P. Kosmidis, C. Bacoyiannis, A. Nicolaou, E. Samantas, E. Briassoulis, N. Pavlidis, D. Skarlos, J. Daniilidis, G. Fountzilas
Anticancer Res. 1998 Jan-Feb;18(1B):587-93
Bcl2 AND p53 PROTEIN EXPRESSION IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY ORIGIN: BIOLOGICAL AND CLINICAL IMPLICATIONS. A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
E. Briassoulis, M. Tsokos, G. Fountzilas, D. Bafaloukos, P. Kosmidis, E. Samantas, D. Skarlos, C. Nicolaides, N. Pavlidis
Anticancer Res. 1998 May-Jun;18(3B):1907-14
PRIMARY EXTRANODAL NON HODGKIN’S LYMPHOMA OF THE HEAD AND NECK TO ADULTS: A CLINICOPATHOLOGICAL COMPARISON BETWEEN TONSILLAR AND NON TONSILLAR LYMPHOMAS
T. Economopoulos, G. Fountzilas, A. Kostourou, J. Daniilidis, N. Pavlidis, H. Andreopoulou, A. Nicolaou, E. Papageorgiou, S. Mellou, J. Dervenoulas, N. Stathakis
Anticancer Res. 1998 Nov-Dec;18(6B):4655-60
P53/MDM-2 IMMUNOHISTOCHEMICAL EXPRESSION CORRELATED WITH PROLIFERATIVE ACTIVITY IN DIFFERENT SUBTYPES OF HUMAN SARCOMAS: A TEN-YEAR FOLLOW-UP STUDY
D.G. Stefanou, A.V. Nonni, N.J. Agnantis, S.E. Athanassiadou, E. Briassoulis, N. Pavlidis
Anticancer Res. 1998 Nov-Dec;18(6B):4673-81
P53 AND BCL-2 EXPRESSION IN LOCALLY ADVANCED SQUAMOUS CELL HEAD-NECK CANCER TREATED WITH PLATINUM BASED CHEMOTHERAPY AND RADIOTHERAPY
Al. Giatromanolaki, M. Koukourakis, T. Zaramboukas, A. Skordalaki, P. Arapantoni, V. Georgoulias, G. Fountzilas
Anticancer Res. 1998 Nov-Dec;18(6B):4685-92
IMAGING OF METASTATIC MELANOMA UTILISING A TECHNETIUM-99m LABELLED RGD-CONTAINING SYNTHETIC PEPTIDE
G.B. Sivolapenko, D. Skarlos, D. Pectasides, E. Stathopoulou, A. Milonakis, G. Sirmalis, A. Stuttle, N.S. Courtenay-Luck, K. Konstantinides, A.A. Epenetos
Eur. J Nucl. Med. 1998 Oct;25(10):1383-9
TREATMENT OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA AND IMPAIRED RENAL FUNCTION WITH SINGLE-AGENT DOCETAXEL
M.A. Dimopoulos, C. Deliveliotis, L.A. Moulopoulos, C. Papadimitriou, D. Mitropoulos, A. Anagnostopoulos, P. Athanassiades, C. Dimopoulos
Urology 1998 Jul;52(1):56-60
SUBCUTANEOUS LOW DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA
D. Bafaloukos, G. Fountzilas, D. Skarlos, N. Pavlidis, C. Bakoyiannis, N. Karvounis, P. Kosmidis
Oncology. 1998 Jan-Feb;55(1):48-52
DIFFUSE LARGE CELL LYMPHOMAS: IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKIN’S LYMPHOMA PROGNOSTIC INDEX. A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
C. Nicolaides, G. Fountzilas, N. Zoumbos, D. Skarlos, P. Kosmidis, D. Pectasides, A. Karabelis, Th. Giannakakis, A. Symeonidis, A. Papadopoulos, F. Antoniou, N. Pavlidis
Oncology. 1998 Sep-Oct;55(5):405-15
COMBINATION REGIMEN WITH CARBOPLATIN, EPIRUBICIN AND ETOPOSIDE IN METASTATIC CARCINOMAS OF UNKNOWN PRIMARY SITE: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
E. Briasoulis, N. Tsavaris, G. Fountzilas, A. Athanasiadis, P. Kosmidis, D. Bafaloukos, D. Skarlos, E. Samantas, N. Pavlidis
Oncology. 1998 Sep-Oct;55(5):426-30
DOSE-DENSE ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN MONOTHERAPY IN PATIENTS WITH OPERABLE BREAST CANCER AND >=10 POSITIVE AXILLARY LYMPH NODES
G. Fountzilas, C. Nicolaides, G. Aravantinos, D. Skarlos, P. Kosmidis, P. Papakostas, G.P. Stathopoulos, E. Kontostolis, D. Bafaloukos, N. Pavlidis
Oncology. 1998 Nov-Dec;55(6):508-12
A RANDOMIZED COMPARATIVE STUDY OF ANTIEMETIC PROPHYLAXIS WITH ONDASENTRON IN A SINGLE 32-mg LOADING DOSE VERSUS 8mg EVERY 6h IN PATIENTS UNDERGOING CISPLATIN-BASED CHEMOTHERAPY
N. Tsavaris, G. Fountzilas, N. Mylonakis, A. Athanassiadis, C. Kosmas, C. Karakousis, C. Bacoyiannis, P. Kosmidis
Oncology. 1998 Nov-Dec;55(6):513-6
FAVORABLE OUTCOME OF OVARIAN GERM CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
M.A. Dimopoulos, M. Papadopoulou, E. Andreopoulou, C. Papadimitriou, N. Pavlidis, G. Aravantinos, A. Aspropotamitis, A. Anagnostopoulos, G. Fountzilas, S. Michalas, D. Pectasides
Gynecol Oncol. 1998 Jul;70(1):70-4
LOCAL IMMUNE RESPONSE AFTER INTRAVESCICAL INTERFERON GAMMA IN SUPERFICIAL BLADDER CANCER
N.E. Stavropoulos, E. Ioachim, N. Pavlidis, L. Pappa, P. Kalomiris, N.J. Agnantis
Br J Urol.1998 Jun;81(6):875-9
Δημοσιεύσεις 1999
ANGIOGENESIS VS RESPONSE AFTER COMBINED CHEMORADIOTHERAPY OF SQUAMOUS CELL HEAD AND NECK CANCER
A.Giatromanolaki, M.I.Koukourakis, V.Georgoulias, K.C.Gatter, A.L.Harris, G.Fountzilas
Inter J Cancer. 1999 Mar 15;80(6):810-7
C.A.Papadimitriou, K.Sarris, L.A.Moulopoulos, G.Fountzilas, A.Anagnostopoulos, Z.Voulgaris, D.Gika, N.Giannakoulis, E.Diakomanolis, M.A.Dimopoulos
J Clin Oncol. 1999 Mar;17(3):761-6
N.Xiros, T.Economopoulos, G.Fountzilas, N.Pavlidis, E.Samantas, S.Raptis.
Hematologica. 1999 Feb;84(2):189-90
PACLITAXEL AND GEMCITABINE IN ADVANCED NON-NASOPHARYNGEAL HEAD AND NECK CANCER: A PHASE II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G.Fountzilas, G.Stathopoulos, C.Nicolaides, A.Kalogera-Fountzila, H.Kalofonos, A.Nikolaou, C.Bacoyiannis, E.Samantas, C.Papadimitriou, P.Kosmidis, J.Daniilidis, N.Pavlidis.
Ann Oncol. 1999 Apr;10(4):475-8
WEEKLY ALTERNATING NON-CROSS RESISTANT CHEMOTHERAPY IN GOOD PROGNOSIS SMALL CELL LUNG CANCER
D.V.Skarlos, E.Samantas, D.Pectasides, N.Pavlidis, Ch.Kalofonos, G.Klouvas, E.Panoussaki, E.Tsiakopoulos, N.Poulaki, G.Fountzilas
Am J Clin Oncol 1999 Feb;22(1):87-93
PLATINUM-BASED CHEMOTHERAPY OF PRIMARY EXTRAGONADAL GERM CELL TUMORS. THE HELLENIC COOPERATIVE ONCOLOGY GROUP EXPERIENCE
D.Pectasides, G.Aravantinos, A.Visvikis, Ch.Bakoyiannis, A.Halkia, Ch.Kalofonos, P.Kosmidis, D.Skarlos, G.Fountzilas
Oncology 1999 Jul;57(1):1-9
COMBINATION CHEMOTHERAPY WITH LOW DOSES OF WEEKLY CARBOPLATIN AND ORAL ETOPOSIDE IN POOR RISK SMALL CELL LUNG CANCER
E.Samantas, D.V.Skarlos, D.Pectasides, P.Nicolaides, H.Kalofonos, N.Mylonakis, Th.Vardoulakis, P.Kosmidis, N.Pavlidis, G.Fountzilas
Lung Cancer. 1999 Feb;23(2):159-68
E.Briassoulis, V.Karavasilis, D.Anastasopoulos, E.Tzamakou, G.Fountzilas, D.Rammou, V.Kostadima, N.Pavlidis
Ann Oncol. 1999 Jun;10(6):701-6
POSTOPERTIVE RADIATION AND CONCOMITANT BOLUS FLUOROURACIL WITH OR WITHOUT ADDITIONAL CHEMOTHERAPY AS ADJUVANT TREATMENT IN PATIENTS WITH HIGH RISK RECTAL CANCER. A RANDOMIZED PHASE III STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G.Fountzilas, A.Zisiadis, U.Dafni, Ch.Konstantaras, G.Hatzitheoharis, A.Liaros, E.Athanassiou, N.Dombros, Ch.Dervenis, G.Basdanis, O.Gamvros, A.Souparis, E.Briassoulis, E.Samantas, A.Kappas, P.Kosmidis, D.Skarlos, N.Pavlidis
Ann Oncol 1999 Jun;10(6):671-6
D.Pectasides, D.Tsavdaridis, Ch.Aggouridaki, V.Tsavdaridou, A.Visvikis, K.Tsatalas, G.Fountzilas
Anticancer Res. 1999 Jul-Aug;19(4C):3521-6
DOCETAXEL AND CISPLATIN COMBINATION CHEMOTHERAPY IN ADVANCED CARCINOMA OF THE UROTHELIUM: A MULTICENTER PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
M.A.Dimopoulos, C.Bacoyannis, V.Georgoulias, C.Papadimitriou, L.A.Moulopoulos, C.Deliveliotis, A.Karayannis, I.Varkarakis, G.Aravantinos, A.Zervas, D.Pantazopoulos, G.Fountzilas, A.Bamias, Z.Kyriakakis, A.Anagnostopoulos, A.Giannopoulos & P.Kosmidis
Ann Oncol. 1999 Nov;10(11):1385-8
D.Bafaloukos, G.Aravantinos, G.Samonis, G.Katsifis, C.Bacoyiannis, D.Skarlos, P.Kosmidis
Oncology 1999 Apr;56(3):198-201
G.Fountzilas, A.Karavelis, A.Capizzello, A.Kalogera-Fountzila, G.Karkavelas, N.Zamboglou, P.Selviaridis, G.Foroglou, Achilles Tourkantonis.
J Neuro- Oncol 1999;45(2):159-65
P.Makrantonakis, D.Pectasides, Ch.Aggouridakis, A.Visvikis, J.Daniilidis, G.Fountzilas
Am J Clin Oncol. 1999 Dec;22(6):542-9
IRINOTECAN (CPT-11) IN PATIENTS WITH ADVANCED COLORECTAL CANCER PREVIOUSLY TREATED WITH h 5-FLUOROURACIL-BASED CHEMOTHERAPY
G.Aravantinos, D.Skarlos, P.Kosmidis, V.Georgoulias, I.Sgouros, D.Bafaloukos, N.Androlakis, S.Florou, A.Athanassiades, G.Fountzilas
Crit Rev Oncol Hematol. 1999 Dec;32(3):209-19
RADIOIMMUNOSCINTIGRAPHY IN PATIENTS WITH OVARIAN CANCER
H. P. Kalofonos, C. Giannakenas, C. Kosmas, D. Apostolopoulos, A. Onienadum, T. Petsas, D. Dimopoulos, A.A. Epenetos, P.J. Vassilakos
Acta Oncol 1999;38(5):629-34
Δημοσιεύσεις 2000
D.Pectasides, Th.Economopoulos, G.Kouvatseas, A.Antoniou, Z.Zoumbos, G.Aravantinos, C.Tsatalas, A.Halkia, C.Nikolaides, Ch.Kiamouris, E.Pappa, N.Pavlidis, D.Skarlos, G.Fountzilas, M.A.Dimopoulos
Oncology 2000 May;58(4):286-92
J.Janinis, P.Papakostas, G.Samelis, D.Skarlos, P.Papagianopoulos, & G.Fountzilas
Ann Oncol. 2000 Feb;11(2):163-7
G.Fountzilas, A. Zisiadis, U. Dafni, C. Konstantaras, G. Hatzitheoharis, S. Papavramidis, A. Bousoulegas, G. Basdanis, E. Giannoulis, J. Dokmetzioglou, C. Katsohis, E. Nenopoulou, N. Karvounis, E. Briassoulis, G. Aravantinos, P. Kosmidis, D. Skarlos, N. Pavlidis
Oncology. 2000 Apr;58(3):227-36
G. Aravantinos, MA Dimopoulos, P. Kosmidis, D. Bafaloukos, Ch Papadimitriou, Ch Kiamouris, N. Pavlidis, K. Sikiotis K, P. Papakostas and DV Skarlos
Ann Oncol. 2000 May;11(5):607-12
G.Fountzilas, C.Nicolaides, D.Bafaloukos, A.Kalogera-Fountzila, H.Kalofonos, G.Samelis, G.Aravantinos, N.Pavlidis
Cancer Invest 2000;18(6):503-9
P. Kosmidis, N. Mylonakis, A. Dimopoulos, N. Pavlidis, G. Fountzilas, E. Samantas, K. Dimitriadis, H.P. Kalofonos, D. Tsavdaridis, D. Skarlos
Semin Oncol. 2000 Feb;27(1 Suppl 2):3-8
C. Nicolaides, M.A Dimopoulos, E. Samantas, D. Bafaloukos, H.P Kalofonos, G. Fountzilas, E. Razi, P. Kosmidis, N. Pavlidis
Ann Oncol 2000 Jul;11(7):873-5
E. Briassoulis, H. Kalofonos, D. Bafaloukos, E. Samantas, G. Fountzilas, N. Xiros, D. Skarlos, C. Christodoulou, P. Kosmidis, N. Pavlidis
J Clin Oncol. 2000 Sep;18(17):3101-7
J.Janinis, T.Giannakakis, A.Athanassiades, G.Fountzilas, D.Bafaloukos, P.Kosmidis, C.Nicolaides, N.Pavlidis, D.Skarlos
Tumori. 2000 Jan-Feb;86(1):37-41
BURKITT’S LYMPHOMA IN GREEK ADULTS. A STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
T. Economopoulos, MA Dimopoulos, A. Foudoulakis, C. Nikolaidis, C. Tsatalas, D. Pectasides, N. Xiros, D. Rontogianni, E. Papageorgiou, G. Fountzilas
Leuk Res. 2000 Dec;24(12):993-8
PHASE II STUDY OF PEGYLATED LIPOSOMAL DOXORUBICIN: IS INACTIVE IN RECURRENT SMALL CELL LUNG CANCER
E. Samantas, H. Kalofonos, H. Linardou, C. Nikolaides, N. Mylonakis, G. Fountzilas, P. Kosmidis, D. Skarlos
Ann Oncol. 2000 Nov;11(11):1395-7
MA. Dimopoulos, CA. Papadimitriou, V. Georgoulias, LA. Moulopoulos, G. Aravantinos, D. Gika, S. Karpathios, S. Stamatelopoulos
Gynecol Oncol. 2000 Jul;78(1):52-7
P.Kosmidis, N.Mylonakis, D.Skarlos, E.Samantas, M.Dimopoulos, C.Papadimitriou, C.Kalofonos, N.Pavlidis, C.Nikolaides, C.Papaconstantinou, G.Fountzilas
Ann Oncol. 2000 Jul;11(7):799-805
E. Razi, A.M.Dimopoulos, D. Bafaloukos, C. Papadimitriou, A. Kalogera-Fountzila, H. Kalofonos, E. Briassoulis, E. Samantas, A. Keramopoulos, N. Pavlidis, P. Kosmidis, G. Fountzilas
Cancer Invest. 2000; 19:1-8
C-erbB-2 ONCOPROTEIN IS OVEREXPRESSED IN POORLY VASCULARISED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, BUT IS NOT ASSOCIATED WITH RESPONSE TO CYTOTOXIC THERAPY OR SURVIVAL
A. Giatromanolaki, M.I. Koukourakis, E. Sivridis, G. Fountzilas
Anticancer Res. 2000 Mar-Apr;20(2A):997-1004
BRCA 1 MUTATION ANALYSIS IN BREAST CANCER/OVARIAN CANCER FAMILIES FROM GREECE
I. Konstantopoulou, C. Kroupis, A. Ladopoulou, A. Pentazidis, D. Boumba, E. Lianidou, MB. Petersen, L. Florentin, E. Chiotellis, G. Nounesis, E. Efstathiou, D. Skarlos, C. Tsionou, G. Fountzilas, D. Yannoukakos
Hum Mutat. 2000 Sep;16(3):272-3
M.I. Koukourakis, A. Giatromanolaki, G. Fountzilas, E. Sivrdis, K.C. Gatter, A.L. Harris
Clin Cancer Res. 2000 Feb;6(2):381-9
A. Giatromanolaki, M.I. Koukourakis, E. Sivridis, PE. Thorpe, RA. Brekken K. Simopoulos, G. Fountzilas, KC. Gatter, AL. Harris
Clin Exp Metastasis. 2000;18(4):313-9
Δημοσιεύσεις 2001
G. Fountzilas, C. Papadimitriou, U. Dafni, D. Bafaloukos, D. Skarlos, L.A. Moulopoulos, E. Razis, H.P. Kalofonos, G. Aravantinos, E. Briassoulis, P. Papakostas, K. Abela, E. Gogas, P. Kosmidis, N. Pavlidis and M.A. Dimopoulos
J Clin Oncol. 2001 Apr 15;19(8):2232-9
DOSE-DENSE SEQUENTIAL CHEMOTHERAPY WITH EPIRUBICIN AND PACLITAXEL IN ADVANCED BREAST CANCER
E. Razis, A.M. Dimopoulos, D. Bafaloukos, C. Papadimitriou, A. Kalogera-Fountzila, H.P. Kalofonos, E. Briassoulis, E. Samantas, A. Keramopoulos, N. Pavlidis, P. Kosmidis and G. Fountzilas
Cancer Invest. 2001;19(2):137-44
P. Papakostas, C. Kouroussis, N. Androulakis, G. Samelis, G. Aravantinos, K. Kalbakis, E. Sarra, J. Souglakos, S. Kakolyris, V. Georgoulias
Eur J Cancer. 2001 Oct;37(15):1833-8
M.I. Koukourakis, A. Giatromanolaki, S. Kakolyris, E. Sivridis, V. Georgoulias, G. Fountzilas, I.D. Hickson, K.C. Gatter and A.L. Harris
Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):27-36
PHASE II STUDY OF TEMOZOLOMIDE IN HEAVILY PRETREATED CANCER PATIENTS WITH BRAIN METASTASES
C. Christodoulou, D. Bafaloukos, P. Kosmidis, E. Samantas, A. Bamias, P. Papakostas, A. Karabelis, C. Bacoyiannis & D.V. Skarlos
Ann Oncol. 2001 Feb;12(2):249-54
D. Pectasides, H.P Kalofonos, E. Samantas, C. Nicolaides, P. Papacostas, A. Onyenadum, A. Visvikis, D. Skarlos, G. Fountzilas
Anticancer Res. 2001 Jul-Aug;21(4B):3005-10
E. Briassoulis, E. Andreopoulou, C.F. Tolis, E. Bairaktari, A. Katsaraki, M.A. Dimopoulos, G. Fountzilas, C. Seferiadis, N. Pavlidis
Cancer. 2001 Mar 1;91(5):909-17
THALIDOMIDE AND DEXAMETHASONE COMBINATION FOR REFRACTORY MULTIPLE-MYELOMA
M.A Dimopoulos, K. Zervas, G. Kouvatseas, E. Galani, V. Grigoraki, C. Kiamouris, E. Vervessou, E. Samantas, C. Papadimitriou, O. Economou, D. Gika, P. Panayiotidis, I. Christakis, N. Anagnostopoulos
Ann Oncol. 2001 Jul;12(7):991-5
G. Agiostratidou, I. Sgouros, E. Galani, A. Voulgari, N. Chondrogianni, E. Samantas, M.A Dimopoulos , D. Skarlos, E.S Gonos
Anticancer Res. 2001 Jan-Feb;21(1A):455-9
G. Fountzilas, C. Papadimitriou, G. Aravantinos, C. Nicolaides, G. Stathopoulos, D. Bafaloukos, H.P. Kalofonos, T. Economopoulos, D. Skarlos, N. Pavlidis, A.M. Dimopoulos
Oncology. 2001;60(3):214-20
BAX PROTEIN EXPRESSION IN COLORECTAL CANCER: ASSOCIATION WITH p53, bcl-2 AND PATTERNS OF RELAPSE
A. Giatromanolaki, E. Sivridis, G. Stathopoulos, G. Fountzilas, H.P. Kalofonos, A. Tsamandas, E. Vrettou, C. Scopa, A. Polychronidis, K. Simopoulos and M.I. Koukourakis
Antincancer Res. 2001 Jan-Feb;21(1A):253-9
KOMBINIERTE RADIOCHEMOTHERAPIE BEI LOKAL FORTGESCHRITTENEM NASOPHARYNXKARZINOM
J. Daniilidis, J. Constantinidis, G. Fountzilas
HNO. 2001 Sep;49(9):732-8
D.V. Skarlos, E. Samantas, E. Briassoulis, E. Panoussaki, N. Pavlidis, H.P. Kalofonos, D. Kardamakis, E. Tsiakopoulos, P. Kosmidis, D. Tsavdaridis, J. Tzitzikas, P. Tsekeris, G. Kouvatseas, N. Zamboglou & G. Fountzilas
Ann Oncol. 2001 Sep;12(9):1231-8
D. Pectasides, G. Aravantinos, H.P. Kalofonos, C. Kiamouris, D. Bafaloukos, N. Xiros, C. Nicolaides, A. Visvikis & M.A. Dimopoulos
Ann Oncol. 2001 Oct;12(10):1417-22
G. Fountzilas, D. Tsavdaridis, A. Kalogera-Fountzilas, C. Christodoulou, E. Timotheadou, H.P. Kalofonos, P. Kosmidis, A. Adamou, P. Papakostas, H. Gogas, D. Bafaloukos, D. Skarlos
Ann Oncol. 2001 Nov;12(11):1545-51
D. Pectasides, M.A Dimopoulos, G. Aravantinos, H.P. Kalofonos, P. Papakostas, E. Briasoulis, E. Goga, C. Papadimitriou, D. Skarlos, P. Kosmidis, G. Fountzilas
Anticancer Res. 2001 Sep-Oct;21(5):3575-80
PACLITAXEL: EPIRUBICIN IN METASTATIC BREAST CANCER-A REVIEW
E.D. Razis & G. Fountzilas
Ann Oncol. 2001 May;12(5):593-8
A. Giatromanolaki, G.P. Stathopoulos, M.I. Koukourakis, S. Rigatos, E. Vrettou, C. Kittas, G. Fountzilas and E. Sivridis
Am J Clin Oncol. 2001 Jun;24(3):222-6
Δημοσιεύσεις 2002
TEMOZOLOMIDE IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH ADVANCED MELANOMA: A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Bafaloukos D, Gogas H, Georgoulias V, Briassoulis E, Fountzilas G, Samantas E, Kalofonos Ch, Skarlos D, Karabelis A, Kosmidis P
J Clin Oncol. 2002 Jan 15;20(2):420-5
PACLITAXEL AND CARBOPLATIN IN PRETREATED ADVANCED GASTRIC CANCER: A PHASE II STUDY
G.P Stathopoulos, S.K Rigatos, G. Fountzilas, A. Polyzos, J.G Stathopoulos
Oncol Rep. 2002 Jan-Feb;9(1):89-92
PRIMARY TREATMENT OF LOW-GRADE NON-HODGKIN’S LYMPHOMA WITH THE COMBINATION OF FLUDARABINE AND MITOXANTRONE: A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
M.A. Dimopoulos, G. Fountzilas, E. Papageorgiou, C. Kiamouris, G. Mantzios, A. Anagnostopoulos, C. Nicolaides and T. Economopoulos
Leuk Lymphoma. 2002 Jan;43(1):111-4
COMBINATION OF IFOSFAMIDE, PACLITAXEL, AND CICPLATIN FOR THE TREATMENT OF METASTATIC AND RECURRENT CARCINOMA OF THE UTERINE CERVIX: A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
M.A. Dimopoulos, C.A. Papadimitriou, K. Sarris, G. Aravantinos, H.P. Kalofonos, D. Gika, G.M. Gourgoulis, E. Efstathiou, D. Skarlos and D. Bafaloukos
Gynecol Oncol. 2002 Jun;85(3):476-82
A PHASE III STUDY OF 5-FLUOROURACIL VS 5-FLUOROURACIL PLUS INTERERON ALPHA 2b VS 5-FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED COLORECTAL CANCER. A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) STUDY
H.P. Kalofonos, C. Nicolaides, E. Samantas, N. Mylonakis, G. Aravantinos, M.A. Dimopoulos, C. Gennatas, G. Kouvatseas, E. Giannoulis, C. Dervenis, G. Basdanis, N. Pavlidis, I. Androulakis and G. Fountzilas
Am J Clin Oncol. 2002 Feb;25(1):23-30
VINBLASTINE AND INTERFERON-GAMMA COMBINATION WITH AND WITHOUT 13-Cis RETINOIC ACID FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
C. Bacoyiannis, M.A. Dimopoulos, H.P. Kalofonos, C. Nicolaides, G. Aravantinos, D. Bafaloukos, G. Samelis, A. Onyenadum, Ch. Kiamouris, D. Skarlos, N. Pavlidis, A. Triantafillidis, P. Kosmidis
Oncology. 2002;63(2):130-8
TREATMENT OF INTERMEDIATE-AND HIGH-GRADE NON-HODGKIN’S LYMPHOMA USING CEOP VERSUS CNOP. A HELLENIC COOPERATIVE ONCOLOGY GROUP
T. Economopoulos, MA Dimopoulos, S. Mellou, N. Pavlidis, E. Samantas, C. Nicolaides, C. Tsatalas, A. Papadopoulos, E. Papageorgiou, P. Papasavvas, G. Fountzilas
Eur J Haematol. 2002 Mar;68(3):135-43
PROGNOSTIC SIGNIFICANCE OF THE SEQUENTIAL DETECTION OF CIRCULATING MELANOMA CELLS BY RT-PCR IN HIGH-RISK MELANOMA PATIENTS RECEIVING ADJUVANT INTERFERON
H. Gogas, G. Kefala, D. Bafaloukos, K. Frangia, A. Polyzos, D. Pectasides, D. Tsoutsos, P. Panagiotou, J. Joannovich and D. Loukopoulos
Br J Cancer. 2002 Jul 15;87(2):181-6
INTRATUMORAL DOXORUBICIN IN PATIENTS WITH MALIGNANT BRAIN GLIOMAS
S. Voulgaris, M. Partheni, M. Karamouzis, P. Dimopoulos, N. Papadakis and H.P. Kalofonos
Am J Clin Oncol. 2002 Feb;25(1):60-4
PACLITAXEL PLUS CARBOPLATIN VERSUS GEMCITABINE PLUS PACLITAXEL IN ADVANCED NON-SMALL CELL LUNG CANCER: A PHASE III RANDOMIZED TRIAL
P. Kosmidis, N. Mylonakis, C. Nicolaides, H.P. Kalofonos, E. Samantas, J. Boukovinas, G. Fountzilas, D. Skarlos, T. Economopoulos, D. Tsavsaridis, P. Papakostas, C. Bacoyiannis, and M. Dimopoulos
J Clin Oncol. 2002 Sep 1;20(17):3578-85
A CHANGE IN THE LAST BASE OF BRCA1 EXON 23, 5586G -> A, RESULTS IN THE ABNORMAL RNA SPLICING
A. Ladopoulou, I. Konstantopoulou, S. Armaou, E. Efstathiou, M. Mihalatos, G. Nasioulas, G. Bardi, N. Pandis, D. Yannoukakos
Cancer Genet Cytogenet. 2002 Apr 15;134(2):175-7
LYMPHOCYTE SUBPOPULATIONS AND INTERLEUKIN LEVELS IN HIGH-RISK MELANOMA PATIENTS TREATED WITH HIGH-DOSE INTERFERON A-2B
H. Gogas, G. Paterakis, K. Frangia, D. Bafaloukos, D. Pectasides, H.P. Kalofonos, D. Loukopoulos, C. Stavropoulou-Giokas, J. Joannovich and M.C. Mihm Jr
Am J Clin Oncol. 2002 Dec;25(6):591-6
PROGNOSTIC FACTORS IN GREEK PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
C. Christodoulou, N. Pavlidis, E. Samantas, G. Fountzilas, G. Kouvatseas, K. Pagdatoglou, F. Palamidas, C. Nicolaidis, M. Angelidou, H.P. Kalofonos, P. Kosmidis and D.V. Skarlos
Anticancer Res. 2002 Nov-Dec;22(6B):3749-57
TUMOR VOLUMETRY AS PREDICTIVE AND PROGNOSTIC FACTORS IN THE MANAGEMENT OF OVARIAN CANCER
E. Andreopoulou, D. Andreopoulos, C. Adamides, A. Kalogera-Fountzila, G. Fountzilas, M.A. Dimopoulos, G. Aravantinos, N. Zamboglou, D. Baltas, N. Pavlidis
Anticancer Res. 2002 May-Jun;22(3):1903-8
GERM LINE BRCA1 & BRCA2 MUTATION IN GREEK BREAST/OVARIAN CANCER FAMILIES: 5382insC IS THE MOST FREQUENT MUTATION OBSERVED
A.Ladopoulou, C.Kroupis, I.Konstantopoulou, L.Ioannidou-Mouzaka, A.C.Schofield, A.Pantazidis, S.Armaou, I.Tsiagas, E.Lianidou, E.Efstathiou, C.Tsionou, C.Panopoulos, M.Mihalatos, G.Nasioulas D.Skarlos, N.E.Haites G.Fountzilas, N.Pandis D.Yannoukakos
Cancer Lett. 2002 Nov 8;185(1):61-70
NEOADJUVANT CHEMOTHERAPY WITH COMBINATION OF PEGYLATED LPOSOMAL DOXORUBICIN (CAELYX) AND PACLITAXEL IN LOCALLY ADVANCED BREAST CANCER. A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
H.Gogas, C.Papadimitriou, H.P.Kalofonos, D.Bafaloukos, G.Fountzilas, D.Tsavdaridis, A.Anagnostopoulos, A.Onyenadum, P.Papakostas, T.Economopoulos, C.Christodoulou, P.Kosmidis, C.Markopoulos.
Ann Oncol. 2002 Nov;13(11):1737-42
IRINOTECAN AND VINORELBINE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY. A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
D. Pectasides, G. Fountzilas, A. Rigopoulos, N.G. Bountouroglou, A. Koutras, J. Glotsos, A. Onyenadum, Th. Makatsoris, H.P. Kalofonos
Anticancer Res. 2002 Nov-Dec;22(6B):3501-6
DOCETAXEL IN COMBINATION WITH DACARBAZINE IN PATIENTS WITH ADVANCED MELANOMA
D. Bafaloukos, G. Aravantinos, G. Fountzilas, G. Stathopoulos, H. Gogas, G. Samonis, E. Briasoulis, N. Mylonakis, D.V. Skarlos, P. Kosmidis
Oncology. 2002;63(4):333-7
Δημοσιεύσεις 2003
PREVENTION OF ANEMIA IN PATIENTS WITH SOLID TUMORS RECEIVING PLATINUM BASED CHEMOTHERAPY BY RECOMBINANT HUMAN ERYTHROPOIETIN (RHUEPO): A PROSPECTIVE, OPEN LABEL, RANDOMIZED TRIAL BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Bamias, G. Aravantinos, H.P. Kalofonos, N. Timotheadou, V. Siafaka, I. Vlahou, D. Janinis, D. Pectasides, N. Pavlidis, G. Fountzilas
Oncology. 2003;64(2):102-10
ADJUVANT CHEMOTHERAPY USING CPT-11, LEUCOVORIN PLUS BOLUS 5-FLUOROURACIL AND RADIOTHERAPY IN PATIENTS WITH RECTAL CANCER. A FEASIBILITY STUDY
H.P. Kalofonos, D. Kardamakis, A. Bamias, D. Skarlos, P. Papakostas, D. Bafaloukos, A. Sakantamis, N. Pavlidis and G. Fountzilas
Anticancer Res. 2003 Mar-Apr;23(2C):1687-91
RITUXIMAB IN COMBINATION WITH CNOP CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED INDOLENT NON-HODGKIN’S LYMPHOMA
T. Economopoulos, G. Fountzilas, N. Pavlidis, D. Kalantzis, E. Papageorgiou, C. Christodoulou, G. Hamilos, C. Nicolaides and M. Dimopoulos
Hematol J. 2003;4(2):110-5
TREATMENT OF PANCREATIC CANCER WITH A COMBINATION OF IRINOTECAN (CPT-11) AND GEMCITABINE: A MULTICENTER PHASE II STUDY BY THE GREEK COOPERATIVE GROUP FOR PANCREATIC CANCER
G.P. Stathopoulos, S.K. Rigatos, M.A.Dimopoulos, T. Giannakakis, G. Fountzilas, C. Kouroussis, D. Janninis, G. Aravantinos, N. Androulakis, S. Agelaki, J.G. Stathopoulos & V. Georgoulias
Ann Oncol. 2003 Mar;14(3):388-94
PHASE II STUDY OF DOCETAXEL-VINORELBINE IN PLATINUM-RESISTANT,PACLITAXEL-PRETREATED OVARIAN CANCER
G. Aravantinos, D. Bafaloukos, G. Fountzilas, C. Christodoulou, C. Papadimitriou, N. Pavlides, H.P. Kalofonos, H. Gogas, P. Kosmidis, M.A. Dimopoulos
Ann Oncol. 2003 Jul;14(7):1094-9
RITUXIMAB IN COMBINATION WITH VINORELBINE / GEMCITABINE CHEMOTHERAPY IN PATIENTS WITH PRIMARY REFRACTORY OR EARLY RELAPSED T CELL RICH B CELL LYMPHOMA. A PILOT STUDY
N. Xiros, T. Economopoulos, S. Valsami, D. Rontogianni, G. Fountzilas, S. Raptis
Leuk Res. 2003 Dec;27(12):1097-9
CONTINUATION OF TRASTUZUMAB BEYOND DISEASE PROGRESSION IS SAFE AND EFFECTIVE IN PATIENTS WITH ADVANCED BREAST CANCER
G. Fountzilas, E. Razis, D. Tsavdaridis, M. Karina, S. Lambropoulos, C. Christodoulou, D. Mavroudis, H. Gogas, V. Georgoulias, D. Skarlos
Clin Breast Cancer. 2003 Jun;4(2):120-5
TREATMENT OF INTERMEDIATE AND ADVANCED STAGE HODGKIN’S DISEASE WITH MODIFIED BASELINE BEACOPP REGIMEN: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
T. Economopoulos, G. Fountzilas, M.A. Dimopoulos, S. Papageorgiou, N. Xiros, D. Kalantzis, J. Dervenoulias, S. Raptis
Eur J Hematol 2003 Oct;71(4):257-62
DOCETAXEL AND GEMCITABINE COMBINATION, AS FIRST-LINE TREATMENT, IN PATIENTS WITH EXTENSIVE DISEASE SMALL-CELL LUNG CANCER. A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
D.V.Skarlos, A. M. Dimopoulos, P. Kosmidis, P. Papakostas, N. Pavlidis, C. Bacoyiannis, C. Kiamouris, G. Klouvas, H. Gogas, G. Fountzilas, E. Samantas
Lung Cancer. 2003 Jul;41(1):107-11
NOVEL MUTATIONS OF THE APC GENE IN FAMILIAL ADENOMATOUS POLYPOSIS IN GREEK PATIENTS
M.Mihalatos, I.Danielides, J.Belogianni, E.Harokopos, E.Papadopoulou, G.Kalimanis, M.Tsiava, J.K.Triantafillidis, P.A.Kosmidis, G.Fountzilas, G.Basdanis, N.J.Agnantis, D.Yannoukakos, G.Nasioulas
Cancer Genet Cytogenet. 2003 Feb;141(1):65-70
THE ROLE OF TAXANES AS SINGLE-AGENTS OR IN COMBINATION WITH ANTHRACYCLINES IN NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER. A REVIEW
H.Gogas, G.Fountzilas
Ann Oncol 2003; 14(5): 667-674
USEFULNESS OF TUMOR VOLUMETRY AS A PROGNOSTIC FACTOR OF SURVIVAL IN HEAD AND NECK CANCER
R.Kurek, A.Kalogera-Fountzila, K.Muskalla, U.Dafni, T.Schnabel, B.Kober, S.Roddiger, T.Martin, G.Fountzilas, N.Zamboglou
Strahlenther Onkol. 2003 May;179(5):292-7
TECHNOLOGY EVALUATION : TRIGEM, TITAN
E.Razis, G.Fountzilas
Curr Opin Mol Ther. 2003 Apr;5(2):204-7
EVALUATION OF dHPLC IN MUTATION SCREENING OF THE APC GENE IN A GREEK FAP COHORT
M.Mihalatos, A.Apessos, J.Triantafillidis, P.A.Kosmidis, G.Fountzilas, N.J.Agnantis, D.Yannoukakos, G.Nasioulas
Anticancer Res. 2003 May-Jun;23(3B):2691-5
TWO-CYCLES OF CARBOPLATIN-BASED ADJUVANT CHEMOTHERAPY FOR HIGH-RISK CLINICAL STAGE I AND STAGE IM NON-SEMINOMATOUS GERM CELL TUMOURS OF THE TESTIS: A HECOG TRIAL
D. Pectasides, D. Skarlos, A.M. Dimopoulos, D. Farmakis, M. Pectasides, G. Fountzilas, G. Aravantinos
Anticancer Res. 2003 Sep-Oct;23(5b):4239-44
GENETIC ALTERATIONS OF THE APC GENE IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS OF THE HELLENIC GROUP FOR THE STUDY OF COLORECTAL CANCER
M. Mihalatos, A. Apessos, E. Papadopoulou, N.J. Agnantis, D. Yannoukakos, G. Fountzilas, G. Nasioulas
Anticancer Res. 2003 May-Jun;23(3A):2191-3
RECOMBINANT HUMAN ERYTHROPOIETIN FOR PLATINUM-BASED CHEMOTHERAPY-INDUCED ANAEMIA: A SINGLE-CENTRE RANDOMISED STUDY
G. Aravantinos, H. Linardou, D. Makridaki, E. Laiou, A. Zafiropoulos, J. Janninis, G. Sofos, D. Gikas, E. Samantas, S. Markantoni-Kyroudi
J BUON. 2003 Apr-Jun;8(2):127-32
THE COMBINATION OF ESTRAMUSTINE AND MITOXANTRONE IN HORMONE-REFRACTORY PROSTATE CANCER: A PHASE II FEASIBILITY STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G.F. Samelis, D. Skarlos, D. Bafaloukos, P. Kosmidis, A. Anagnostopoulos, G. Aravantinos, M.A. Dimopoulos
Urology. 2003 Jun;61(6):1211-5
A PHASE II STUDY WITH CPT-11 PLUS LEUCOVORIN AND BOLUS IV 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMA
H.P. Kalofonos, D. Skarlos, D. Bafaloukos, P. Papakostas, A. Bamias, J. Janinis, E. Timotheadou, G. Kouvatseas, M. Stavropoulou, T. Economopoulos, G. Fountzilas
Cancer Invest. 2003;21(6):855-62
PROGNOSTIC SIGNIFICANCE OF CA 125, CD44 AND EPITHELIAL MEMBRANE ANTIGEN IN RENAL CELL CARCINOMA
Bamias, M. Chorti, C. Deliveliotis, N. Trakas, A. Skolarikos, B. Protogerou, S. Legaki, G. Tsakalou, N. Tamvakis and M.A. Dimopoulos
Urology. 2003 Aug;62(2):368-73
Δημοσιεύσεις 2004
ADJUVANT CYTOTOXIC AND ENDOCRINE THERAPY IN PRE- AND POST MENOPAUSAL PATIENTS WITH BREAST CANCER AND 1-9 INFILTRATED NODES: 5 YEAR RESULRS OF HeCOG RANDOMISED HE 10/92 STUDY
G.Fountzilas, G.Stathopoulos, G.Kouvatseas, A.Polychronis, G.Klouvas, E.Samantas, N.Zamboglou, K.Kyriakou, A.Adamou, D.Pectasidis, Th.Ekonomopoulos, Ch.Kalofonos, D.Bafaloukos, V.Georgoulias, E.Razi, D.Koukouras, V.Zombolas, P.Kosmidis, D.Skarlos, N.Pavlidis
Am J Clin Oncol. 2004 Feb;27(1):57-67
CONCOMITANT RADIO-CHEMOTHERAPY VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH HEAD AND NECK CANCER. A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE III STUDY
G.Fountzilas, E.Ciuleanu, U.Dafni, G.Plataniotis, A.Kalogera-Fountzila, E.Samantas, E.Athanassiou, J.Tzitzikas, T.Ciuleanu, A.Nikolaou, P.Pantelakos, T.Zaraboukas, N.Zamboglou, J. Daniilidis, N. Ghilezan
Med Oncol. 2004;21(2):95-107
PACLITAXEL AND EPIRUBICIN VERSUS PACLITAXEL AND CARBOPLATIN, AS FIRST LINE CHEMOTHERAPY, IN PATIENTS WITH ADVANCED BREAST CANCER. A PHASE III STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G. Fountzilas, H.P. Kalofonos, U. Dafni, C. Papadimitriou, D. Bafaloukos, P. Papakostas, A. Kalogera-Fountzila, H. Gogas, G. Aravantinos, L.A. Moulopoulos, T. Economopoulos, D. Pectasides, N. Maniadakis, V. Siafaka, E. Briasoulis, C. Christodoulou, D. Tsavdaridis, P. Makrantonakis, E. Razis, P. Kosmidis, D. Skarlos, M.A. Dimopoulos
Ann Oncol.2004 Oct;15(10):1517-26
PACLITAXEL AND GEMCITABINE, AS FIRST LINE CHEMOTHERAPY, COMBINED WITH TRASTUZUMAB IN PATIENTS WITH ADVANCED BREAST CANCER
G. Fountzilas, C. Christodoulou, D. Tsavdaridis, A. Kalogera-Fountzila, G. Aravantinos, E. Razis, J. Kostopoulos, H.P. Kalofonos, P. Papakostas, M. Karina, H. Goga, D. Skarlos.
Cancer Invest. 2004;22(5):655-62
SECOND LINE CHEMOTHERAPY WITH 5-FLUOROURACIL AND VINORELBINE IN ANTHRACYCLINE AND TAXANE PRETREATED PATIENTS WITH METASTATIC BREAST CANCER
E.Razis, P.Kosmidis, G.Aravantinos, C.Bacoyiannis, J.Janninis, H.Timotheadou, C.Christodoulou, G.Fountzilas
Cancer Invest. 2004;22(1):10-5
CONTINUATION OF TRASTUZUMAB BEYOND DISEASE PROGRESSION: MORE QUESTIONS THAN ANSWERS
E.Razis, G.Fountzilas.
Clin Br Cancer 2004;5:59-62
DOCETAXEL AND CISPLATIN WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) VERSUS M-VAC WITH G-CSF IN ADVANCED UROTHELIAL CARCINOMA: A MULTICENTER, RANDOMISED, PHASE III SUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Α. Bamias, G. Aravantinos, Ch. Deliveliotis, D. Bafaloukos, H.P. Kalofonos, N. Xiros, A. Zervas, D. Mitropoulos, E. Samantas, D. Pectasides, P. Papakostas, D. Gika, C. Kourousis, A. Koutras, C. Papadimitriou, C. Bamias, P. Kosmidis, M.A. Dimopoulos
J. Clin Oncol. 2004 Jan 15;22(2):220-8
ADJUVANT CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED CARCINOMA OF THE UPPER URINARY TRACT. A STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
A. Bamias, Ch. Deliveliotis, G. Fountzilas, D. Gika, A. Anagnostopoulos, M.P. Zorzou, E. Kastritis, C. Konstantindis, P. Kosmidis, M.A. Dimopoulos.
J Clin Oncol. 2004 Jun 1;22(11):2150-4
ADJUVANT CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED BLADDER CANCER: A STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
A.Bamias, Ch.Deliveliotis, G.Aravantinos, H.P.Kalofonos, A. Karayiannis, M.A. Dimopoulos
J Urol. 2004 Apr;171(4):1467-70
INTENSIFIED BIMONTHLY CISPLATIN WITH BOLUS 5-FLUOROURACIL, CONTINUOUS 5-FLUOROURACIL AND HIGH DOSE LEUCOVORIN (LV5FU2) IN PATIENTS WITH ADVANCED GASTROINTESTINAL CARCINOMAS: A PHASE I DOSE-FINDING AND PHARMACOKINETIC STUDY
A. Bamias, K. Syrigos, G. Fountzilas, E. Tzamakou, K. Soulti, V. Karavasilis, Y. Alamanos, C. Christodoulou, N. Pavlidis
Am J Clin Oncol. 2004 Oct;27(5):465-71
SECOND-LINE CHEMOTHERAPY WITH GEMCITABINE AND CARBOPLATIN IN PACLITAXEL PRETREATED, PLATINUM-SENSITIVE OVARIAN CANCER PATIENTS
Ch.A. Papadimitriou, G. Fountzilas, G. Aravantinos, Ch. Kalofonos, L.A. Moulopoulos, E. Briassoulis, D. Gika, M-A. Dimopoulos
Gynecol Oncol. 2004 Jan;92(1):152-9
GEMCITABINE AND OXALIPLATIN (GEMOX) IN PATIENTS WITH CISPLATIN-REFRACTORY GERM CELL TUMORS. A PHASE II STUDY
D. Pectasides, M. Pectasides, D. Farmakis, G. Aravantinos, M. Nikolaou, M. Koumpou, A. Gaglia, V. Kostopoulou, N. Mylonakis, D. Skarlos
Ann Oncol. 2004 Mar;15(3):493-7
FRONT-LINE TREATMENT OF INOPERABLE OR METASTATIC PANCREATIC CANCER WITH GEMCITABINE AND CAPECITABINE: AN INTERGROUP, MULTICENTER, PHASE II STUDY
G. P. Stathopoulos, K. Syrigos, A. Polyzos, G. Fountzilas, S. K. Rigatos, N. Ziras, A. Potamiannou, I. Tsiakopoulos, N. Androulakis, G. Aravantinos, A. Athanasiadis, P. Papakotoulas, V. Georgoulias
Ann Oncol. 2004 Feb;15(2):224-9
PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE(PLD) AND PACLITAXEL IN RECURRENT OR METASTATIC HEAD AND NECK CARCINOMA: A PHASE I/II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
J. Janinis, G.P. Stathopoulos, P. Nikolaidis, H.P. Kalofonos, A. Kalogera-Fountzila, E. Samantas, G. Aravantinos, A. Anagnostopoulos, C. Tolis, T. Makatsoris, S.K. Rigatos, D. Bafaloukos, M.A. Dimopoulos, J. Daniilidis, G. Fountzilas
Anticancer Drugs. 2004 Jun;15(5):479-87
PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA. CLINICAL STUDY OF A DISTINCT CLINICAL ENTITY AND TREATMENT
E. Andreopoulou, D. Pectasides, M.A.D imopoulos, C. Nicolaides, G. Fountzilas, S. Valsami, T. Economopoulos
Am J Clin Oncol. 2004 Jun;27(3):312-6
THE PROGNOSTIC IMPACT OF TUMOR VOLUMENTRY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS (NON-NASOPHARYNGEAL) TREATED EITHER BY BY RADIOTHERAPY ALONE OR BY COMBINED RADIOCHEMOTHERAPY IN A RANDOMIZED TRIAL
A.G. Plataniotis, M-E. Theofanopoulou, A. Kalogera-Fountzila, A.A. Haritanti, E. Ciuleanou, N. Ghilezan, N. Zamboglou, A. Dimitriadis I. Sofroniadis, G. Fountzilas
Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1018-26
TOLERABILITY OF ADJUVANT HIGH-DOSE INTERFERON ALFA-2b: 1 MONTH VERSUS 1 YEAR. A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
H. Gogas, D. Bafaloukos, J. Ioannovich, D. karlos, A. Polyzos, G. Fountzilas, H.P. Kalofonos, G. Aravantinos, D. Tsoutsos, P. Panagiotou, K. Frangia, T. Petrakopoulou, D. Pectasides
Anticancer Res. 2004 May-Jun;24(3b):1947-52
VINORELBINE IN COMBINATION WITH INTERLEUKIN-2 AS SECOND LINE TREATMENT IN PATIENTS WITH METASTATIC MELANOMA. A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
H.Gogas, D.Bafaloukos, G.Aravantinos, G.Fountzilas, D.Tsoutsos, P.Panagiotou, K.Frangia, H.P.Kalofonos, E.Briasoulis, O.Castana, A.Polyzos, D. Pectasides, J.Ioannovich
Cancer Invest. 2004;22(6):832-9
CAVITATING SQUAMOUS CELL LUNG CARCINOMA-DISTINCT ENTITY OR NOT? ANALYSIS OF RADIOLOGICAL, HISTOLOGICAL AND CLINICAL FEATURES
G.Pentheroudakis, L.Kostadima, G.Fountzilas, A.Kalogera-Fountzila, G.Klouvas, C.Kalofonos, N.Pavlidis
Lung Cancer. 2004 Sep;45(3):349-55
METASTATIC BREAST CARCINOMA CONFINED TO BONE: PORTRAIT OF A CLINICAL ENTITY
E. Briasoulis, V. Karavasilis, L. Kostadima, M. Ignatiadis, G. Fountzilas, N. Pavlidis
Cancer. 2004 Oct 1;101(7):1524-8
BIWEEKLY ADMINISTRATION OF 24-h INFUSION OF IRINOTECAN FOLLOWED BY A 1-h INFUSION OF DOCETAXEL: A PHASE I STUDY
E. Briasoulis, G. Pentheroudakis, H. Timotheadou, D. Rammou, N. Pavlidis, G.Fountzilas
Anticancer Drugs. 2004 Sep;15(8):747-52
COMBINATION OF PEGYLATED LIPOSOMAL DOXORUBICIN (PLD)AND PACLITAXEL IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA: A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
D. Bafaloukos, C. Papadimitriou, H. Linardou, G. Aravantinos, P. Papakostas, D. Skarlos, P. Kosmidis, G. Fountzilas, H. Gogas, C. Kalofonos, A.M. Dimopoulos
Br J Cancer. 2004 Nov 1;91(9):1639-44
THE EFFECT OF TEMOZOLOMIDE-BASED CHEMOTHERAPY IN PATIENTS WITH CEREBRAL METASTASES FROM MELANOMA
D. Bafaloukos, D. Tsoutsos, G. Fountzilas, H. Linardou, C. Christodoulou, H.P. Kalofonos, E. Briassoulis, P. Panagiotou, H. Hatzichristou, H. Gogas
Melanoma Res. 2004 Aug;14(4):289-94
THE TREATMENT OF BRAIN METASTASES IN MELANOMA PATIENTS
D. Bafaloukos, H. Gogas
Cancer Treatment Rev. 2004 Oct;30(6):515-20
GEMCITABINE AND CARBOPLATIN COMBINATION AS FIRST-LINE TREATMENT IN ELDERLY AND UNFIT FOR CISPLATIN-BASED CHEMOTHERAPY PATIENTS WITH ADVANCED BLADDER CARCINOMA. A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
H. Linardou, G. Aravantinos, E. Efstathiou, H. Kalofonos, A. Anagnostopoulos, C. Deliveliotis, D. Bafaloukos, M.A. Dimopoulos, A. Bamias
Urology. 2004 Sep;64(3):479-84
THE PREVALENCE OF HEPATITIS C AND HEPATITIS G VIRUS INFECTION IN PATIENTS WITH NON-HODGKIN LYMPHOMA IN GREECE
E. Giannoulis, K. Mandraveli, K. Giannoulis, C. Nikolaides, E. Zervou, E. Papageorgiou, D. Zoulias, A. Tourkantonis, T. Economopoulos, G.Fountzilas
Acta Hematol. 2004;112(4):189-93
SERUM LEVELS OF bcl-2 IN PATIENTS WITH COLORECTAL CANCER
K. Giannoulis, G. Fountzilas, N. Angouridakis, C. Angouridaki, E. Giannoulis, O. Gamvros
Tech Coloprocto. 2004 Nov;8 Suppl 1:s56-8
SERUM CONCENTRATIONS OF SOLUBLE ICAM-1 AND VCAM-1 IN PATIENTS WITH COLORECTAL CANCER. CLINICAL IMPLICATIONS
K. Giannoulis, C. Angouridaki, G. Fountzilas, C. Papapolychroniadis, E. Giannoulis, O. Gamvros.
Tech Coloproctol. 2004 Nov;8 Suppl 1:s65-7
CHARACTERIZATION OF A NOVEL LARGE DELETION AND SINGLE POINT MUTATIONS IN THE BRCA1 GENE IN A GREEK COHORT OF FAMILIES WITH SUSPECTED HEREDITARY BREAST CANCER
Ι. Belogianni, A. Apessos, M. Mihalatos, E. Razis, S. Labropoulos, A. Petounis, V. Gaki, A. Karamopoulos, N. Pandis, K. Kyriacou, A. Hadjisavas, P. Kosmidis, D. Yannoukakos, G. Nasioulas
BMC Cancer. 2004 Sep 7;4:61
ADRIAMYCIN AND CISPLATINUM AS FIRST LINE TREATMENT IN UNRESECTABLE LOCALLY ADVANCED OR METASTATIC ADULT SOFT TISSUE SARCOMAS
H.P. Kalofonos, D. Bafaloukos, T.G. Kourelis, M.V. Karamouzis, P. Megas, G. Iconomou, E. Tsiata, D. imitropoulos, P. Kosmidis and E. Lampiris
Am J Clin Oncol. 2004 Jun;27(3):307-11
Δημοσιεύσεις 2005
TEMOZOLOMIDE (TMZ) COMBINED WITH CISPLATIN (CDDP) IN PATIENTS WITH BRAIN METASTASES FROM SOLID TUMORS: A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) PHASE II STUDY
C. Christodoulou, D. Bafaloukos, H. Linardou, G. Aravantinos, A. Bamias, M. Carina, G. Klouvas, D. Skarlos
J Neurooncol. 2005 Jan;71(1):61-5
POSTOPERATIVE DOSE-DENSE SEQUENTIAL CHEMOTHERAPY WITH EPIRUBICIN, FOLLOWED BY CMF WITH OR WITHOUT PACLITAXEL, IN PETIENTS WITH HIGH-RISK OPERABLE BREAST CANCER: A RANDOMIZED PHASE III STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G. Fountzilas, D. Skarlos, U. Dafni, H. Gogas, E. Briasoulis, D. Pectasides, Ch. Papadimitriou, Ch. Markopoulos, A. Polychronis, H.P. Kalofonos, V. Siafaka, P. Kosmidis, E. Timotheadou, D. Tsavdaridis, D. Bafaloukos, P. Papakostas, E. Razis, P. Makrantonakis, G. Aravantinos, Ch. Christodoulou, A. M. Dimopoulos
Ann Oncol 2005 Nov;16(11):1762-71
CHEMOTHERAPY FOR PATIENTS WITH TWO FAVOURABLE SUBSETS OF UNKNOWN PRIMARY CARCINOMA: ACTIVE, BUT HOW EFFECTIVE?
G. Pentheroudakis, E. Briassoulis, V. Karavassilis, G. Fountzilas, N. Xiros, G. Samelis, E. Samantas & N. Pavlidis
Acta Oncol. 2005;44(2):155-60
ADVANCED STAGE MUCINOUS EPITHELIAL dOVARIAN CANCER: THE HELLENIC COOPERATIVE ONCOLOGY GROUP EXPERIENCE
D. Pectasides, G. Fountzilas, G. Aravantinos, H.P. Kalofonos, E. Efstathiou, E. Salamalekis, D. Farmakis, D. Skarlos, E. Briasoulis, Th. Economopoulos, M.A. Dimopoulos
Gynecol Oncol. 2005 May;97(2):436-41
NON-HODGKIN’S LYMPHOMA IN GREECE ACCORDING TO THE WHO CLASSIFICATION OF LYMPHOID NEOPLASMS. A RETROSPECTIVE ANALYSIS OF 810 CASES
T. Economopoulos, S. Papageorgiou, M.A. Dimopoulos, N. Pavlidis, C. Tsatalas, A. Symeonidis, A. Foudoulakis, D. Pectasides, D. Rontogianni, E. Rizos, P. Chalkia, A. Anagnostopoulos, M. Melachrinou, E. Papageorgiou, G. Fountzilas
Acta Haematol. 2005;113(2):97-103
TREATMENT OF NON-SMALL CELL LUNG CANCER WITH GEFITINIB (“IRESSA”, ZD1839): THE GREEK EXPERIENCE WITH A COMPASSIONATE-USE PROGRAM
E. Razis, D. Skarlos, E. Briasoulis, M. Dimopoulos, G. Fountzilas, S. Lambropoulos, S. Rigatos, P. Kopterides, H. Efstathiou, E. Tzamakou, C. Bakoyannis, D. Pectasides, T. Makatsoris, G. Varthalitis, S. Papadopoulos and P. Kosmidis
AntiCancer Drugs. 2005 Feb;16(2):191-8
IRINOTECAN OR OXALIPLATIN COMBINED WITH LEUCOVORIN AND 5-FLUOROURACIL AS FIRST-LINE TREATMENT IN ADVANCED COLORECTAL CANCER: A MULTICENTER, RANDOMIZED, PHASE II STUDY
H.P. Kalofonos, G. Aravantinos, P. Kosmidis, P. Papakostas, T. Economopoulos, M. Dimopoulos, D. Skarlos, A. Bamias, D. Pectasides, S. Chalkidou, M. Karina, A. Koutras, E. Samantas, C. Bacoyiannis, G.F. Samelis, G. Basdanis, F. Kalfarentzos and G. Fountzilas
Ann Oncol. 2005 Jun;16(6):869-77
PACLITAXEL, CISPLATIN, LEUCOVORIN, AND CONTINUOUS INFUSION FLUOROURACIL FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE II STUDY
G. Fountzilas, C. Tolis, A. Kalogera-Fountzila, D. Misailidou, P. Tsekeris, M. Karina, A. Nikolaou, E. Samantas, T. Makatsoris, E. Athanassiou, D. Skarlos, A. Bamias, N. Zamboglou, T. Economopoulos, S. Karanastassi, N. Pavlidis, and J. Daniilidis
Med Oncol. 2005;22(3):269-79
A PHASE II STUDY OF CAPECITABINE PLUS OXALIPLATIN (XELOX). A NEW FIRST-LINE OPTION IN METASTATIC COLORECTAL CANCER
T. Makatsoris, H.P. Kalofonos, G. Aravantinos, C. Papadimitriou, E. Kastritis, S. K. Rigatos, N. Xiros, T. Petsas, T. Economopoulos, A.K. Sakadamis, and G. Fountzilas
Int J Gastrointest Cancer. 2005;35(2):103-9
PROGNOSTIC FACTORS IN PATIENTS WITH COLORECTAL CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR CHEMORADIOTHERAPY. A POOLED ANALYSIS OF TWO RANDOMIZED STUDIES
Bamias, G. Basdanis, I. Xanthakis, N. Pavlidis, and G. Fountzilas
Int J Gastrointest Cancer. 2005;36(1):29-38
ANGIOGENESIS IN CANCER OF UNKNOWN PRIMARY: CLINICOPATHOLOGICAL STUDY OF CD34, VEGF AND TSP-I
V. Karavasilis, V. Malamou-Mitsi, E. Briassoulis, E. Tsanou, E. Kitsou, H. P. Kalofonos, G. Fountzilas, T. Fotsis and N. Pavlidis
BMC Cancer. 2005 Mar 3;5:25
PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY COMBINED WITH GEFITINIB (IRESSA) IN PATIENTS WITH ADVANCED BREAST CANCER: A PHASE I/II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G. Fountzilas, D. Pectasides, A. Kalogera-Fountzila, D. Skarlos, H.P. Kalofonos, C. Papadimitriou, D. Bafaloukos, S. Lambropoulos, S. Papadopoulos, H. Kourea, C. Markopoulos, H. Linardou, D. Mavroudis, E. Briasoulis, N. Pavlidis, E. Razis, P. Kosmidis and H. Gogas
Breast Cancer Res Treat. 2005 Jul;92(1):1-9
INDUCTION CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN, AND PACLITAXEL (CEP), FOLLOWED BY CONCOMITANT RADIOTHERAPY AND WEEKLY PACLITAXEL FOR THE MANAGEMENT OF LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA. A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE II STUDY
G. Fountzilas, C. Tolis, A. Kalogera-Fountzila, C. Karanikiotis, M. Bai, D. Misailidou, E. Samantas, E. Athanassiou, D. Papamichael, P. Tsekeris, N. Catodritis, A. Nicolaou, G. Plataniotis, T. Makatsoris, P. Papakostas, N. Zamboglou, J. Daniilidis
Strahlentherapie Onkol. 2005 Apr;181(4):223-30
GEMCITABINE PLUS PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER RESISTANT/REFRACTORY TO PLATINUM AND/OR TAXANES. A HeCOG PHASE II STUDY
D. Skarlos, H.P. Kalofonos, G. Fountzilas, M.A. Dimopoulos, N. Pavlidis, E. Razis, T. Economopoulos, D. Pectasides, H. Gogas, P. Kosmidis, D. Bafaloukos, G. Klouvas, G. Kyratzis and G. Aravantinos
Anticancer Res. 2005 Jul-Aug;25(4):3103-8
IRINOTECAN AND OXALIPLATIN COMBINATION, AS SECOND-LINE TREATMENT, IN FLUOROPYRIMIDINE-PRETREATED ADVANCED COLORECTAL CANCER. A PHASE II STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
E. Timotheadou, P. Papakostas, D. Tsavdaridis, G. Basdanis, H. Kalofonos, G. Aravantinos, D. Bafaloukos and G. Fountzilas
Tumori. 2005 Jul-Aug;91(4):309-13
TEMOZOLOMIDE AND CISPLATIN VERSUS TEMOZOLOMIDE IN PATIENTS WITH ADVANCED MELANOMA: A RANDOMIZED PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
D. Bafaloukos, D. Tsoutsos, H. Kalofonos, S. Chalkidou, P. Panagiotou, E. Linardou, E. Briassoulis, E. Efstathiou, A. Polyzos, G. Fountzilas, C. Christodoulou, C. Kouroussis, T. Iconomou, H. Gogas
Ann Oncol. 2005 Jun;16(6):950-7
THE COMBINATION OF ESTRAMUSTINE, VINORELBINE, AND MITOXANTRONE IN HORMONE-REFRACTORY PROSTATE CANCER: A PHASE II FEASIBILITY STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G.F. Samelis, H.P. Kalofonos, A. Adamou, P. Kosmidis, D. Skarlos, G. Aravantinos, C. Kiamouris, A. Onyenadum, G. Fountzilas and A.M. Dimopoulos
Urology. 2005 Aug;66(2):382-5
MATRIX METALLOPROTEINASES IN CARCINOMA OF UNKNOWN PRIMARY
V. Karavasilis, V. Malamou-Mitsi, E. Briasoulis, E. Tsanou, E. Kitsou, H. Kalofonos, G. Fountzilas, T. Fotsis, PN. avlidis
Cancer. 2005 Nov 15;104(10):2282-7
A PHASE II STUDY OF THE DOCETAXEL-IFOSFAMIDE-CARBOPLATIN COMBINATION IN ADVANCED NON-SMALL-CELL LUNG CANCER
C. Kosmas, N. Tsavaris, A. Koutras, T. Makatsoris, N. Mylonakis, G. Tzelepis, A. Dimitrakopoulos, K. Spyropoulos, A. Polyzos, A. Karabelis, H.P. Kalofonos
Oncology. 2005;69(4):333-41
CARBOPLATIN PLUS GEMCITABINE IN PATIENTS WITH INOPERABLE OR METASTATIC PANCREATIC CANCER: A PHASE II MULTICENTER STUDY BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
N. Xiros, P. Papacostas, T. Economopoulos, G. Samelis, E. Efstathiou, E. Kastritis, H. Kalofonos, A. Onyenadum, D. Skarlos, A. Bamias, H. Gogas, D. Bafaloukos, E. Samantas, P. Kosmidis
Ann Oncol. 2005 May;16(5):773-9
PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL PLUS ALTERNATING CARBOPLATIN AND CISPLATIN FOR INITIAL TREATMENT OF ADVANCED OVARIAN CANCER: LONG-TERM EFFICACY RESULTS: A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) STUDY
G. Aravantinos, G. Fountzilas, P. Kosmidis, M.A Dimopoulos, G.P Stathopoulos, N. Pavlidis, D. Bafaloukos, C. Papadimitriou, S. Karpathios, V. Georgoulias, P. Papakostas, H.P Kalofonos, E. Grimani, D.V Skarlos
Ann Oncol. 2005 Jul;16(7):1116-22
BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER. THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) EXPERIENCE AND REVIEW OF THE LITERATURE
D. Pectasides, G. Aravantinos, G. ountzilas, C. Kalofonos, E. Efstathiou, M. Karina, N. Pavlidis, D. Farmakis, T. Economopoulos, M.A Dimopoulos
Anticancer Res. 2005 Sep-Oct;25(5):3553-8
PHASE I STUDY OF ETOPOSIDE, CISPLATIN, AND IRINOTECAN TRIPLET IN PATIENTS WITH ADVANCED-STAGE SMALL-CELL LUNG CANCER
E. Briasoulis, E. Samantas, H. Kalofonos, D. Skarlos, T. Makatsoris, C. Christodoulou, G. Fountzilas, A. Bamias, MA. Dimopoulos, P. Kosmidis, N. Pavlidis. Cancer Chemother Pharmacol. 2005 Nov;56(5):521-8
MULTIFOCAL EXTRANODAL NON-HODGKIN LYMPHOMA: A CLINICOPATHOLOGIC STUDY OF 37 CASES IN GREECE
T. Economopoulos, S. Papageorgiou, D. Rontogianni, V. Kaloutsi, G. Fountzilas, C. Tsatalas, N. Pavlidis, D. Pectasides, E. Papageorgiou, M. Dimopoulos
The Oncologist. 10(9): 734-8, 2005
hMSH2 IS THE MOST COMMONLY MUTATED MMR GENE IN A COHORT OF GREEK HNPCC PATIENTS
A Apessos, M Mihalatos, I Danielidis, G Kallimanis, NJ Agnantis, JK Triantafillidis, G Fountzilas, PA Kosmidis, E Razis, VA Georgoulias and G Nasioulas
Br J Cancer. 2005 Jan 31;92(2):396-404
CLINICAL AND MOLECULAR PROGNOSTIC FACTORS IN OPERABLE LARYNGEAL CANCER
K. Vlachtsis, A. Nikolaou, K. Markou, G. Fountzilas, I. Daniilidis
Eur Arch Otorhinolaryngol. 2005 Nov;262(11):890-8
Δημοσιεύσεις 2006
PROGNOSTIC SIGNIFICANCE OF AUTOIMMUNITY DURING TREATMENT OF MELANOMA WITH INTERFERON ALFA-2b
H. Gogas, J. Ioannovich, U. Dafni, C. Stavropoulou-Giokas, K. Frangia, D. Tsoutsos, P. Panagiotou, A. Polyzos, O. Papadopoulos, A. Stratigos, C. Markopoulos, D. Bafaloukos, D. Pectasides, G. Fountzilas, J.M. Kirkwood
N Engl J Med 2006 Feb 16;354(7):709-18
COMBINATION OF TOPOTECAN AND CISPLATIN IN RELAPSED PATIENTS WITH SMALL CELL CANCER: A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
C. Christodoulou, H.P. Kalofonos, E. Briasoulis, D. Bafaloukos, T. Makatsoris, A. Koutras, D.V. Skarlos, E. Samantas.
Cancer Chemother Pharmacol. 2006 Jan;57(2):207-12 (Epub 2005 Jul 19)
MUTATIONS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN AND ASSOCIATIONS WITH
CLINICOPATHOLOGICAL FEATURES IN NON-SMALL CELL LUNG CANCER PATIENTS
S.Murray, E.Timotheadou, H.Linardou, AV.Vrettou, I.Kostopoulos, J.Skrickova, C.Papakostantinou, C.Christodoulou, D.Pectasides, E.Samantas, P.Papakostas, D.V.Skarlos, P.Kosmidis, G.Fountzilas.
Lung Cancer. 2006 May;52(2):225-33 (Epub 2006 Mar 29)
PACLITAXEL-CARBOPLATIN COMBINATION CHEMOTHERAPY IN ADVANCED BREAST CANCER. ACCUMULATIING EVIDENCE FOR SYNERGY, EFFICACY AND SAFETY
G. Pentheroudakis, E. Razis, A. Athanassiadis, N. Pavlidis and G. Fountzilas
Med Oncol. 2006;23(2):147-60
COMBINATION DOCETAXEL (TAXOTERE), FLUOROURACIL AND LEUCOVORIN (TFL), AS FIRST LINE CHEMOTHERAPY, IN ADVANCED GASTRIC CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE II STUDY
P. Papakostas, D. Tsavdaridis, P. Kosmidis, H.P. Kalofonos, A. Sakantamis, D. Janinis, D. Skarlos, D. Bafaloukos, A. Bamias, N. Xiros, G. Fountzilas.
Gastric Cancer. 2006;9(1):26-31
EVALUATION OF THE PROGNOSTIC VALUE OF HER-2 AND VEGF IN BREAST CANCER PATIENTS PARTICIPATING
IN A RANDOMIZED STUDY WITH DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY
I. Kostopoulos, P. Arapantoni-Dadioti, H. Gogas, S. Papadopoulos, V. Malamou-Mitsi, C.D. Scopa, S. Markaki, E. Karagianni, V. Kyriakou, A. Margariti, E. Kyrkou, K. Pavlakis, T. Zaramboukas, A. Skordalaki, A. Bourli, C. Markopoulos, D. Pectasides, M.A. Dimopoulos, D. Skarlos, G. Fountzilas
Breast Cancer Res. Treat. 2006 Apr;96(3):251-61
ELDERLY PATIENTS WITH SQUAMOUS LUNG CARCINOMA: FARING BETTER OR WORSE?
G. Pentheroudakis, K. Neanidis, L. Kostadima, G. Fountzilas, N. Pavlidis
Support Care Cancer. 2006 Aug;14(8):867-70
THE COMBINATION OF GEMCITABINE AND CARBOPLATIN AS FIRST-LINE TREATMENT IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA
A. Bamias, L.AA Moulopoulos, A. Koutras, G. Aravantinos, G. Fountzilas, D. Pectasides, E. Kastritis, D. Gika, D. Skarlos, H. inardou, H.P. Kalofonos, M.A. Dimopoulos
Cancer. 2006 Jan 15;106(2):297-303
EXPRESSION OF p27KIP1, p21WAF1 AND p53 DOES NOT CORRELATE WITH PROGNOSIS IN NODE-NEGATIVE INVASIVE DUCTAL CARCINOMA OF THE BREAST
H.P. Kourea, A.K. Koutras, V. Zolota, I. Grimani, E. Tzoracoeleftherakis, D. Koukouras, G. Fountzilas, H. Gogas, K. Kyriakou, A. Adamou, H.P. Kalofonos
Anticancer Res. 2006 Mar-Apr;26(2B):1657-68
ADVANCES IN THE TREATMENT OF LOCALLY ADVANCED NON-NASOPHARYNGEAL SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK REGION
Psyrri D, Fountzilas G
Med Oncol. 2006;23(1):1-15
MITOXANTRONE PLUS GEMCITABINE IN PRETREATED PATIENTS WITH METASTATIC BREAST CANCER
A. Onyenadum, H. Gogas, P. Kosmidis, G. Aravantinos, D. Bafaloukos, H. Bacoyiannis, C. Markopoulos, A. Koutras, E. Tzorakoelefterakis, T. Makatsoris, G.Fountzilas, HP. Kalofonos; Hellenic Cooperative Oncology Group
J Chemother. 2006 Apr;18(2):192-8
ADVANCED STAGE CLEAR CELL EPITHELIAL OVARIAN CANCER: THE HELLENIC COOPERATIVE ONCOLOGY GROUP EXPERIENCE
D. Pectasides, G. Fountzilas, G. Aravantinos, C. Kalofonos, H. Efstathiou, D. Farmakis, D. Skarlos, N. Pavlidis, Th. Economopoulos, M.A. Dimopoulos.
Gynecol Oncol. 2006 Aug;102(2):285-91
TEMOZOLOMIDE IN COMBINATION WITH CELECOXIB IN PATIENTS WITH ADVANCED MELANOMA. A PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
H. Gogas, A. Polyzos, I. Stavrinidis, K. Frangia, D. Tsoutsos, P. Panagiotou, C. Markopoulos, O. Papadopoulos, D. Pectasides, M. Mantzourani, M. Middleton, G. Vaiopoulos, G. Fountzilas
Ann Oncol. 2006 Dec;17(12):1835-41
FOUR CYCLES OF PACLITAXEL AND CARBOPLATIN AS ADJUVANT TREATMENT IN EARLY-STAGE OVARIAN CANCER: A SIX-YEAR EXPERIENCE OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Α. Bamias, C. Papadimitriou, E. Efstathiou, A. Rodolakis, G. Vlahos, Z. Voulgaris, G. Bozas, G. Fountzilas, G. Aravantinos, E. Razis, D. Gika, M.A. Dimopoulos.
BMC Cancer. 2006 Sep 25;6:228
EVALUATION OF THE PROGNOSTIC AND PREDICTIVE VALUE OF p53 AND Bcl-2 IN BREAST CANCER PATIENTS PARTICIPATING IN A RANDOMIZED STUDY WITH DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY
V. Malamou-Mitsi, H. Gogas, U. Dafni, A. Bourli, T. Fillipidis, M. Sotiropoulou, D. Vlachodimitropoulos, S. Papadopoulos, O. Tzaida, G. Kafiri, V. Kyriakou, S. Markaki, I. Papaspyrou, E. Karagianni, K. Pavlakis, T. Toliou, C.D. Scopa, P. Papakostas, D. Bafaloukos, C. Christodoulou, G. Fountzilas
Ann Oncol. 2006 Oct;17(10):1504-11
PACLITAXEL AND GEMCITABINE VS PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN IN ADVANCED NON-NASOPHARYNGEAL HEAD AND NECK CANCER. AN EFFICACY AND COST ANALYSIS RANDOMIZED STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
G. Fountzilas, P. Papakostas, U. Dafni, T. Makatsoris, M. Karina, A. Kalogera-Fountzila, N. Maniadakis, G. Aravantinos, K. Syrigos, A. Bamias, C. Christodoulou, T. Economopoulos, H.P. Kalofonos, A. Nikolaou, N. Angouridakis, G. Stathopoulos D. Bafaloukos, N. Pavlidis, J. Daniilidis
Ann Oncol. 2006 Oct;17(10):1560-7
ADJUVANT DOSE-DENSE SEQUENTIAL CHEMOTHERAPY WITH EPIRUBICIN, CMF AND WEEKLY DOCETAXEL IS FEASIBLE AND SAFE IN PATIENTS WITH OPERABLE BREAST CANCER
G. Fountzilas, D. Pectasides, C. Christodoulou, E. Timotheadou, Th. Economopoulos, P. Papakostas, Ch. Papadimitriou, H. Gogas, I. Efstratiou, D. Skarlos
Med Oncol. 2006;23(4):479-88
METASTATIC BREAST CANCER WITH LIVER METASTASES: A REGISTRY ANALYSIS OF CLINICOPATHOLOGIC, MANAGEMENT AND OUTCOME CHARACTERISTICS OFF 500 WOMEN
G. Pentheroudakis, G. Fountzilas, D. Bafaloukos, V. Koutsoukou, D. Pectasides, D. Skarlos, E. Samantas, H.P. Kalofonos, H. Gogas, N. Pavlidis
Breast Cancer Res Treat. 2006 Jun;97(3):237-44
CAN THE STANDARD CHEMOTHERAPEUTIC REGIMEN BE IMPROVED UPON FOR SMALL-CELL LUNG CANER?
A. Psyrri, G. Fountzilas
Nat Clin Pract Oncol. 2006 Jul;3(7):360-1
NON-SMALL CELL LUNG CANCER IN THE YOUNG: A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, MANAGEMENT AND OUTCOME DATA
D. Mauri, G. Pentheroudakis, D. Bafaloukos, D. Pectasides, E. Samantas, E. Efstathiou, H.P. Kalofonos, K. Syrigos, G. Klouvas, P. Papakostas, P. Kosmidis, G. Fountzilas, N. Pavlidis; Hellenic Coopeprative Oncologic Group (HeCOG).
Anticancer Res. 2006 Jul-Aug;26(4B):3175-81
PROGNOSTIC FACTORS AND SIGNIFICANCE OF THE REVISED 6TH EDITION OF THE AJCC CLASSIFICATION IN PATIENTS WITH LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
A. Kalogera-Fountzila, D. Karanikolas, N. Katodritis, E. Samantas, A. Sarafopoulos, I. Ikonomou, N. Zamboglou, N. Tselis, A.S. Dimitriadis, G. Fountzilas; AJCC (American Joint Committee on Cancer).
Strahlenther Onkol. 2006 Aug;182(8):458-66
A MULTICENTER PHASE III TRIAL COMPARING IRINOTECAN-GEMCITABINE (IG) WITH GEMCITABINE (G) MONOTHERAPY AS FIRST-LINE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER
G.P. Stathopoulos, K. Syrigos, G. ravantinos, A. Polyzos, P. Papakotoulas, G. Fountzilas, A. Potamianou, N. Ziras, J. Boukovinas, J. Varthalitis, N. Androulakis, A. Kotsakis, G. Samonis, V. Georgoulias
Br J Cancer. 2006 Sep 4;95(5):587-92 (Epub 2006 Aug 8)
THREE CASES REPORTS OF HAND-FOOT SYNDROME WITH GEFITINIB
E. Razis, M. Karina, S. Karanastassi, G. Fountzilas
Cancer Invest. 2006 Aug-Sep; 24(5): 514-6
PRIMARY GASTROINTESTINAL NON-HODKIN’S LYMPHOMA:A CLINICOPATHOLOGIC STUDY OF 128 CASES IN GREECE. A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY (HeCOG)
G. Papaxoinis, S. Papageorgiou, D. Rontogianni, V. Kaloutsi, G. Fountzilas, N. Pavlidis, M. Dimopoulos, C. Tsatalas, N. Xiros, T. Economopoulos
Leuk Lymphoma. 2006 Oct;47(10):2140-6
TWO CASES OF COMPLETE RESPONSE AFTER IMATINIB MESYLATE TREATMENT OF ADVANCED GIST
G. Papaxoinis, M. Nikolaou, E. Lianos, A. Gaglia, T. Oikonomopoulos, D. Pectasides
Anticancer Res. 2006 Nov-Dec;26(6C):4869-72
LIVER METASTASIS OF ADENOID CYSTIC CARCINOMA OF SALIVARY ORIGIN: REPORT OF A CASE PREPARED BY THIN-PREP METHOD
D. Aninos, A. Koumarianou, J. Georgoulakis, D.Pectasides, E. Brountzos, CH. Zoumpouli, T.Economopoulos, P. Karakitsos
Cytopathology. 2007 Aug;18(4):268-9
FALLOPIAN TUBE CARCINOMA: A REVIEW
D. Pectasides, E. Pectasides, T. Economopoulos
Oncologist. 2006 Sep;11(8):902-12
SYSTEMIC CHEMOTHERAPY IN LOCALLY ADVANCED AND/OR METASTATIC BLADDER CANCER
D. Pectasides, M. Pectasides, T. Economopoulos
Cancer Treat Rev. 2006 Oct;32(6):456-70 (Epub 2006 Aug 28)
MAINTENANCE OR CONSOLIDATION THERAPY IN ADVANCED OVARIAN CANCER
D. Pectasides, E. Pectasides
Oncology. 2006;70(5):315-24 (Epub 2006 Dec 12)
CISPLATIN-BASED CHEMOTHERAPY FOR MERKEL CELL CARCINOMA OF THE SKIN
D. Pectasides, M. Pectasides, A. Psyrri, A. Koumarianou, N. Xiros, E. Pectasides, A. Gaglia, E. Lianos, G. Papaxoinis, V. Lampadiari, T. Economopoulos
Cancer Invest. 2006 Dec;24(8):780-5
TREATMENT ISSUES IN CLEAR CELL CARCINOMA OF THE OVARY: DIFFERENT ENTITY?
D. Pectasides, E. Pectasides, A. Psyrri, T. Economopoulos
Oncologist. 2006 Nov-Dec;11(10):1089-94
SURVIVIN AND GLYCODELIN GLYCODELIN TRANSCRIPTIONAL ACTIVITY IN NODE-POSITIVE EARLY BREAST CANCER: mRNA EXPRESSION OF TWO KEY REGULATORS OF CELL SURVIVAL
L. Kostadima, G. Pentheroudakis, G. Fountzilas, M.A. Dimopoulos, D. Pectasides, H. Gogas, U. Stropp, Ch.Christodoulou, E. Samantas, R. Wirtz, G. Hennig, D. Bafaloukos, P. Arapantoni, H.P. Kalofonos, P.Papakostas, T. Economopoulos, A. Bamias, G. Fountzilas, N. Pavlidis
Breast Cancer Res Treat. 2006 Nov;100(2):161-7 (Epub 2006 Jul 18)
POST-OPERATIVE COMBINED RADIATION AND CHEMOTHERAPY WITH TEMOZOLOMIDE AND IRINOTECAN IN PATIENTS WITH HIGH-GRADE ASTROCYTIC TUMORS. A PHASE II STUDY WITH BIOMARKER EVALUATION
G. Fountzilas, G. Karkavelas, A. Kalogera-Fountzila, M. Karina, M. Ignatiadis, G. Koukoulis, G. Plataniotis, D. Misailidou, M. Bobos, D. Pectasides, E. Razis, A. Karavelis, P. Selviaridis
Anticancer Res. 2006 Nov-Dec;26(6C):4675-86
Δημοσιεύσεις 2008
P.A Kosmidis, H.P Kalofonos, C. Christodoulou, K. Syrigos, T. Makatsoris, D. Skarlos, C. Bakogiannis, C. Nicolaides, D. Bafaloukos, A. Bamias, E. Samantas, N. Xiros, I. Boukovinas, G. Fountzilas, M.A Dimopoulos.
Ann Oncol. 2008;19(1):115-22
I. Konstantopoulou, T. Rampias, A. Ladopoulou, G. Koutsodontis, S. Armaou, T. Anagnostopoulos, G. Nikolopoulos, S. Kamakari, G. Nounesis, A. Stylianakis, C. Karanikiotis, E. Razis, H. Gogas, A. Keramopoulos, V. Gaki, C. Markopoulos, D. Skarlos, N. Pandis, T. Bei, I. Arzimanoglou, G. Fountzilas, D. Yannoukakos.
Breast Cancer Res Treat. 2008;107(3):431-41
E. Briasoulis, G. Fountzilas, A. Bamias, M.A Dimopoulos, N. Xiros, G. Aravantinos, E. Samantas, H. Kalofonos, T. Makatsoris, N. Mylonakis, P. Papakostas, D. Skarlos, I. Varthalitis, N. Pavlidis.
Cancer Chemother Pharmacol. 2008;62(2):277-84
T. Anagnostopoulos, M. Pertesi, I. Konstantopoulou, S. Armaou, S. Kamakari, G. Nasioulas, A. Athanasiou, A. Dobrovic, MA Young, D. Goldgar, G. Fountzilas, D. Yannoukakos.
Breast Cancer Res Treat. 2008;110(2):377-85
G. Fountzilas, U. Dafni, H. Gogas, H. Linardou, H.P Kalofonos, E. Briasoulis, D. Pectasides, E. Samantas, D. Bafaloukos, G.P Stathopoulos, M. Karina, C. Papadimitriou, D. Skarlos, N. Pisanidis, P. Papakostas, C. Markopoulos, E. Tzorakoeleftherakis, K. Dimitrakakis, P. Makrantonakis, N. Xiros, A. Polichronis, I. Varthalitis, C. Karanikiotis, A.M Dimopoulos; Hellenic Cooperative Oncology Group.
Ann Oncol. 2008;19(5):853-60
L. Dova, G. Pentheroudakis, V. Golfinopoulos, V. Malamou-Mitsi, I. Georgiou, G. Vartholomatos, A. Ntemou, G. Fountzilas, N. Pavlidis.
J Cancer Res Clin Oncol. 2008;134(6):697-704
G. Papaxoinis, G. Fountzilas, D. Rontogianni, M.A Dimopoulos, N. Pavlidis, C. Tsatalas, D. Pectasides, N. Xiros, T. Economopoulos.
Ann Oncol. 2008;19(4):780-6
T. Economopoulos, A. Psyrri, G. Fountzilas, C. Tsatalas, A. Anagnostopoulos, S. Papageorgiou, N. Xiros, M.A Dimopoulos.
Leuk Lymphoma. 2008;49(1):68-74
G. Pentheroudakis, G. Fountzilas, H.P Kalofonos, V. Golfinopoulos, G. Aravantinos, D. Bafaloukos, P. Papakostas, D. Pectasides, C. Christodoulou, K. Syrigos, T. Economopoulos, N. Pavlidis; Hellenic Cooperative Oncology Group.
Crit Rev Oncol Hematol. 2008;66(3):237-47
CARBOPLATIN AND PACLITAXEL IN ADVANCED OR METASTATIC ENDOMETRIAL CANCER
D. Pectasides, N. Xiros, G. Papaxoinis, E. Pectasides, C. Sykiotis, A. Koumarianou, A. Psyrri, A. Gaglia, D. Kassanos, P. Gouveris, J. Panayiotidis, G. Fountzilas, T. Economopoulos.
Gynecol Oncol. 2008;109(2):250-4
C.A Papadimitriou, D. Bafaloukos, G. Bozas, H. Kalofonos, P. Kosmidis, G. Aravantinos, G. Fountzilas, M.A Dimopoulos; Hellenic Co-operative Oncology Group.
Gynecol Oncol. 2008;110(1):87-92
D. Pectasides, G. Papaxoinis, G. Fountzilas, G. Aravantinos, E. Pectasides, D. Mouratidou, T. Economopoulos, Ch. Andreadis.
Anticancer Res. 2008 Mar-Apr;28(2B):1421-7
C. Karanikiotis, M. Daniilidis, N. Karyotis, C. Bakogiannis, T. Economopoulos, S. Murray, D. Papamichael, E. Samantas, A. Nikolaou, L. Skoura, N. Tselis, N. Zamboglou, G. Fountzilas.
Strahlenther Onkol. 2008;184(6):325-31
C.A Papadimitriou, P. Papakostas, E. Timotheadou, G. Aravantinos, A. Bamias, G. Fountzilas.
Cancer Invest. 2008;26(5):491-8
PERSONALITY FACTORS ASSOCIATED WITH PSYCHOLOGICAL DISTRESS IN TESTICULAR CANCER SURVIVORS
V. Siafaka, T.N Hyphantis, I. Alamanos, G. Fountzilas, D. Skarlos, D. Pectasides, V. Mavreas, N. Pavlidis.
J Pers Assess. 2008;90(4):348-55
G. Lazaridis, G. Pentheroudakis, G. Fountzilas, N. Pavlidis.
Cancer Treat Rev. 2008;34(8):693-700
IJ. Dahabreh, H. Linardou, F. Siannis, G. Fountzilas, S. Murray.
Oncologist. 2008 Jun;13(6):620-30
G. Pentheroudakis, E. Briasoulis, H.P Kalofonos, G. Fountzilas, T. Economopoulos, G. Samelis, A. Koutras, M. Karina, N. Xiros, E. Samantas, A. Bamias, N. Pavlidis;Hellenic Cooperative Oncology Group.
Acta Oncol. 2008;47(6):1148-55
H.P Kalofonos, A. Bamias, A. Koutras, P. Papakostas, G. Basdanis, E. Samantas, M. Karina, D. Misailidou, N. Pisanidis, G. Pentheroudakis, T. Economopoulos, C. Papadimitriou, D.V Skarlos, D. Pectasides, M. Stavropoulos, D. Bafaloukos, D. Kardamakis, C. Karanikiotis, G. Vourli, G. Fountzilas; Hellenic Cooperative Oncology Group Study.
Eur J Cancer. 2008 Aug;44(12):1693-700
C.A Papadimitriou, G. Fountzilas, D. Bafaloukos, G. Bozas, H. Kalofonos, D. Pectasides, G. Aravantinos, A. Bamias, M.A Dimopoulos; Hellenic Co-operative Oncology Group.
Gynecol Oncol. 2008 Oct;111(1):27-34
G. Aravantinos, G. Fountzilas, A. Bamias, I. Grimani, S. Rizos, H.P Kalofonos, D.V Skarlos, T. Economopoulos, P.A Kosmidis, G.P Stathopoulos, E. Briasoulis, D. Pectasides, E. Samantas, E. Timotheadou, C. Papadimitriou, A. Papanikolaou, A. Onyenadum, P. Papakostas, D. Bafaloukos, M.A Dimopoulos; Hellenic Cooperative Oncology Group study.
Eur J Cancer. 2008 Oct;44(15):2169-77
POTENTIAL VALUE OF PTEN IN PREDICTING CETUXIMAB RESPONSE IN COLORECTAL CANCER: AN EXPLORATORY STUDY
E. Razis, E. Briasoulis, E. Vrettou, D.V Skarlos, D. Papamichael, I. Kostopoulos, E. Samantas, I. Xanthakis, M. Bobos, E. Galanidi, M. Bai, I. Gikonti, A. Koukouma, G. Kafiri, P. Papakostas, K.T Kalogeras, P. Kosmidis, G. Fountzilas.
BMC Cancer. 2008 Aug 13;8: 234
Murray S, Dahabreh IJ, Linardou H, Manoloukos M, Bafaloukos D, Kosmidis P.
J Thorac Oncol. 2008 Aug;3(8):832-9
Koutras AK, Fountzilas G, Dafni U, Dimopoulos MA, Pectasides D, Klouvas G, Papakostas P, Kosmidis P, Samantas E, Gogas H, Briasoulis E, Vourli G, Petsas T, Xiros N, Kalofonos HP; Hellenic Cooperative Oncology Group.
Anticancer Res. 2008 Sep-Oct;28(5B):2913-20
Koutras AK, Kalogeras KT, Dimopoulos MA, Wirtz RM, Dafni U, Briasoulis E, Pectasides D, Gogas H, Christodoulou C, Aravantinos G, Zografos G, Timotheadou E, Papakostas P, Linardou H, Razis E, Economopoulos T, Kalofonos HP, Fountzilas G; Hellenic Cooperative Oncology Group (HeCOG).
Br J Cancer. 2008 Dec 2;99(11):1775-85
Fountzilas G, Bobos M, Kalogera-Fountzila A, Xiros N, Murray S, Linardou H, Karayannopoulou G, Koutras AK, Bafaloukos D, Samantas E, Christodoulou C, Economopoulos T, Kalogeras KT, Kosmidis P.
Cancer Invest. 2008 Oct;26(8):784-93
Linardou H, Dahabreh IJ, Kanaloupiti D, Siannis F, Bafaloukos D, Kosmidis P, Papadimitriou CA, Murray S.
Lancet Oncol. 2008 Oct;9(10):962-72
Chemotherapy with Paclitaxel/Carboplatin: a Hellenic Cooperative Oncology Group (HECOG) Study
A.Bamias, F.Kyriakou, M.Chorti, N.Kavantzas, A.Noni, A.Kyroudi-Voulgari, D.Rontoyianni, E.Kastritis, N.Xiros, E.S.Patsouris, S.Murray, N.Tamvakis, M.A.Dimopoulos
Anticancer Res. 2008 Jul-Aug;28(4C):2479-86
A. Bamias, G. Fountzilas, M. Michael, C. Konstantaras, E. Vrettou, E. Eleftheriadis, P. Papakostas, K. Papadimitriou, N. Pavlidis, N. Xiros, M. Bai
Cent Eur J Med. 2008 ; 3(1) : 29-39
H. Gogas, G. Pentheroudakis, A. Antoniadis, S. Murray, G. Fountzilas
Cancer and Chemotherapy Rev. 2008; 3
D. Pectasides, N. Xiros, G. Papaxoinis, G. Aravantinos, C. Sykiotis, E. Pectasides, A. Psyrri, A. Koumarianou, A. Gaglia, P. Gouveris, T. Economopoulos
Gynecol Oncol 2008; 108 (1): 47-52
Δημοσιεύσεις 2009
D. Pectasides, G. Papaxoinis, G. Fountzilas, G. Aravantinos, A. Bamias, N. Pavlidis, H.P. Kalofonos, E. Timotheadou, E. Samantas, E. Briasoulis, D.V. Skarlos, T. Economopoulos, M.A. Dimopoulos
Anticancer Research 2009 Feb;29(2):745-5
N. Maniadakis, U. Dafni, V. Fragoulakis, I. Grimani, E. Galani, A. Fragkoulidi, G. Fountzilas
Annals of Oncology 2009 Feb;20(2):278-85 [Epub 2008 Oct]
G. Pentheroudakis, KT Kalogeras, RM Wirtz, I. Grimani, G. Zografos, H. Gogas, U. Stropp, D. Pectasides, D. Skarlos, G. Hennig, E. Samantas, D. Bafaloukos, P. Papakostas, H.P Kalofonos, N. Pavlidis, G. Fountzilas
Breast Cancer Research and Treatment 2009 Jul;116(1):131-43 [Epub 2008 Jul 31]
G. Fountzilas, U. Dafni, M.A Dimopoulos, A. Koutras, D. Skarlos, P. Papakostas, H. Gogas, D. Bafaloukos, A. Kalogera-Fountzila, E. Samantas, E. Briasoulis, D. Pectasides, N. Maniadakis, F. Matsiakou, G. Aravantinos, C. Papadimitriou, M. Karina, C. Christodoulou, P. Kosmidis, H.P Kalofonos
Breast Cancer Research and Treatment 2009 May;115(1):87-99 [Epub 2008 May 16]
C. Christodoulou, U. Dafni, G. Aravantinos, A. Koutras, E. Samantas, M. Karina, J. Janinis, P. Papakostas, D. Skarlos, H. Kalofonos, G. Fountzilas
Anticancer Research 2009 Feb;29(2):693-702
G. Fountzilas, A. Bamias, A. Kalogera-Fountzila, G. Karayannopoulou, M. Bobos, E. Athanassiou, K.T. Kalogeras, C. Tolis, P. Tsekeris, P. Papakostas, C. Vamvouka, T. Zaramboukas, P. Kosmidis, N. Zamboglou, D. Misailidou
Anticancer Research 2009 Feb;29(2):529-38
C. Christodoulou, I. Kostopoulos, H.P. Kalofonos, E. Lianos, M. Bobos, E. Briasoulis, H. Gogas, E. Razis, D.V. Skarlos, G. Fountzilas
Oncology 2009;76(4):275-85 [Epub 2009 Mar 5]
D. Pectasides, G. Papaxoinis, M. Nikolaou, C. Valavanis, G. Aravantinos, G. Fountzilas, N. Tamvakis, E. Pectasides, I. Lekka, P. Arapantoni-Dadioti, A. Zizi, I. Ghiconti, T. Economopoulos
Anticancer Research 2009 Feb;29(2):737-44
I. Kostopoulos, V. Karavasilis, M. Karina, M. Bobos, N. Xiros, G. Pentheroudakis, G. Kafiri, P. Papakostas, E. Vrettou, G. Fountzilas
BMC Cancer 2009 Sep 24;9:339
TARGETED KRAS MUTATION ASSESSMENT ON PATIENT TUMOR HISTOLOGIC MATERIAL IN REAL TIME DIAGNOSTICS
V. Kotoula, E. Charalambous, B. Biesmans, A. Malousi, E. Vrettou, G. Fountzilas, G. Karkavelas
PLoS One 2009 Nov 4;4(11):e7746
S. Armaou, M. Pertesi, F. Fostira, G. Thodi, P.S Athanasopoulos, S. Kamakari, A. Athanasiou, H. Gogas, D. Yannoukakos, G .Fountzilas and I. Konstantopoulou
British Journal of Cancer 2009 Jul 7;101(1):32-7 [Epub 2009 Jun 2]
E. Razis, P. Selviaridis, S. Labropoulos, J.L. Norris, M.J Zhu, D.D. Song, T. Kalebic, M. Torrens, A. Kalogera-Fountzila, G. Karkavelas, S. Karanastasi, J.A. Fletcher, and G. Fountzilas
Clinical Cancer Research 2009 Oct 1;15(19):6258-66 [Epub 2009 Sep 29]
G. Mountzios, M. A. Dimopoulos, A. Bamias, G. Vourli, H. Kalofonos, G. Aravantinos, G. Fountzilas & C. A. Papadimitriou
Annals of Oncology 2009 Aug;20(8):1362-8 [Epub 2009 May 20]
G. Pentheroudakis, N. Angouridakis, R.M. Wirtz, A. Nikolaou, K.T. Kalogeras, N. Pavlidis, G. Fountzilas
Journal of Oncology 2009;2009:854127 [Epub 2009 Oct 7]
DOSE-RANGING STUDY OF METRONOMIC ORAL VINORELBINE IN PATIENTS WITH ADVANCED REFRACTORY CANCER
E. Briasoulis, P. Pappas, C. Puozzo, C. Tolis, G. Fountzilas, U. Dafni, M. Marselos, and N. Pavlidis
Clinical Cancer Research 2009 Oct 15;15(20):6454-61 [Epub 2009 Oct 6]
D.V. Skarlos, E. Timotheadou, E. Galani, E. Samantas, I. Grimani, E. Lianos, G. Aravantinos, I. Xanthakis, G. Pentheroudakis, D. Pectasides, G. Fountzilas.
Oncology 2009;77(2):107-12 [Epub 2009 Jul 21]
MANAGEMENT OF ADVANCED STAGE UTERINE SARCOMAS: A BONE OF CONTENTION
F. Zagouri, H. Linardou, A.M Dimopoulos, C.A Papadimitriou
European Journal of Gynaecologic Oncology 2009;30(5):483-92
SOMATIC EGFR MUTATIONS AND EFFICACY OF TYROSINE KINASE INHIBITORS IN NSCLC
H. Linardou, I.J Dahabreh, D. Bafaloukos, P. Kosmidis, S. Murray
Nature Reviews Clinical Oncology 2009 Jun;6(6):352-66
D. Pectasides, U. Dafni, D. Bafaloukos, D. Skarlos, A. Polyzos, D. Tsoutsos, H. Kalofonos, G. Fountzilas, P. Panagiotou, G. Kokkalis, O. Papadopoulos, O. Castana, S. Papadopoulos, E. Stavrinidis, G. Vourli, J. Ioannovich†, H.G ogas
Journal of Clinical Oncology 2009 Feb 20;27(6):939-44 [Epub 2009 Jan 12]
PRIMARY FALLOPIAN TUBE CARCINOMA: RESULTS OF A RETROSPECTIVE ANALYSIS OF 64 PATIENTS
D. Pectasides, E. Pectasides, G. Papaxoinis, C. Andreadis, G. Papatsibas, G. Fountzilas, K. Pliarchopoulou, A. Macheras, G. Aravantinos, T. Economopoulos
Gynecol Oncol 2009 Oct;115(1):97-101 [Epub 2009 Jul 16]
XELOX versus FOLFOX6 AS AN ADJUVANT TREATMENT IN COLORECTAL CANCER: AN ECONOMIC ANALYSIS
N. Maniadakis, V. Fragoulakis, D. Pectasides, G. Fountzilas
Curr Med Res Opin 2009 Mar;25(3):797-805
CARBOPLATIN AND PACLITAXEL IN METASTATIC OR RECURRENT CERVICAL CANCER
D. Pectasides D, Fountzilas G, Papaxoinis G, Pectasides E, Xiros N, Sykiotis C, Koumarianou A, Psyrri A, Panayiotides J, Economopoulos T.
Int J Gynecol Cancer 2009 May;19(4):777-81
GASTRIC METASTASES ORIGINATING FROM BREAST CANCER: REPORT OF 8 CASES AND REVIEW OF THE LITERATURE
D. Pectasides, A. Psyrri, K. Pliarchopoulou, T. Floros, G. Papaxoinis, M. Skondra, G. Papatsibas, A. Macheras, G. Athanasas, P. Arapantoni-Datioti, T. Economopoulos
Anticancer Res 2009 Nov;29(11):4759-63
A. Koumarianou, G. Fountzilas, P. Kosmidis, G. Klouvas, E. Samantas, C. Kalofonos, G. Pentheroudakis, T. Economopoulos, D. Pectasides
J Chemother 2009 Nov;21(5):573-83
G. Lainakis, A. Bamias, E. Psimenou, G. Fountzilas, M.A. Dimopoulos
Clin Nephrology 2009 Jul;72(1):73-8
G. Iliadis, P. Selviaridis, A. Kalogera-Fountzila, A. Fragkoulidi, D. Baltas, N. Tselis, A. Chatzisotiriou, D. Misailidou, N. Zamboglou, G. Fountzilas
Strahlentherapie und Onkologie 2009 Nov;185(11):743-50 [Epub 2009 Nov 10]
STAGE I TESTICULAR SEMINOMA: MANAGEMENT AND CONTROVERSIES
D. Pectasides, E. Pectasides, A. Constantinidou, G. Aravantinos
Critical Reviews in Oncology/Hematology 2009 Jul;71(1):22-8 [Epub 2008 Nov 28]
CURRENT MANAGEMENT OF STAGE I TESTICULAR NON-SEMINOMATOUS GERM CELL TUMOURS
D. Pectasides, E. Pectasides, A. Constantinidou, G. Aravantinos
Crit Rev Oncol Hematol 2009 May;70(2):114-23. Epub 2008 Sep 19
C.A Papadimitriou, H. Kalofonos, F. Zagouri, P. Papakostas, G. Bozas, T. Makatsoris, M.A Dimopoulos, G. Fountzilas
Oncology 2009;77(3-4):212-6 [Epub 2009 Sep 4]
G. Fountzilas, A. Kalogera-Fountzila, S. Lambaki, R.M. Wirtz, A. Nikolaou, G. Karayannopoulou, M. Bobos, V. Kotoula, S. Murray, A. Lambropoulos, G. Aravantinos, K. Markou, E. Athanassiou, D. Misailidou, K.T. Kalogeras, D. Skarlos
J Oncol 2009;2009:305908 [Epub 2009 Dec 29]
E. Razis, I. Belogianni, V. Siamanta, A. Apessos, V. Kyriakopoulou, E. Papadopoulou, M. Sariyanni, D. Theofilopoulos, S. Labropoulos, G. Nasioulas
Cancer Genomics Proteomics 2009 Jul-Aug;6(4):215-7
Δημοσιεύσεις 2010
G. Pentheroudakis, L. Kostadima, L. Dova, I. Georgiou, T. Tzavaras, G. Vartholomatos, R. M.Wirtz, G. Fountzilas, V. Malamou-Mitsi, N. Pavlidis
Neoplasma 2010;57(1):47-54
D. Bafaloukos, H. Linardou, G. Aravantinos, C. Papadimitriou, A. Bamias, G. Fountzilas, H.P Kalofonos, P. Kosmidis, E. Timotheadou, T. Makatsoris, E. Samantas, E. Briasoulis, C. Christodoulou, P. Papakostas, D. Pectasides, A.M Dimopoulos
BMC Med 2010 Jan 7;8:3.
IJ Dahabreh, H. Linardou, F. Siannis, P. Kosmidis, D. Bafaloukos, S. Murray
Clinical Cancer Research 2010 Jan 1;16(1):291-303
A. Bamias, A. Karadimou, S. Lampaki, G. Lainakis, L. Malettou, E. Timotheadou, K. Papazisis, Ch. Andraeadis, L. Kontovinis, I. Anastasiou, K. Stravodimos, I. Xanthakis, A. Skolarikos, Ch. Christodoulou, K. Syrigos, Ch. Papandreou, E. Razi, U. Dafni, G. Fountzilas and M.A Dimopoulos
BMC Cancer 2010 Feb 18;10:45
H. Gogas, D. Pectasides, I. Kostopoulos, E. Lianos, D. Skarlos, G. Papaxoinis, M. Bobos, H.P. Kalofonos, K. Petraki, K. Pavlakis, D. Bafaloukos, G. Fountzilas
Clinical Breast Cancer 2010 Jun;10(3):230-7
A.C. Antoniou….D. Yannoukakos, G. Fountzilas… et al
Nature Genetics 2010 Oct;42(10):885-92 [Epub 2010 Sep 19]
E.Pectasides, A.M.Egloff, C.Sasaki, P.Kountourakis, B.Burtness, G.Fountzilas, U.Dafni, T.Zaramboukas, T.Rampias, D.Rimm, J.Grandis, A.Psyrri
Clin Cancer Res 2010 Apr 15;16(8):2427-34 [Epub 2010 Apr 6]
G.Fountzilas, A.Fragkoulidi, A.Kalogera-Fountzila, M.Nikolaidou, M. Bobos, J.Calderaro, F.Andreiuolo, M.Marselos
Cancer Chemother Pharmacol 2010 Mar;65(4):649-60 [Epub 2009 Aug 5]
N. Katirtzoglou, I. Gkiozos, N. Makrilia, E. Tsaroucha, A. Rapti, G. Stratakos, G. Fountzilas, KN. Syrigos
Clin Lung Cancer 2010 Jan;11(1):30-5
FIFTEEN-YEAR TRENDS IN METASTATIC BREAST CANCER SURVIVAL IN GREECE
U.Dafni, I.Grimani, A.Xyrafas, AG.Eleftheraki, G.Fountzilas
Breast Cancer Res Treat 2010 Feb;119(3):621-31
A. Bamias, M. Karina, P. Papakostas, I. Kostopoulos, M. Bobos, G. Vourli, E. Samantas, Ch. Christodoulou, G. Pentheroudakis, D. Pectasides, M.A. Dimopoulos, G. Fountzilas
Cancer Chemotherapy and Pharmacology 2010 May;65(6):1009-21
BEVACIZUMAB IN THE TREATMENT OF BREAST CANCER
A.K.Koutras, G.Fountzilas, T.Makatsoris, S.Peroukides, H.P.Kalofonos
Cancer Treat Rev 2010 Feb;36(1):75-82
W. De Roock, B. Claes, D. Bernasconi, J. De Schutter, B. Biesmans, G. Fountzilas, KT Kalogeras, V. Kotoula, D. Papamichael, P. Laurent-Puig, F. Penault-Llorca, P. Rougier, B. Vincenzi, D. Santini, G. Tonini, F. Cappuzzo, M. Frattini, F. Molinari, P. Saletti, S. De Dosso, M. Martini, A. Bardelli, S. Siena, A. Sartore-Bianchi, J. Tabernero, T. Macarulla, F. Di Fiore, AO Gangloff, F. Ciardiello, P. Pfeiffer, C. Qvortrup, TP Hansen, E. Van Cutsem, H. Piessevaux, D. Lambrechts, M. Delorenzi, S. Tejpar
Lancet Oncol 2010 Aug;11(8):753-62 [Epub 2010 Jul 8]
G. Thodi, F. Fostira, R. Sandaltzopoulos, G. Nasioulas, A.A. Grivas, I. Boukovinas, M. Mylonaki, C. Panopoulos, M. Brankovic Magic, G. Fountzilas, D. Yannoukakos
BMC Cancer 2010 Oct 11;10:544
THE UPGRADED ROLE OF HER3 AND HER4 RECEPTORS IN BREAST CANCER
AK. Koutras, G. Fountzilas, KT. Kalogeras, I. Starakis, G. Iconomou, HP. Kalofonos
Crit Rev Oncol Hematol 2010 May;74(2):73-8 [Epub 2009 May 30]
M. Ihnen, R.M. Wirtz, K.T. Kalogeras, K. Milde-Langosch, M. Schmidt, I. Witzel, A.G. Eleftheraki, C. Papadimitriou, F. Jänicke, E. Briassoulis, D. Pectasides, A. Rody, G. Fountzilas and V. Müller
Brit J Cancer 2010 Sep 28;103(7):1048-56 [Epub 2010 Aug 24]
TP53 ARG72PRO POLYMORPHISM AND COLORECTAL CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS
IJ Dahabreh, H. Linardou, P. Bouzika, V. Varvarigou, S. Murray
Cancer Epidemiol Biomarkers Prev 2010 Jul;19(7):1840-7
S. Murray, H. Linardou, G. Mountzios, M. Manoloukos, S. Markaki, E. Eleutherakis-Papaiakovou, MA Dimopoulos, CA Papadimitriou
Mutat Res 2010 Apr 1;686(1-2):68-73 [Epub 2010 Feb 1]
MUTATIONAL SPECTRUM OF APC AND GENOTYPE-PHENOTYPE CORRELATIONS IN GREEK FAP PATIENTS
F. Fostira, G. Thodi, R. Sandaltzopoulos, G. Fountzilas and D. Yannoukakos
BMC Cancer 2010 Jul 22;10:389
E. Briasoulis, V. Golfinopoulos, M.Karina, P. Papakostas, N. Pavlidis, G. Fountzilas
Anticancer Drugs 2010 Sep;21(8):785-9
D. Pectasides, E. Pectasides, G. Papaxoinis, A. Psyrri, K. Pliarchopoulou, A. Koumarianou, A. Macheras, G. Athanasas, N. Xiros, T. Economopoulos
Gynecologic Oncology 2010 Jul;118(1):52-7 [Epub 2010 Apr 20]
H. Gogas, J.M Kirkwood, C.S. Falk, U. Dafni, V.K. Sondak, D. Tsoutsos, A. Stratigos, C. Markopoulos, D. Pectasides, M. Spyropoulou-Vlachou
Cancer 2010 Sep 15;116(18):4326-33
H. P. Kalofonos, P. Papakostas, T. Makatsoris, D. Papamichael, G. Vourli, I. Xanthakis, G. Aravantinos, C. Papadimitriou, G. Pentheroudakis, I. Varthalitis, G. Samelis, K.N. Syrigos, N. Xiros, M. Stavropoulos, P. Kosmidis, C. Christodoulou, H. Linardou, M. Skondra, D. Pectasides, T. Economopoulos, G. Fountzilas
Anticancer Res 2010 Oct;30(10):4325-33
H. Gogas, U. Dafni, H. Koon, M. Spyropoulou-Vlachou, Y. Metaxas, E. Buchbinder, E. Pectasides, D. Tsoutsos, A. Polyzos, A. Stratigos, C. Markopoulos, P. Panagiotou, G. Fountzilas, O. Castana, P. Skarlos, M.B. Atkins, J.M. Kirkwood
J Transl Med 2010 Nov 3;8:108
S. Murray, M. Bobos, N. Angouridakis, A. Nikolaou, H. Linardou, E. Razis, G. Fountzilas
Journal of Oncology 2010;2010:709678 [Epub 2011 Jan 3]
Δημοσιεύσεις 2011
C.A. Papadimitriou, P. Papakostas, M. Karina, L. Malettou, M.A. Dimopoulos, G. Pentheroudakis, E. Samantas, A. Bamias, D. Miliaras, G. Basdanis, N. Xiros, G. Klouvas, D. Bafaloukos, G. Kafiri, I. Papaspirou, D. Pectasides, C. Karanikiotis, T. Economopoulos, I. Efstratiou, I. Korantzis, N. Pisanidis, T. Makatsoris, F. Matsiakou, G. Aravantinos, H. P. Kalofonos, G. Fountzilas
BMC Med 2011 Jan 31;9:10
H. Linardou, E. Briasoulis, I.J. Dahabreh, G. Mountzios, C. Papadimitriou, S. Papadopoulos, D. Bafaloukos, P. Kosmidis, S. MurrayCancer
Cancer Treat Rev 2011 May;37(3):221-33 [Epub 2010 Sep 29]
V. Kotoula, S. Lambaki, D. Televantou, A. Kalogera-Fountzila, A. Nikolaou, K. Markou, D. Misailidou, K.N. Syrigos, G. Fountzilas
Transl Oncol 2011 Feb 1;4(1):47-58
E. Pectasides, T. Rampias, P. Kountourakis, C. Sasaki, D. Kowalski, G. Fountzilas, T. Zaramboukas, D. Rimm, B. Burtness, A. Psyrri
Clin Cancer Res 2011 May 1;17(9):2947-54 [Epub 2011 Feb 25]
P.A. Kosmidis, G. Fountzilas, A.G. Eleftheraki, H.P. Kalofonos, G. Pentheroudakis, D. Skarlos, M.A. Dimopoulos, D. Bafaloukos, D. Pectasides, E. Samantas, I. Boukovinas, S. Lambaki, N. Katirtzoglou, C. Bakogiannis & K.N. Syrigos
Annals of Oncology 2011 Apr;22(4):827-34 [Epub 2010 Sep 29]
I.J. Dahabreh, H. Linardou, P. Kosmidis, D. Bafaloukos, S. Murray
Annals of Oncology 2011 Mar;22(3):545-52. [Epub 2010 Sep 8]
A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis, S. Murray
Current Medicinal Chemistry 2011;18(11):1613-28
G. Pentheroudakis, A. Batistatou, K.T. Kalogeras, R. Kronenwett, R.M. Wirtz, E. Bournakis, A.G. Eleftheraki, D. Pectasides, M. Bobos, D. Miliaras, I. Papaspirou, S. Kamina, H. Gogas, A.K. Koutras, N. Pavlidis, G. Fountzilas
Breast Cancer Research and Treatment 2011 May;127(1):179-93. [Epub 2011 Mar 9]
A. Bamias, G. Aravantinos, I. Kastriotis, G. Alivizatos, I. Anastasiou, C. Christodoulou, R. Gyftaki, H.P Kalofonos, M.A Dimopoulos
Urologic Oncology 2011 Mar-Apr;29(2):189-93. [Epub 2009 Apr 11]
G. Fountzilas, H.P. Kourea, M. Bobos, D. Televantou, V. Kotoula, C. Papadimitriou, K.T. Papazisis, E. Timotheadou, I. Efstratiou, A. Koutras, G. Pentheroudakis, C. Christodoulou, G. Aravantinos, D. Miliaras, K. Petraki, C.N. Papandreou, P. Papakostas, D. Bafaloukos, D. Repana, E. Razis, D. Pectasides, A.M. Dimopoulos
Anticancer Research 2011 Sep;31(9):3007-18
G. Fountzilas, Ch. Valavanis, V. Kotoula, A.G. Eleftheraki, K.T. Kalogeras, O. Tzaida, A. Batistatou, R. Kronenwett, R.M. Wirtz, M. Bobos, E.Timotheadou, N. Soupos, G. Pentheroudakis, H. Gogas, D. Vlachodimitropoulos, G. Polychronidou, G. Aravantinos, A. Koutras, Ch. Christodoulou, D. Pectasides, and P. Arapantoni
Journal of Translational Medicine, On line
A.K. Koutras, A. Antonacopoulou, A.G. Eleftheraki, A. Koumarianou, I. Varthalitis, F. Fostira, I. Sgouros, E. Briasoulis, E. Bournakis, D. Bafaloukos, I. Bombolaki, E. Galani, D. Pectasides, G. Foutzilas, H.P. Kalofonos
Pharmacogenomics J. 2012 Dec;12(6):468-75. doi: 10.1038/tpj.2011.37. [Epub 2011 Aug 16]
G. Fountzilas, E. Ciuleanu, M. Bobos, A. Kalogera-Fountzila, A.G Eleftheraki, G. Karayannopoulou, T. Zaramboukas, A. Nikolaou, K. Markou, L. Resiga, D. Dionysopoulos, E. Samantas, H. Athanassiou, D. Misailidou, D. Skarlos, T. Ciuleanu
Annals of Oncology, 2012 Feb;23(2):427-35. [Epub 2011 Apr 27]
E.Razis, M. Bobos, V. Kotoula, A.G. Eleftheraki, H.P. Kalofonos, K. Pavlakis, P. Papakostas, G. Aravantinos, G. Rigakos, I. Efstratiou, K. Petraki, D. Bafaloukos, I. Kostopoulos, D. Pectasides, K.T. Kalogeras, D. Skarlos, G. Fountzilas
Breast Cancer Research and Treatment 2011 Jul;128(2):447-56. [Epub 2011 May 19]
COMMON BREAST CANCER SUSCEPTIBILITY LOCI ARE ASSOCIATED WITH TRIPLE NEGATIVE BREAST CANCER
K.N Stevens, C.M Vachon, A.M Lee, S. Slager, T. Lesnick, C. Olswold, P.A Fasching, P. Miron, D. Eccles, J.E Carpenter, A.K Godwin, C. Ambrosone, R. Winqvist, H. Brauch H; GENICA consortium, M.K Schmidt, A. Cox, S.S Cross, E. Sawyer, A. Hartmann, M.W Beckmann, R. Schulz-Wendtland, A.B Ekici, W.J Tapper, S.M Gerty, L. Durcan, N. Graham, R. Hein, S. Nickels, D. Flesch-Janys, J. Heinz, H.P Sinn, I. Konstantopoulou, F. Fostira, D. Pectasides, A.M Dimopoulos, G. Fountzilas, C.L Clarke, R. Balleine, J.E Olson, Z. Fredericksen, R.B Diasio, H. Pathak, E. Ross, J. Weaver, T. Rüdiger, A. Försti, T. Dünnebier, F. Ademuyiwa, S. Kulkarni, K. Pylkäs, A. Jukkola-Vuorinen,Y.D Ko, E. Van Limbergen, H. Janssen, J. Peto, O. Fletcher, G.G Giles, L. Baglietto, S. Verhoef, I. Tomlinson, V.M Kosma, J. Beesley, D. Greco, C. Blomqvist, A. Irwanto, J. Liu, F.M Blows, S.J Dawson, S. Margolin, A. Mannermaa, N.G Martin, G.W Montgomery, D. Lambrechts, I. dos Santos Silva, G. Severi, U. Hamann, P. Pharoah, D.F Easton, J. Chang-Claude, D. Yannoukakos, H. Nevanlinna, X. Wang, F.J Couch
Cancer Research, 2011 Oct 1;71(19):6240-9. [Epub 2011 Aug 15]
C.A Haiman, G.K Chen, C.M Vachon, F. Canzian, A. Dunning, R.C Millikan, X. Wang, F. Ademuyiwa, S. Ahmed, C.B Ambrosone, L. Baglietto, R. Balleine, E.V Bandera, M.W Beckmann, C.D Berg, L. Bernstein, C. Blomqvist, W.J Blot, H. Brauch, J.E Buring, L.A Carey, J.E Carpenter, J. Chang-Claude, S.J Chanock, D.I Chasman, C.L Clarke, A. Cox, S.S Cross, S.L Deming, R.B Diasio, A.M Dimopoulos, W.R Driver, T. Dünnebier, L. Durcan, D. Eccles, C.K Edlund, A.B Ekici, P.A Fasching, H.S Feigelson, D. Flesch-Janys, F. Fostira, A. Försti, G. Fountzilas, S.M Gerty; Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium, G.G Giles, A.K Godwin, P. Goodfellow, N. Graham, D. Greco, U. Hamann, S.E Hankinson, A. Hartmann, R. Hein, J. Heinz, A. Holbrook, R.N Hoover, J.J Hu, D.J Hunter, S.A Ingles, A. Irwanto, J. Ivanovich, E.M John, N. Johnson, A. Jukkola-Vuorinen, R. Kaaks, Y.D Ko, L.N Kolonel, I. Konstantopoulou, V.M Kosma, S. Kulkarni, D. Lambrechts, A.M Lee, L.L Marchand, T. Lesnick, J. Liu, S. Lindstrom, A. Mannermaa, S. Margolin, N.G Martin, P. Miron, G.W Montgomery, H. Nevanlinna, S. Nickels, S. Nyante, C. Olswold, J. Palmer, H. Pathak, D. Pectasides, C.M Perou, J. Peto, P.D Pharoah, L.C Pooler, M.F Press, K. Pylkäs, T.R Rebbeck, J.L Rodriguez-Gil, L. Rosenberg, E. Ross, T. Rüdiger, S. Silva Idos, E. Sawyer, M.K Schmidt, R. Schulz-Wendtland, F. Schumacher, G. Severi, X. Sheng, L.B Signorello, H.P Sinn, K.N Stevens, M.C Southey, W.J Tapper, I. Tomlinson, F.B Hogervorst, E. Wauters, J. Weaver, H. Wildiers, R. Winqvist, D. Van Den Berg, P. Wan, L.Y Xia , D. Yannoukakos, W. Zheng, R.G Ziegler, A. Siddiq, S.L Slager, D.O Stram, D. Easton, P. Kraft, B.E Henderson, F.J Couch
Nature Genetics, 2011 Oct 30;43(12):1210-4. doi: 10.1038/ng.985
P. Skarlos, C. Christodoulou, K.T Kalogeras, A.G Eleftheraki, M. Bobos, A. Batistatou, C. Valavanis, O. Tzaida, E. Timotheadou, R. Kronenwett, R.M Wirtz, I. Kostopoulos, D. Televantou, E. Koutselini, I. Papaspirou, C.A Papadimitriou, D. Pectasides, H. Gogas, G. Aravantinos, N. Pavlidis, P. Arapantoni, D.V Skarlos, G. Fountzilas
Cancer Chemotherapy Pharmacology [Epub 2011 Sep 8]
H. Gogas, U. Dafni, M. Karina, C. Papadimitriou, A. Batistatou, M. Bobos, H.P Kalofonos, A.G Eleftheraki, E. Timotheadou, D. Bafaloukos, C. Christodoulou, C. Markopoulos, E. Briasoulis, P. Papakostas, E. Samantas, P. Kosmidis, G.P Stathopoulos, C. Karanikiotis, D. Pectasides, M.A Dimopoulos, G. Fountzilas
Breast Cancer Research and Treatment [Epub 2011 Dec 21]
D. Pectasides, G. Papaxoinis, V. Kotoula, H. Fountzilas, I. Korantzis, A. Koutras, A.M. Dimopoulos, P. Papakostas, G. Aravantinos, I. Varthalitis, P. Kosmidis, D. Skarlos, E. Bournakis, D. Bafaloukos, H.P. Kalofonos, K.T. Kalogeras, G.Fountzilas
Oncology Reports, doi: 10.3892/or.2011.1504. [Epub 2011 Oct 13]
Δημοσιεύσεις 2012
VOLUMETRIC AND MGMT PARAMETERS IN GLIOBLASTOMA PATIENTS: SURVIVAL ANALYSIS
G. Iliadis, V. Kotoula, A.Chatzisotiriou, D. Televantou, A.G. Eleftheraki, S. Lambaki, D. Misailidou, P. Selviaridis, G. Fountzilas
BMC Cancer 2012 Jan 3;12:3
H. Gogas, U. Dafni, M. Karina, C. Papadimitriou, A. Batistatou, M. Bobos, H.P Kalofonos, A.G Eleftheraki, E. Timotheadou, D. Bafaloukos, C. Christodoulou, C. Markopoulos, E. Briasoulis, P. Papakostas, E. Samantas, P. Kosmidis, G.P Stathopoulos, C. Karanikiotis, D. Pectasides, M.A Dimopoulos, G. Fountzilas
Breast Cancer Res Treat 2012 Apr;132(2):609-19. doi: 10.1007/s10549-011-1913-4 (Epub 2011 Dec 21)
A. Psyrri, K.T. Kalogeras, R. Kronenwett, R.M. Wirtz, A. Batistatou, E. Bournakis, E. Timotheadou, H. Gogas, G. Aravantinos, C. Christodoulou, T. Makatsoris, H. Linardou, D. Pectasides, N. Pavlidis, T. Economopoulos, G. Fountzilas
Ann Oncol 2012 Jun;23(6):1422-7. doi: 10.1093/annonc/mdr527 (Epub 2011 Nov 4)
D. Pectasides, G. Papaxoinis, V. Kotoula, H. Fountzilas, I. Korantzis, A. Koutras, A.M. Dimopoulos, P. Papakostas, G. Aravantinos, I. Varthalitis, P. Kosmidis, D. Skarlos, E. Bournakis, D. Bafaloukos, H.P. Kalofonos, K.T. Kalogeras, G. Fountzilas
Oncology Reports 2012 Jan;27(1):216-24. doi: 10.3892/or.2011.1504
HER2 AND TOP2A IN HIGH-RISK EARLY BREAST CANCER PATIENTS TREATED WITH ADJUVANT EPIRUBICIN-BASED DOSE-DENSE SEQUENTIAL CHEMOTHERAPY
G. Fountzilas, Ch. Valavanis, V. Kotoula, A.G. Eleftheraki, K.T. Kalogeras, O. Tzaida, A. Batistatou, R. Kronenwett, R.M. Wirtz, M. Bobos, E. Timotheadou, N. Soupos, G. Pentheroudakis, H. Gogas, D. Vlachodimitropoulos, G. Polychronidou, G. Aravantinos, A. Koutras, Ch. Christodoulou, D. Pectasides and P.Arapantoni
J Trans Med. 2012 Jan 12;10:10. doi: 10.1186/1479-5876-10-10
IDENTIFICATION AND VALIDATION OF GENE EXPRESSION MODELS THAT PREDICT CLINICAL OUTCOME IN PATIENTS WITH EARLY-STAGE LARYNGEAL CANCER
E. Fountzilas, K. Markou, K. Vlachtsis, A. Nikolaou, P. Arapantoni-Dadioti, E. Ntoula, G. Tassopoulos, M. Bobos, P. Konstatninopoulos, G. Fountzilas & D. Spentzos
Ann Oncol.2012 Aug;23(8):2146-53. doi: 10.1093/annonc/mdr576
VINORELBINE VERSUS PACLITAXEL FOR PATIENTS WITH ADVANCED NON–SMALL CELL LUNG CANCER (NSCLC) AND A PERFORMANCE STATUS OF 2
P.A. Kosmidis, K. Syrigos, H.P. Kalofonos, M.A Dimopoulos, D. Skarlos, N. Pavlidis, I. Boukovinas, D. Bafaloukos, D. Pectasides, Ch. Bacoyiannis and G. Fountzilas
Anticancer Res. 2012 Jan;32(1):175-81
PROGNOSTIC UTILITY OF ANGIOGENESIS AND HYPOXIA EFFECTORS IN PATIENTS WITH OPERABLE SQUAMOUS CELL CANCER OF THE LARYNX
G. Pentheroudakis, I. Nicolaou, V. Kotoula, H. Fountzilas, K. Markou, A.G. Eleftheraki, A. Fragkoulidi, I. Karasmanis, A. Tsigka, N. Angouridakis, K. Vlachtsis, A. Nikolaou, N. Pavlidis, G. Fountzilas
Oral Oncol. 2012 Aug;48(8):709-16. doi: 10.1016/j.oraloncology.2012.02.002 (Epub 2012 Feb 25)
THE PROGNOSTIC AND PREDICTIVE VALUE OF MRNA EXPRESSION OF VEGF FAMILY MEMBERS IN BREAST CANCER: A STUDY IN PRIMARY TUMORS OF HIGH-RISK EARLY BREAST CANCER PATIENTS PARTICIPATING IN A RANDOMIZED HELLENIC COOPERATIVE ONCOLOGY GROUP TRIAL
H. Linardou, , K.T. Kalogeras, R. Kronenwett, G. Kouvatseas, R.M. Wirtz, F. Zagouri, H. Gogas, Ch. Christodoulou, A.K. Koutras, E. Samantas, D. Pectasides, D. Bafaloukos, G. Fountzilas
Breast Cancer Res. 2012 Nov 12;14(6):R145
DIFFERENTIAL RESPONSE OF IMMUNOHISTOCHEMICALLY DEFINED BREAST CANCER SUBTYPES TO DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY
G. Fountzilas, U. Dafni, M. Bobos, A. Batistatou, V. Kotoula, H. Trihia, V. Malamou-Mitsi, S. Miliaras, S. Chrisafi, S. Papadopoulos, M. Sotiropoulou, Th. Fillipidis, H. Gogas, T. Koletsa, D. Bafaloukos, D. Televantou, K.T. Kalogeras, D. Pectasides, D.V. Skarlos, A. Koutras, M.A. Dimopoulos
PloS One. 2012;7(6):e37946. doi: 10.1371/journal.pone.0037946 (Epub 2012 Jun 5)
IMPROVED OUTCOME OF HIGH-RISK EARLY HER2-POSITIVE BREAST CANCER WITH HIGH CXCL13/CXCR5 MRNA EXPRESSION
E. Razis, K.T. Kalogeras, V. Kotoula, A.G. Eleftheraki, N. Nikitas, R. Kronenwett, E. Timotheadou, Ch. Christodoulou, D. Pectasides, H. Gogas, R.M. Wirtz, Th.Makatsoris, Di. Bafaloukos, G. Aravantinos, D. Televantou, N. Pavlidis, G. Fountzilas
Clin Breast Cancer. 2012 Jun;12(3):183-93. doi: 10.1016/j.clbc.2012.03.006
IMMUNOHISTOCHEMICAL STUDY OF THE EPITHELIAL MESENCHYMAL TRANSITION PHENOTYPE IN CANCER OF UNKNOWN PRIMARY: INCIDENCE, CORRELATIONS AND PROGNOSTIC UTILITY
A. Stoyianni, A. Goussia, G. Pentheroudakis, V.Siozopoulou, E. Ioachim, D. Krikelis, V. Golfinopoulos, A. Cervantes, M. Bobos, Th. Fotsis, S. Bellou, G. Fountzilas, V. Malamou-Mitsi, N. Pavlidis
Anticancer Res. 2012 Apr;32(4):1273-81
INTRACELLULAR SIGNALLING VIA THE AKT AXIS AND DOWNSTREAM EFFECTORS IS ACTIVE AND PROGNOSTICALLY SIGNIFICANT IN CARCINOMAS OF UNKNOWN PRIMARY (CUP): A STUDY OF 100 CUP CASES
V. Golfinopoulos, G. Pentheroudakis, A. Goussia, V. Siozopoulou, M. Bobos, D. Krikelis, A. Cervantes, T. Ciuleanu, M. Marsellos, G. Fountzilas, V. Malamou-Mitsi, N. Pavlidis
Ann Oncol. 2012 Oct;23(10):2725-30 (Epub 2012 May 6)
PROFILING IMMUNOHISTOCHEMICAL EXPRESSION OF NOTCH1-3, JAGGED1, CMET, PHOSPHO-MAPK IN 100 CARCINOMAS OF UNKNOWN PRIMARY
D. Krikelis, G. Pentheroudakis, A.Goussia, V.Siozopoulou, M. Bobos, D. Petrakis, A. Stoyianni, V. Golfinopoulos, A. Cervantes, T. Ciuleanu, G. Fountzilas, V. Malamou-Mitsi, N. Pavlidis
Clin Exp Metastasis. 2012 Aug;29(6):603-14. doi: 10.1007/s10585-012-9474-4 (Epub 2012 Apr 19)
INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT RADIOTHERAPY AND WEEKLY CISPLATIN VERSUS THE SAME CONCOMITANT CHEMORADIOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA: A RANDOMIZED PHASE II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) WITH BIOMARKER EVALUATION
G. Fountzilas, E. Ciuleanu, M. Bobos, A. Kalogera-Fountzila, A.G. Eleftheraki, G. Karayannopoulou, T. Zaramboukas, A. Nikolaou, K. Markou, L. Resiga, D. Dionysopoulos, E. Samantas, H. Athanassiou, D. Misailidou, D. Skarlos, T. Ciuleanu
Ann Oncol. 2012 Feb;23(2):427-35. doi: 10.1093/annonc/mdr116 (Epub 2011 Apr 27)
TRIPLE-NEGATIVE PHENOTYPE IS OF ADVERSE PROGNOSTIC VALUE IN PATIENTS TREATED WITH DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY: A TRANSLATIONAL RESEARCH ANALYSIS IN THE CONTEXT OF A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) RANDOMIZED PHASE III TRIAL
P. Skarlos, C. Christodoulou, K.T. Kalogeras, A.G. Eleftheraki, M. Bobos, A. Batistatou, C. Valavanis, O. Tzaida, E. Timotheadou, R. Kronenwett, R.M Wirtz, I. Kostopoulos, D. Televantou, E. Koutselini, I. Papaspirou, C.A Papadimitriou, D. Pectasides, H. Gogas, G. Aravantinos, N. Pavlidis, P. Arapantoni, D.V. Skarlos, G. Fountzilas
Cancer Chemother Pharmacol. 2012 Feb;69(2):533-46. doi: 10.1007/s00280-011-1730-9 (Epub 2011 Sep 8)
XELΙRI-BEVACIZUMAB VERSUS FOLFIRI-BEVACIZUMAB AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE III TRIAL WITH COLLATERAL BIOMARKER ANALYSIS
D. Pectasides, G. Papaxoinis, K.T. Kalogeras, A.G. Eleftheraki, I. Xanthakis, Th. Makatsoris, E. Samantas, I. Varthalitis, P. Papakostas, N. Nikitas, C.N. Papandreou, G. Pentheroudakis, E. Timotheadou, A. Koutras, J. Sgouros, D. Bafaloukos, G. Klouvas, Th. Economopoulos, K.N. Syrigos, G. Fountzilas
BMC Cancer. 2012 Jun 29;12:271. doi: 10.1186/1471-2407-12-271
TOPOISOMERASE II alpha GENE AMPLIFICATION IS A FAVORABLE PROGNOSTIC FACTOR IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER TREATED WITH TRASTUZUMAB
G. Fountzilas, Ch. Christodoulou, M. Bobos, V. Kotoula, A.G. Eleftheraki, I. Xanthakis, A. Batistatou, G. Pentheroudakis, N. Xiros, I. Papaspirou, A. Koumarianou, P. Papakostas, D. Bafaloukos, D.V. Skarlos, K.T. Kalogeras
J Transl Med. 2012 Oct 23;10:212. doi: 10.1186/1479-5876-10-212
PREVALENCE OF BRCA1 MUTATIONS AMONG 403 WOMEN WITH TRIPLE-NEGATIVE BREAST CANCER: IMPLICATIONS FOR GENETIC SCREENING SELECTION CRITERIA: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
F. Fostira, M. Tsitlaidou, C. Papadimitriou, M. Pertesi, E. Timotheadou, A.V. Stavropoulou, S. Glentis, E. Bournakis, M. Bobos, D. Pectasides, P. Papakostas, G. Pentheroudakis, H. Gogas, P. Skarlos, E. Samantas, D. Bafaloukos, P.A. Kosmidis, A. Koutras, D. Yannoukakos, I. Konstantopoulou, G. Fountzilas
Breast Cancer Res. Treat. 2012 Jul;134(1):353-62. doi: 10.1007/s10549-012-2021-9 (Epub 2012 Mar 21)
PROGNOSTIC SIGNIFICANCE OF RACGAP1 MRNA EXPRESSION IN HIGH-RISK EARLY BREAST CANCER.A HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG) STUDY
K. Pliarchopoulou, K.T. Kalogeras, R. Kronenwett, R.M. Wirtz, A.G. Eleftheraki, A. Batistatou, M. Bobos, N. Soupos, G. Polychronidou, H. Gogas, E. Samantas, C. Christodoulou, T. Makatsoris, N. Pavlidis, D. Pectasides, G. Fountzilas
Cancer Chemother Pharmacol. 2013 Jan;71(1):245-55. doi: 10.1007/s00280-012-2002-z (Epub 2012 Oct 25.)
LAPATINIB AND CAPECITABINE COMBINATION FOR HER2 POSITIVE METASTATIC BREAST CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
H. Linardou, D.V. Skarlos, C. Christodoulou, A. Koutras, D. Bafaloukos, P. Papakostas, E. Kostouras, I. Grossi, E. Galani, D. Pectasides, G. Fountzilas
Mediterranean Oncology Journal (MOJ). 2012;1:40-44
COMBINATION TREATMENT WITH METRONOMIC TEMOZOLOMIDE, BEVACIZUMAB AND LONG-ACTING OCTREOTIDE FOR MALIGNANT NEUROENDOCRINE TUMOURS
A. Koumarianou, S. Antoniou, G. Kanakis, N. Economopoulos, D. Rontogianni, A. Ntavatzikos, N. Tsavaris, D. Pectasides, G. Dimitriadis, G. Kaltsas
Endocr Relat Cancer. 2012 Jan 9;19(1):L1-4. doi: 10.1530/ERC-11-0287. Print 2012 Feb
EXPRESSION OF DNA REPAIR AND REPLICATION GENES IN NON-SMALL CELL LUNG CANCER (NSCLC): A ROLE FOR THYMIDYLATE SYNTHETASE (TYMS)
V. Kotoula, D. Krikelis, V. Karavasilis, T. Koletsa, A.G. Eleftheraki, D. Televantou, Ch. Christodoulou, S. Dimoudis, I. Korantzis, D. Pectasides, K.N. Syrigos, P. A Kosmidis, G. Fountzilas
BMC Cancer. 2012 Aug 6;12:342. doi: 10.1186/1471-2407-12-342
MOLECULAR PREDICTORS OF RESPONSE TO TYROSINE KINASE INHIBITORS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER
S. Murray, V. Karavasilis, M. Bobos, E. Razis, S. Papadopoulos, Ch. Christodoulou, P. Kosmidis, G. Fountzilas
J Exp Clin Cancer Res. 2012 Sep 19;31(1):77. doi: 10.1186/1756-9966-31-77
COST-MINIMIZATION ANALYSIS OF THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER IN GREECE
V. Fragoulakis, V. Papagiannopoulou, G. Kourlaba, N. Maniadakis and G. Fountzilas
Clin Ther. 2012 Oct;34(10):2132-42. doi: 10.1016/j.clinthera.2012.09.005
ASSOCIATION OF ERCC1SNPs WITH OUTCOME IN PLATINUM-TREATED PATIENTS WITH ADVANCED UROTHELIAL CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
N. Nikitas, A. Karadimou, E. Tsitoura, N. Soupos, M. Tsiatas, V. Karavasilis, D. Pectasides, N. Pavlidis, M. Chrisofos, I. Adamakis, S. Murray, G. Fountzilas, M.A. Dimopoulos, A. Bamias
Pharmacogenomics. 2012 Nov;13(14):1595-607. doi: 10.2217/pgs.12.162
PROSPECTIVE, OPEN-LABEL, RANDOMIZED, PHASE III STUDY OF TWO DOSE-DENSE REGIMENS MVAC VERSUS GEMCITABINE/CISPLATIN IN PATIENTS WITH INOPERABLE, METASTATIC OR RELAPSED UROTHELIAL CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY (HE1603)
A. Bamias, U. Dafni, A. Karadimou, E. Timotheadou, G. Aravantinos, A. Psyrri, I. Xanthakis, M. Tsiatas, M. Koutoulidis, C. Constantinidis, C. Hatzimouratidis, E. Samantas, A. Visvikis, M. Chrisophos, K. Stravodimos, C. Deliveliotis, A. Eleftheraki, D. Pectasides, G. Fountzilas, M.A. Dimopoulos
Ann Oncol. 2013 Apr;24(4):1011-7. doi: 10.1093/annonc/mds583. (Epub 2012 Nov 7)
SURVIVAL FROM BREAST CANCER IN RELATION TO ACCESS TO TERTIARY HEALTHCARE, BODY MASS INDEX, TUMOR CHARACTERISTICS AND TREATMENT: A HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG) STUDY
P. Panagopoulou, H. Gogas, N. Dessypris, N. Maniadakis, G. Fountzilas, E.T. Petridou
Eur J Epidemiol. 2012 Nov;27(11):857-66. doi: 10.1007/s10654-012-9737-z. (Epub 2012 Oct 20)
GLOBAL MICRORNA PROFILING IN FAVORABLE PROGNOSIS SUBGROUPS OF CANCER OF UNKNOWN PRIMARY (CUP) DEMONSTRATES NO SIGNIFICANT EXPRESSION DIFFERENCES WITH METASTASES OF MATCHED KNOWN PRIMARY TUMORS
G. Pentheroudakis, Y. Spector, D. Krikelis, V. Kotoula, E. Meiri, V. Malamou-Mitsi, G. Fountzilas, M. Sanden, N. Pavlidis, H. Benjamin, R. Aharonov
Clin Exp Metastasis. 2013 Apr;30(4):431-9. doi: 10.1007/s10585-012-9548-3. (Epub 2012 Nov 4)
DARPP32, STAT5 AND STAT3 MRNA EXPRESSION RATIOS IN GLIOBLASTOMAS ARE ASSOCIATED WITH PATIENT OUTCOME
D. Televantou, G. Karkavelas, P. Hytiroglou, S. Lampaki, G. Iliadis, P. Selviaridis, K.S. Polyzoidis, G. Fountzilas, V. Kotoula
Pathol Oncol Res. 2013 Apr;19(2):329-43. doi: 10.1007/s12253-012-9588-7. (Epub 2012 Dec 20)
SAMPLE PARAMETERS AFFECTING THE CLINICAL RELEVANCE OF RNA BIOMARKERS IN TRANSLATIONAL BREAST CANCER RESEARCH
V. Kotoula, K.T. Kalogeras, G. Kouvatseas, D. Televantou, R. Kronenwett, R.M. Wirtz, G. Fountzilas
Virchows Arch. 2013 Feb;462(2):141-54. doi: 10.1007/s00428-012-1357-1. (Epub 2012 Dec 20)
EXPRESSION OF ANGIOGENIC MARKERS IN THE PERIPHERAL BLOOD OF PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH WEEKLY DOCETAXEL
I. Korantzis, K.T Kalogeras, G. Papaxoinis, V. Kotoula, A. Koutras, N. Soupos, P. Papakostas, D. Dionysopoulos, E. Samantas, Ch. Christodoulou, H. Linardou, D. Pectasides, G. Fountzilas
Anticancer Res. 2012 Oct;32(10):4569-80
Δημοσιεύσεις 2013
TMA CONSTRUCTION AND IMMUNOHISTOCHEMISTRY {additional file 1}
RNA EXTRACTION AND RT‐PCR METHODOLOGY {additional file 2}
DESCRIPTIVES OF PROTEIN AND mRNA EXPRESSION {Supplementary Table 1, additional file 3}
PROGNOSTIC SIGNIFICANCE OF RACGAP1 mRNA EXPRESSION IN HIGH-RISK EARLY BREAST CANCER: A STUDY IN PRIMARY TUMORS OF BREAST CANCER PATIENTS PARTICIPATING IN A RANDOMIZED HELLENIC COOPERATIVE ONCOLOGY GROUP TRIAL
K. Pliarchopoulou, K.T. Kalogeras, R. Kronenwett, R.M. Wirtz, A.G. Eleftheraki, A. Batistatou, M. Bobos, N. Soupos, G. Polychronidou, H. Gogas, E. Samantas, C. Christodoulou, T. Makatsoris, N. Pavlidis, D. Pectasides, G. Fountzilas
Cancer Chemother Pharmacol. 2013 Jan;71(1):245-55. doi: 10.1007/s00280-012-2002-z (Epub 2012 Oct 25)
A PHASE I STUDY OF TEMOZOLOMIDE AND LAPATINIB COMBINATION IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
V. Karavasilis, V. Kotoula, G. Pentheroudakis, D.Televantou, S. Lambaki, S. Chrisafi,M. Bobos, G. Fountzilas
J Neurol. 2013 Jun;260(6):1469-80. doi: 10.1007/s00415-012-6812-z.
INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R) EXPRESSION AND SURVIVAL IN OPERABLE SQUAMOUS-CELL LARYNGEAL CANCER
G. Mountzios, I. Kostopoulos, V. Kotoula, I. Sfakianaki, E. Fountzilas, K. Markou, I. Karasmanis, S. Levva, N. Angouridakis, K. Vlachtsis, A. Nikolaou, J. Constantinidis, G. Fountzilas
PLoS One. 2013;8(1):e54048. doi: 10.1371/journal.pone.0054048 (Epub 2013 Jan 24)
EXPRESSION PROFILING OF 21 BIOMOLECULES IN LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMAS OF CAUCASIAN PATIENTS
D. Krikelis, M. Bobos, G. Karayannopoulou, L. Resiga, S. Chrysafi, E. Samantas, D. Andreopoulos, V. Vassiliou, E. Ciuleanu, G. Fountzilas G
BMC Clin Pathol. 2013 Jan 29;13:1. doi: 10.1186/1472-6890-13-1
PSYCHIATRIC MANIFESTATIONS, PERSONALITY TRAITS AND HEALTH-RELATED QUALITY OF LIFE IN CANCER OF UNKNOWN PRIMARY SITE
T. Hyphantis, I. Papadimitriou, D. Petrakis, G. Fountzilas, D. Repana, K. Assimakopoulos, A.F. Carvalho, N. Pavlidis
Psychooncology. 2013 Jan 29. doi: 10.1002/pon.3244. [Epub ahead of print]
SAMPLE PARAMETERS AFFECTING THE CLINICAL RELEVANCE OF RNA BIOMARKERS IN TRANSLATIONAL BREAST CANCER RESEACH
V. Kotoula, K.T Kalogeras, G. Kouvatseas, D. Televantou, R. Kronenwett, R.M Wirtz, G. Fountzilas
Virchows Arch. 2013 Feb;462(2):141-54. doi: 10.1007/s00428-012-1357-1. (Epub 2012 Dec 20)
BIOMARKERS OF BENEFIT FROM CETUXIMAB-BASED THERAPY IN METASTATIC COLORECTAL CANCER: INTERACTION OF EGFR LIGAND EXPRESSION WITH RAS/RAF, PIK3CA GENOTYPES
G. Pentheroudakis, V. Kotoula, W. De Roock, G. Kouvatseas, P. Papakostas, T. Makatsoris, D. Papamichael, I. Xanthakis, J. Sgouros, D. Televantou, G. Kafiri, A.C. Tsamandas, E. Razis, E. Galani, D. Bafaloukos, I. Efstratiou, I. Bompolaki, D. Pectasides, N. Pavlidis, S. Tejpar, G. Fountzilas
BMC Cancer. 2013 Feb 2;13:49. doi: 10.1186/1471-2407-13-49
CYCLIN D1, EGFR, AND Akt/mTOR PATHWAY. POTENTIAL PROGNOSTIC MARKERS IN LOCALIZED LARYNGEAL SQUAMOUS CELL CARCINOMA
D. Dionysopoulos, K. Pavlakis, V. Kotoula, E. Fountzilas, K. Markou, I. Karasmanis, N. Angouridakis, A. Nikolaou, K.T Kalogeras, G. Fountzilas
Strahlenther Onkol. 2013 Mar;189(3):202-14. doi: 10.1007/s00066-012-0275-0 (Epub 2013 Feb 13)
HER2 GENE COPY NUMBER STATUS MAY INFLUENCE CLINICAL EFFICACY TO ANTI-EGFR MONOCLONAL ANTIBODIES IN METASTATIC COLORECTAL CANCER PATIENTS
V. Martin, L. Landi, F. Molinari, G. Fountzilas G, R. Geva, A. Riva, P. Saletti, S. De Dosso, A. Spitale, S. Tejpar, K.T Kalogeras, L. Mazzucchelli, M. Frattini, F. Cappuzzo
Br J Cancer. 2013 Feb 19;108(3):668-75. doi: 10.1038/bjc.2013.4 (Epub 2013 Jan 24)
DOSE SELECTION TRIAL OF METRONOMIC ORAL VINORELBINE MONOTHERAPY IN PATIENTS WITH METASTATIC CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP CLINICALTRANSLATIONAL STUDY
E. Briasoulis, G. Aravantinos, G. Kouvatseas, P. Pappas, E. Biziota, I. Sainis, T. Makatsoris, I. Varthalitis, I. Xanthakis, A. Vassias, G. Klouvas, I. Boukovinas, G. Fountzilas, K.N Syrigos, H. Kalofonos, E. Samantas
BMC Cancer. 2013 May 29;13(1):263 (Epub ahead of print)
MOLECULAR PROFILE OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS BEARING p16 HIGH PHENOTYPE
T. Rampias, E. Pectasides, M. Prasad, C. Sasaki, P. Gouveris, A. Dimou, P. Kountourakis, C. Perisanidis,
B. Burtness, T. Zaramboukas, D. Rimm, G. Fountzilas, A. Psyrri
Ann Oncol. 2013 Aug;24(8):2124-31. doi: 10.1093/annonc/mdt013 (Epub 2013 Feb 13)
EVALUATION OF THE PROGNOSTIC ROLE OF CENTROMERE 17 GAIN AND HER2/TOPOISOMERASE II ALPHA GENE STATUS AND PROTEIN EXPRESSION IN PATIENTS WITH BREAST CANCER TREATED WITH ANTHRACYCLINE-CONTAINING ADJUVANT CHEMOTHERAPY: POOLED ANALYSIS OF TWO HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) PHASE III TRIALS
G. Fountzilas, U. Dafni, M. Bobos, V. Kotoula, A. Batistatou, I. Xanthakis, C. Papadimitriou,
I. Kostopoulos, T. Koletsa, E. Tsolaki, D. Televantou, E. Timotheadou, A. Koutras, G. Klouvas, E. Samantas, N. Pisanidis, C. Karanikiotis, I. Sfakianaki, N. Pavlidis, H. Gogas, H. Linardou, K.T Kalogeras KT, D. Pectasides, M.A Dimopoulos
BMC Cancer. 2013 Mar 28;13:163. doi: 10.1186/1471-2407-13-163
PREVALENCE OF BRCA1 MUTATIONS IN FAMILIAL AND SPORADIC GREEK OVARIAN CANCER CASES
A.V Stavropoulou, F. Fostira, M. Pertesi, M. Tsitlaidou, G.E Voutsinas, O. Triantafyllidou, A. Bamias, M.A Dimopoulos, E. Timotheadou, D. Pectasides, C. Christodoulou, G. Klouvas, C. Papadimitriou, T. Makatsoris, G. Pentheroudakis, G. Aravantinos, V. Karydakis, D. Yannoukakos, G. Fountzilas, I. Konstantopoulou
PLoS One. 2013;8(3):e58182. doi: 10.1371/journal.pone.0058182 (Epub 2013 Mar 11)
DARPP32, STAT5 AND STAT3 mRNA EXPRESSION RATIOS IN GLIOBLASTOMAS ARE ASSOCIATED WITH PATIENT OUTCOME
D. Televantou, G. Karkavelas, P. Hytiroglou, S. Lampaki, Iliadis G, Selviaridis P, Polyzoidis KS,
G. Fountzilas, V. Kotoula
Pathol Oncol Res. 2013 Apr;19(2):329-43. doi: 10.1007/s12253-012-9588-7 (Epub 2012 Dec 20)
GLOBAL microRNA PROFILING IN FAVORABLE PROGNOSIS SUBGROUPS OF CANCER OF UNKNOWN PRIMARY (CUP) DEMONSTRATES NO SIGNIFICANT EXPRESSION DIFFERENCES WITH METASTASES OF MATCHED KNOWN PRIMARY TUMORS
G. Pentheroudakis, Y. Spector, D. Krikelis, V. Kotoula, E. Meiri, V. Malamou-Mitsi, G. Fountzilas, M. Sanden, N. Pavlidis, H. Benjamin, R. Aharonov
Clin Exp Metastasis. 2013 Apr;30(4):431-9. doi: 10.1007/s10585-012-9548-3. (Epub 2012 Nov 4)
EVALUATION OF CURRENT PROGNOSTIC AND PREDICTIVE MARKERS IN BREAST CANCER: A VALIDATION STUDY OF TISSUE MICROARRAYS
A. Batistatou, D. Televantou, M. Bobos, A.G Eleftheraki, E. Kouvaras, S. Chrisafi, G.K Koukoulis, V. Malamou-Mitsi, G. Fountzilas
Anticancer Res. 2013 May;33(5):2139-45
IXABEPILONE ADMINISTERED WEEKLY OR EVERY THREE WEEKS IN HER2-NEGATIVE METASTATIC BREAST CANCER PATIENTS; A RANDOMIZED NON-COMPARATIVE PHASE II TRIAL
G. Fountzilas, V. Kotoula, D. Pectasides, G. Kouvatseas, E. Timotheadou, M. Bobos, X. Mavropoulou, C. Papadimitriou, E. Vrettou, G. Raptou, A. Koutras, E. Razis, D. Bafaloukos, E. Samantas, G. Pentheroudakis, D.V. Skarlos
PLoS One. 2013 Jul 23;8(7):e69256. doi: 10.1371/journal.pone.0069256. Print 2013
DEVELOPMENT AND VALIDATION OF A PROGNOSTIC MODEL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB: A EUROPEAN COLLABORATION
A. Bamias, K. Tzannis, B. Beuselinck, S. Oudard, B. Escudier, D. Diosynopoulos, K. Papazisis, H. Lang, P. Wolter, E. de Guillebon, K. Stravodimos, M. Chrisofos, G. Fountzilas, R.T. Elaidi, M.A. Dimopoulos, C. Bamia
Br J Cancer. 2013 Jul 23;109(2):332-41. doi: 10.1038/bjc.2013.341. Epub 2013 Jun 27
PROGNOSTIC SIGNIFICANCE OF ESR1 GENE AMPLIFICATION, mRNA/PROTEIN EXPRESSION AND FUNCTIONAL PROFILES IN HIGH-RISK EARLY BREAST CANCER: A TRANSLATIONAL STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
G. Pentheroudakis, V. Kotoula, A.G. Eleftheraki, E. Tsolaki, R.M. Wirtz, K.T. Kalogeras, A. Batistatou, M. Bobos, M.A. Dimopoulos, E. Timotheadou, H. Gogas, C. Christodoulou, K. Papadopoulou, I. Efstratiou, C.D Scopa, I. Papaspyrou, D. Vlachodimitropoulos, H. Linardou, E. Samantas, D. Pectasides, N. Pavlidis, G. Fountzilas
PLoS One. 2013 Jul 29;8(7):e70634. doi: 10.1371/journal.pone.0070634. Print 2013
THE PROGNOSTIC ROLE OF EPHRIN A2 AND ENDOTHELIAL GROWTH FACTOR RECEPTOR PATHWAY MEDIATORS IN PATIENTS WITH ADVANCED COLORECTAL CANCER TREATED WITH CETUXIMAB
A. Strimpakos, G. Pentheroudakis, V. Kotoula, W. De Roock, G. Kouvatseas, P. Papakostas,T. Makatsoris, D. Papamichael, A. Andreadou, J. Sgouros, A. Zizi-Sermpetzoglou, A. Kominea, D. Televantou, E. Razis, E. Galani, D. Pectasides, S. Tejpar, K. Syrigos, G. Fountzilas
Clin Colorectal Cancer. 2013 Dec;12(4):267-274.e2. doi: 10.1016/j.clcc.2013.07.001.
THE PROGNOSTIC SIGNIFICANCE OF WNT PATHWAY IN SURGICALLY-TREATED COLORECTAL CANCER: β-CATENIN EXPRESSION PREDICTS FOR DISEASE-FREE SURVIVAL
K. Kamposioras, A. Konstantara, V. Kotoula, S. Lakis, G. Kouvatseas, E. Akriviadis, E. Vrettou, D. Dionysopoulos, D. Krikelis, K. Papadopoulou, E. Charalambous, S. Chrisafi, C. Konstantaras, G. Fountzilas
Anticancer Res. 2013 Oct;33(10):4573-84
MULTIPLE INDEPENDENT VARIANTS AT THE TERT LOCUS ARE ASSOCIATED WITH TELOMERE LENGTH AND RISKS OF BREAST AND OVARIAN CANCER
S.E.Bojesen … D. Yannoukakos … G. Fountzilas et al
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi: 10.1038/ng.2566
VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS AND CLINICAL OUTCOME IN PATIENTS WITH METASTATIC BREAST CANCER TREATED WITH WEEKLY DOCETAXEL
A.K. Koutras, V. Kotoula, C. Papadimitriou, D. Dionysopoulos, F. Zagouri, H.P. Kalofonos,H.P. Kourea, D.V. Skarlos, E. Samantas, K. Papadopoulou, P. Kosmidis, D. Pectasides, G. Fountzilas
Pharmacogenomics J. 2013 Sep 24. doi: 10.1038/tpj.2013.36. [Epub ahead of print]
IDENTIFICATION AND VALIDATION OF A MULTIGENE PREDICTOR OF RECURRENCE IN PRIMARY LARYNGEAL CANCER
E. Fountzilas, V. Kotoula, N. Angouridakis, I. Karasmanis, R.M. Wirtz, A.G. Eleftheraki, E. Veltrup, K. Markou, A. Nikolaou, D. Pectasides, G. Fountzilas
PLoS One. 2013 Aug 9;8(8):e70429. doi: 10.1371/journal.pone.0070429. (eCollection 2013)
NOVEL microRNA-BASED ASSAY DEMONSTRATES 92% AGREEMENT WITH DIAGNOSIS BASED ON CLINICOPATHOLOGIC AND MANAGEMENT DATA IN A COHORT OF PATIENTS WITH CARCINOMA OF UNKNOWN PRIMARY
G. Pentheroudakis, N. Pavlidis, G. Fountzilas, D. Krikelis, A. Goussia, A. Stoyianni, M. Sanden, B. St Cyr, N. Yerushalmi, H. Benjamin, E. Meiri, A. Chajut, S. Rosenwald, R. Aharonov, Y. Spector
Mol Cancer. 2013 Jun 10;12:57. doi: 10.1186/1476-4598-12-57
BEVACIZUMAB AND MICROMETASTASES: REVISITING THE PRECLINICAL AND CLINICAL ROLLERCOASTER
G. Mountzios, G. Pentheroudakis, P. Carmeliet
Pharmacol Ther. 2013 Sep 27. pii: S0163-7258(13)00192-7. doi: 10.1016/j.pharmthera.2013.09.003. [Epub ahead of print]
INSIGHTS INTO THE EPITHELIAL MESENCHYMAL TRANSITION PHENOTYPE IN CANCER OF UNKNOWN PRIMARY FROM A GLOBAL MICRORNA PROFILING STUDY”, HAS BEEN ACCEPTED FOR PUBLICATION IN CLINICAL AND TRANSLATIONAL ONCOLOGY
A. Stoyianni, G. Pentheroudakis, H. Benjamin, A. Cervantes, K. Ashkenazi, G. Lazaridis, N. Pavlidis, Y Spector
Clin Transl Oncol. 2013 Nov 27. [Epub ahead of print]
EXPLORING THE BIOLOGY OF CANCER OF UNKNOWN PRIMARY: BREAKTHROUGHS AND DRAWBACKS
K. Kamposioras, G. Pentheroudakis, N. Pavlidis
Eur J Clin Invest 2013 May;43(5):491-500. doi: 10.1111/eci.12062. Epub 2013 Mar 11. Review
NOVEL APPROACHES FOR CONCURRENT IRRADIATION IN LOCALLY ADVANCED CERVICAL CANCER: PLATINUM COMBINATIONS, NON-PLATINUM-CONTAINING REGIMENS, AND MOLECULAR TARGETED AGENTS
G. Mountzios, A. Soultati, D. Pectasides, M.A dimopoulos and Ch. Papadimitriou
Obstet Gynecol Int. 2013;2013:536765. doi: 10.1155/2013/536765. Epub 2013 May 21
Δημοσιεύσεις 2014
A STUDY OF GENE EXPRESSION MARKERS FOR PREDICTIVE SIGNIFICANCE FOR BEVACIZUMAB BENEFIT IN PATIENTS WITH METASTATIC COLON CANCER: A TRANSLATIONAL RESEARCH STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
G. Pentheroudakis, V. Kotoula, E. Fountzilas, G. Kouvatseas, G. Basdanis, I. Xanthakis, T. Makatsoris, E. Charalambous, PD. apamichael, E. Samantas, P. Papakostas, D. Bafaloukos, E. Razis, C. Christodoulou, I. Varthalitis, N. Pavlidis, G. Fountzilas
BMC Cancer. 2014 Feb 20;14(1):111. doi: 10.1186/1471-2407-14-111
HIGH PREVALENCE OF BRCA1 FOUNDER MUTATIONS IN GREEK BREAST/OVARIAN FAMILIES
I. Konstantopoulou, M. Tsitlaidou, F. Fostira, M. Pertesi, A.V Stavropoulou, O. Triantafyllidou, E. Tsotra, A. Tsiftsoglou, C. Tsionou, S. Droufakou, C. Dimitrakakis, G. Fountzilas, D. Yannoukakos
Clin Genet. 2014 Jan;85(1):36-42. doi: 10.1111/cge.12274. Epub 2013 Oct 20
VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS AND CLINICAL OUTCOME IN PATIENTS WITH METASTATIC BREAST CANCER
AK. Koutras, V. Kotoula, C. Papadimitriou, D. Dionysopoulos, F. Zagouri, HP. Kalofonos, HP. Kourea, DV. Skarlos , E. Samantas , K. Papadopoulou , P. Kosmidis, D. Pectasides, G. Fountzilas
Pharmacogenomics J. 2014 Jun;14(3):248-55. doi: 10.1038/tpj.2013.36. Epub 2013 Sep 24
MARKERS OF EPITHELIAL TO MESENCHYMAL TRANSITIONS IN ASSOCIATION ASSOCIATION WITH SURVIVAL IN HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
E. Pectasides, T. Rampias, C. Sasaki, C. Perisanidis, V. Kouloulias, B. Burtness, T. Zaramboukas, D. Rimm, G. Fountzilas, A. Psyrri
PLoS One. 2014 Apr 10;9(4):e94273. doi: 10.1371/journal.pone.0094273. eCollection 2014
A NEW MATHEMATICAL MODEL FOR THE INTERPRETATION OF TRANSLATIONAL RESEARCH EVALUATING SIX CTLA-4 POLYMORPHISMS IN HIGH-RISK MELANOMA PATIENTS RECEIVING ADJUVANT INTERFERON
P. Pancoska, JM. Kirkwood, S. Bouros, M. Spyropoulou-Vlachou, E. Pectasides, D. Tsoutsos, A. Polyzos, C. Markopoulos, P. Panagiotou, O. Castana, D. Bafaloukos, G. Fountzilas, H. Gogas
PLoS One. 2014 Jan 27;9(1):e86375. doi: 10.1371/journal.pone.0086375. eCollection 2014
PROGNOSTIC SIGNIFICANCE OF THE WNT PATHWAY IN SQUAMOUS CELL LARYNGEAL CANCER
A. Psyrri, V. Kotoula, E. Fountzilas, Z. Alexopoulou, M. Bobos , D. Televantou, G. Karayannopoulou, D. Krikelis, K. Markou, I. Karasmanis, N. Angouridakis, KT. Kalogeras, A. Nikolaou, G. Fountzilas
Oral Oncol. 2014 Apr;50(4):298-305. doi: 10.1016/j.oraloncology.2014.01.005. Epub 2014 Jan 21
EGFR GENE GAIN AND PTEN PROTEIN EXPRESSION ARE FAVORABLE PROGNOSTIC FACTORS IN PATIENTS WITH KRAS WILD-TYPE METASTATIC COLORECTAL CANCER TREATED WITH CETUXIMAB
E. Razis, G. Pentheroudakis, G. Rigakos, M. Bobos, G. Kouvatseas, O. Tzaida, T. Makatsoris, P. Papakostas, M. Bai, A. Goussia, E. Samantas, D. Papamichael, O. Romanidou, I. Efstratiou, E. Tsolaki, A. Psyrri, W. De Roock, D. Bafaloukos, G. Klouvas, S. Tejpar, KT. Kalogeras, D. Pectasides, G. Fountzilas
J Cancer Res Clin Oncol. 2014 May;140(5):737-48. doi: 10.1007/s00432-014-1626-2. Epub 2014 Mar 5
DIFFERENTIAL EXPRESSION OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR AMONG EARLY BREAST CANCER SUBTYPES
G. Mountzios, D. Aivazi, I. Kostopoulos, HP. Kourea, G. Kouvatseas, E. Timotheadou, P. Zebekakis, I. Efstratiou, H. Gogas, C. Vamvouka, S. Chrisafi, A. Stofas, G. Pentheroudakis, A. Koutras, E. Galani, D. Bafaloukos, G. Fountzilas
PLoS One. 2014 Mar 17;9(3):e91407. doi: 10.1371/journal.pone.0091407. eCollection 2014
ASSOCIATION OF VEGF-A SPLICE VARIANT mRNA EXPRESSION WITH OUTCOME IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC BREAST CANCER
G. Pentheroudakis, V. Kotoula, G. Kouvatseas, E. Charalambous, D. Dionysopoulos, F. Zagouri, A. Koutras, K. Papazisis, D. Pectasides, E. Samantas, MA. Dimopoulos, CN. Papandreou, G. Fountzilas
Clin Breast Cancer. 2014 Mar 1. pii: 1526-8209(14)00034-2. doi: 10.1016/j.clbc.2014.02.009. [Epub ahead of print]
GENOME-WIDE ASSOCIATION STUDY IDENTIFIES 25 KNOWN BREAST CANCER SUSCEPTIBILITY LOCI AT RISK FACTORS FOR TRIPLE-NEGATIVE BREAST CANCER
KS. Purrington , S. Slager, D. Eccles, D. Yannoukakos, PA. Fasching, … D. Yannoukakos, I. Konstantopoulou, F. Fostira, A. Vratimos,P. Apostolou, I. Konstanta, V. Kotoula, S. Lakis, MA. Dimopoulos, D. Skarlos, D. Pectasides, G. Fountzilas
Carcinogenesis. 2014 May;35(5):1012-9. doi: 10.1093/carcin/bgt404. Epub 2013 Dec 9
LACK OF ASSOCIATION BETWEEN KRAS MUTATIONS AND 18F-FDG PET/CT IN CAUCASIAN METASTATIC COLORECTAL CANCER PATIENTS
D. Krikelis, E. Skoura, V. Kotoula, P. Rondogianni, N. Pianou, A. Samartzis, I. Xanthakis, G. Fountzilas, IE. Datseris
Anticancer Res. 2014 May;34(5):2571-9
THE ANDROGEN RECEPTOR AS A SURROGATE MARKER FOR MOLECULAR APOCRINE BREAST CANCER SUBTYPING
S. Lakis, V. Kotoula, AG. Eleftheraki, A. Batistatou, M. Bobos, T. Koletsa, E. Timotheadou, S. Chrisafi, G. Pentheroudakis, A. Koutras, F. Zagouri, H. Linardou, G. Fountzilas
Breast. 2014 Jun;23(3):234-43. doi: 10.1016/j.breast.2014.02.013. Epub 2014 Apr 3
p85 PROTEIN EXPRESSION IS ASSOCIATED WITH POOR SURVIVAL IN HER2-POSITIVE PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH TRASTUZUMAB
K. Pavlakis, M. Bobos, A. Batistatou, V. Kotoula, AG. Eleftheraki, A. Stofas, E. Timotheadou, G. Pentheroudakis, A. Psyrri, A. Koutras, D. Pectasides, P. Papakostas, E. Razis, C. Christodoulou, KT. Kalogeras, G. Fountzilas
Pathol Oncol Res. 2014 Aug 8. [Epub ahead of print]
PROGNOSTIC AND PREDICTIVE VALUE OF p-Akt, EGFR, AND p-mTOR IN EARLY BREAST CANCER
G. Lazaridis, S. Lambaki, G. Karayannopoulou, AG. Eleftheraki, I. Papaspirou, M. Bobos, I. Efstratiou, G. Pentheroudakis, N. Zamboglou, G. Fountzilas
Strahlenther Onkol. 2014 Jul;190(7):636-8, 640-5
IN SITU QUANTITATIVE MEASUREMENT OF HER2mRNA PREDICTS BENEFIT FROM TRASTUZUMAB-CONTAINING CHEMOTHERAPY IN A COHORT OF METASTATIC BREAST CANCER PATIENTS
M. Vassilakopoulou, T. Togun, U. Dafni, H. Cheng, J. Bordeaux, VM. Neumeister, M. Bobos, G. Pentheroudakis, DV. Skarlos, D. Pectasides, V. Kotoula, G. Fountzilas,DL. Rimm, A. Psyrri
PLoS One. 2014 Jun 26;9(6):e99131. doi: 10.1371/journal.pone.0099131. eCollection 2014
ADJUSTING BREAST CANCER PATIENT PROGNOSIS WITH NON-HER2-GENE PATTERNS ON CHROMOSOME 17
V. Kotoula, M. Bobos, Z. Alexopoulou, C. Papadimitriou, K. Papadopoulou, E. Charalambous, E. Tsolaki, G. Xepapadakis, I. Nicolaou, I. Papaspirou, G. Aravantinos, C. Christodoulou, I. Efstratiou, H. Gogas, G. Fountzilas
PLoS One. 2014 Aug 6;9(8):e103707. doi: 10.1371/journal.pone.0103707. eCollection 2014
GENETIC VARIATION IN MITOTIC REGULATORY PATHWAY GENES IS ASSOCIATED WITH BREAST TUMOR GRADE
K.S. Purrington…. D. Yannoukakos…. F. Fostira, G. Fountzilas, I. Konstantopoulou….
Hum Mol Genet. 2014 Nov 15;23(22):6034-46. doi: 10.1093/hmg/ddu300. Epub 2014 Jun 13.
T. Koletsa, F. Stavridi, M. Bobos, I. Kostopoulos, V. Kotoula, A.G. Eleftheraki, I.Konstantopoulou, Ch. Papadimitriou, A. Batistatou, H. Gogas, A. Koutras, D.V. Skarlos, G. Pentheroudakis, I. Efstratiou, D. Pectasides, G. Fountzilas
BMC Clin Pathol. 2014 Jun 23;14:28. doi: 10.1186/1472-6890-14-28. eCollection 2014.
H. Cheng, K.V Ballman, M. Vassilakopoulou, A.C Dueck, M. M Reinholz, K. Tenner, J. Gralow, C. Hudis, N.E Davidson, G. Fountzilas, A.E McCullough, B. Chen, A. Psyrri, D.L Rimm, E.A Perez
Br J Cancer. 2014 Sep 9;111(6):1065-71. doi: 10.1038/bjc.2014.442. Epub 2014 Aug 12.
DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY FOLLOWED, AS INDICATED, BY TRASTUZUMAB FOR ONE YEAR IN PATIENTS WITH EARLY BREAST CANCER: FIRST REPORT AT 5-YEAR MEDIAN FOLLOW-UP OF A HELLENIC COOPERATIVE ONCOLOGY GROUP RANDOMIZED PHASE III TRIAL
G. Fountzilas, U. Dafni, C. Papadimitriou, E. Timotheadou, H. Gogas, A.G. Eleftheraki, I. Xanthakis, C.Christodoulou, A. Koutras, C.N. Papandreou, P. Papakostas, S. Miliaras, C. Markopoulos, C. Dimitrakakis, P.Korantzopoulos, C. Karanikiotis, D. Bafaloukos, P. Kosmidis, E. Samantas, I. Varthalitis, N. Pavlidis, D.Pectasides, M.A. Dimopoulos
BMC Cancer, 2014 Jul 15;14:515. doi: 10.1186/1471-2407-14-515
G. Pentheroudakis, V. Kotoula, E. Fountzilas, G.Kouvatseas, G. Basdanis, I. Xanthakis, Th. Makatsoris, E. Charalambous, D. Papamichael, E. Samantas, P. Papakostas, D. Bafaloukos, E. Razis, Ch. Christodoulou, I. Varthalitis, N. Pavlidis and G. Fountzilas
BMC Cancer. 2014 Feb 20;14:111. doi: 10.1186/1471-2407-14-111.
BEVACIZUMAB AND MICROMETASTASES: REVISITING THE PRECLINICAL AND CLINICAL ROLLERCOASTER
G. Mountzios, G. Pentheroudakis, P. Carmeliet
Pharmacol Ther. 2014 Feb; 141(2):117-24. doi:10.1016/j.pharmthera.2013.09.003. Epub 2013 Sep 27.
PROGNOSTIC MARKERS IN EARLY STAGE COLORECTAL CANCER: SIGNIFICANCE OF TYMS rnRNA EXPRESSION
A. Koumarianou, I. Tzeveleki, D. Mekras, A.G. Eleftheraki, M. Bobos, R. Wirtz, E. Fountzilas, Ch. Valavanis, I. Xanthakis, K.T. Kalogeras, G. Basdanis, G. Pentheroudakis, V. Kotoula, G. Fountzilas
Anticancer Research, 2014 Sep;34(9):4949-62.
Δημοσιεύσεις 2015
PROGNOSTIC AND PREDICTIVE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS IN BREAST CANCER
Koutras A, Kotoula V, Fountzilas G.
Pharmacogenomics. 2015 Jan;16(1):79-94. doi: 10.2217/pgs.14.148
H.P. Kourea, V. Kotoula, A. Koutras, Z. Alexopoulou, I. Papaspirou, D.V. Skarlos, I. Efstratiou, M. Bobos, F. Zagouri, P. Papakostas, D. Pectasides, S. Chrisafi, I. Varthalitis, G. Aravantinos, P. Kosmidis, D. Bafaloukos, C.D. Scopa and G. Fountzilas
Histol Histopathol (2015) 30: 1129-1141
F.J. Couch, S.N. Hart, …….I. Konstantopoulou, F. Fostira, A. Vratimos, G. Fountzilas, …..D. Yannoukakos, S.L. Slager, C.M. Vachon, D.M. Eccles, and P.A. Fasching
Journal of Clinical Oncology, 33(4), 304-311, 2015
D.E Carvajal-Hausdorf, K.A Schalper, Pusztai L, A. Psyrri, K.T Kalogeras, V. Kotoula, G. Fountzilas, D.L Rimm
J Natl Cancer Inst. 2015 May 19;107(8). pii: djv136. doi: 10.1093/jnci/djv136. Print 2015 Aug
V. Kotoula, A. Lyberopoulou, K. Papadopoulou, E. Charalambous, Z. Alexopoulou, C. Gakou, S. Lakis, E. Tsolaki, K. Lilakos, G. Fountzilas
PLoS One. 2015 Jun 3;10(6):e0128818. doi: 10.1371/journal.pone.0128818. eCollection 2015
A. Koumarianou, G. Karayannopoulou, G. Gourgioti, A. Batistatou, M. Bobos, I. Efstratiou, D. Miliaras, E. Galani, G. Pentheroudakis, D. Pectasides, G. Aravantinos, D. Bafaloukos, P. Papakostas, E. Razis, H. P. Kalofonos, Kalliopi Petraki, Maria Sotiropoulou, Konstantine T. Kalogeras, George Fountzilas
Cancer Chemother Pharmacol. 2015 Jun;75(6):1289-301. doi: 10.1007/s00280-015-2762-3. Epub 2015 May 7.
CHEK2 c.1100delC ALLELE IS RARELY IDENTIFIED IN GREEK BREAST CANCER CASES
P. Apostolou, F. Fostira, M. Papamentzelopoulou, M. Michelli, C. Panopoulos, G. Fountzilas, I. Konstantopoulou, G.E Voutsinas, D. Yannoukakos
Cancer Genet. 2015 Apr;208(4):129-34. doi: 10.1016/j.cancergen.2015.02.006. Epub 2015 Feb 20
H. Linardou, K.T Kalogeras, R. Kronenwett, Z. Alexopoulou, R.M Wirt, F. Zagouri, C.D. Scopa, H. Gogas, K. Petraki, Ch. Christodoulou, K.Pavlakis, A.K Koutras, E. Samantas, H. Patsea, D. Pectasides, D. Bafaloukos, G. Fountzilas
Anticancer Res. 2015 Jul; 35 (7): 4023-36.
G . Kourlaba, M.A Dimopoulos, D. Pectasides, D.V Skarlos, H. Gogas, G. Pentheroudakis, A. Koutras, G. Fountzilas, N. Maniadakis
Support Care Cancer. 2015 Jul; 23 (7): 2045-51. doi: 10.1007/s00520-014-2555-y.
K. Pavlakis, M. Bobos, A. Batistatou, V. Kotoula, A.G Eleftheraki, A. Stofas, E. Timotheadou, G. Pentheroudakis, A. Psyrri, A. Koutras, D. Pectasides, P. Papakostas, E. Razis, C. Christodoulou, K.T Kalogeras, G. Fountzilas
Pathol Oncol Res. 2015 Apr;21(2):273-82. doi: 10.1007/s12253-014-9818-2.
G.Papaxoinis, V. Kotoula, Z. Alexopoulou, K.T. Kalogeras, F. Zagouri, E. Timotheadou, H. Gogas, G. Pentheroudakis, Ch. Christodoulou, A. Koutras, D. Bafaloukos, G. Aravantinos, P. Papakostas, E. Charalambous, K. Papadopoulou, I. Varthalitis, I. Efstratiou, Th. Zaramboukas, H. Patsea, C. D. Scopa, M. Skondra, P. Kosmidis, D. Pectasides, G. Fountzilas
PLoS One. 2015 Oct 9;10(10):e0140293. doi: 10.1371/journal.pone.0140293. eCollection 2015.
V. Kotoula, K. Chatzopoulos, S. Lakis, Z. Alexopoulou, E. Timotheadou, F. Zagouri, G. Pentheroudakis, H. Gogas, E. Galani, I. Efstratiou, Th. Zaramboukas, A. Koutras, G. Aravantinos, E. Samantas, A. Psyrri, H. Kourea, M. Bobos, P. Papakostas, P. Kosmidis, D. Pectasides, G. Fountzilas
Oncotarget. 2015 Oct 25. doi: 10.18632/oncotarget.6231. [Epub ahead of print]
H. Linardou, G. Pentheroudakis, I. Varthalitis, H. Gogas, D. Pectasides, T. Makatsoris, G. Fountzilas, D. Bafaloukos
Anticancer Res. 2015 Feb;35(2):1105-13
A. Malczewski,….D. Pectasides, G. Fountzilas, H. Gogas, …et al.
Cancer Med. 2015 Dec 8. doi: 10.1002/cam4.563. [Epub ahead of print]
Pentheroudakis G, Raptou G, Kotoula V, Wirtz RM, Vrettou E, Karavasilis V, Gourgioti G, Gakou C, Syrigos KN, Bournakis E, Rallis G, Varthalitis I, Galani E, Lazaridis G, Papaxoinis G, Pectasides D, Aravantinos G, Makatsoris T, Kalogeras KT, Fountzilas G.
PLoS One. 2015 May 13;10(5):e0124612. doi: 10.1371/journal.pone.0124612. eCollection 2015
D. Pectasides, V. Karavasilis, G. Papaxoinis, G. Gourgioti, T. Makatsoris, G. Raptou, E. Vrettou, J. Sgouros, E. Samantas, G. Basdanis, P. Papakostas, D. Bafaloukos, V. Kotoula, H.P Kalofonos, C.D Scopa, G. Pentheroudakis, G. Fountzilas
BMC Cancer. 2015 May 10;15:384. doi: 10.1186/s12885-015-1406-7.
K. Fizazi, R. Jones, S. Oudard, E. Efstathiou, F. Saad, R. de Wit, J. De Bono, F.M Cruz, G. Fountzilas, A. Ulys, F. Carcano, N. Agarwal, D. Agus, J. Bellmunt, D.P Petrylak, S.Y Lee, I.J Webb, B. Tejura, N. Borgstein, R. Dreicer
J Clin Oncol. 2015 Mar 1;33(7):723-31. doi: 10.1200/JCO.2014.56.5119. Epub 2015 Jan 26
K. Koutsoukos, K. Tzannis, C. Christodoulou, V. Karavasilis, C. Bakoyiannis, T. Makatsoris, C.N Papandreou, D. Pectasides, M.A Dimopoulos, A. Bamias
World J Urol, 2015, DOI 10.1007/s00345-015-1695-0
PROGNOSTIC SIGNIFICANCE OF WNT AND HEDGEHOG PATHWAY ACTIVATION MARKERS IN CANCER OF UNKNOWN PRIMARY
G .Fotopoulos, A. Gousia, E. Bareta, E. Koumpis, S. Xrysafi, M. Bobos, V. Malamou-Mitsi, G. Fountzilas, N. Pavlidis, G. Pentheroudakis
Eur J Clin Invest. 2015 Aug 13. doi: 10.1111/eci.12518. Epub 2015 Sep 13.
CHEMOTHERAPY AND RADIOTHERAPY IN NASOPHARYNGEAL CARCINOMA: AN UPDATE OF THE MAC-NPC META-ANALYSIS
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group.
Lancet Oncol. 2015 Jun;16(6):645-55. doi: 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6. PMID:25957714
D. Krikelis, V. Kotoula, M. Bobos, E. Fountzilas, K. Markou, I. Karasmanis, N. Angouridakis, K. Vlachtsis, K.T Kalogeras, A. Nikolaou, G. Fountzilas
Anticancer Res. 2014 Nov;34(11):6495-503
A. Psyrri et al
Clin Cancer Res. 2015 Sep 25. [Epub ahead of print]
V. Kotoula, M. Bobos, M. Vassilakopoulou, E. Tsolaki, S. Chrisafi, A. Psyrri, G. Lazaridis, K. Papadopoulou, I. Efstratiou, C. Michail-Strantzia, L.V Debelenko, P. Kosmidis, G. Fountzilas
Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):60-70. doi: 10.1097/PAI.0000000000000028.
R. Geva, L. Vecchione, K.T. Kalogeras, B. Vittrup Jensen, H.J Lenz , T. Yoshino, D. Paez, C. Montagut, J. Souglakos, F. Cappuzzo, A. Cervantes, M. Frattini, G. Fountzilas, J.S. Johansen, E.V Høgdall , W. Zhang, D. Yang, K. Yamazaki, T. Nishina, D. Papamichael, B. Vincenzi, T. Macarulla, F. Loupakis , J. De Schutter, K.L Garm Spindler, P. Pfeiffer, F. Ciardiello, H. Piessevaux, S. Tejpar
Gut. 2015 Jun;64(6):921-8. doi: 10.1136/gutjnl-2014-307234. Epub 2014 Jul 10.
Δημοσιεύσεις 2016
INTERACTION BETWEEN BETA-CATENIN AND EGFR EXPRESSION BY IMMUNOHISTOCHEMISTRY IDENTIFIES PROGNOSTIC SUBGROUPS IN EARLY HIGH-RISK TRIPLE NEGATIVE BREAST CANCER.
Sotirios Lakis, Stefanos Dimoudis, Vassiliki Kotoula, Zoi Alexopoulou, Ioannis Kostopoulos, Triantafyllia Koletsa, Mattheos Bobos, Eleni Timotheadou, Irene Papaspirou, Ioannis Efstratiou, Gerasimos Aravantinos, Vasilios Karavasilis, Flora Zagouri, Helen Gogas, Evangelia Razis, George Pentheroudakis, Christos Christodoulou, Dimitrios Pectasides, George Fountzilas
Anticancer Res. 2016 May;36(5):2365-78.
SAFETY AND TOLERABILITY OF ANTHRACYCLINE-CONTAINING ADJUVANT CHEMOTHERAPY IN ELDERLY HIGH-RISK BREAST CANCER PATIENTS
Vasilios Karavasilis, Christos Papadimitriou, Helen Gogas, George Kouvatseas, George Pentheroudakis, Angelos Koutras, Christos Christodoulou, Dimitrios Bafaloukos, Epaminontas Samantas, Nikolaos Pisanidis, Pavlos Papakostas, Gerasimos Aravantinos, Charisios Karanikiotis, Paris Kosmidis, Dimitrios Pectasides, Meletios-Athanassios Dimopoulos, George Fountzilas
Clin Breast Cancer. 2016 Aug;16(4):291-298.e3. doi: 10.1016/j.clbc.2015.12.001. Epub 2015 Dec 17.
GENES ASSOCIATED WITH HISTOPATHOLOGIC FEATURES OF TRIPLE NEGATIVE BREAST TUMORS PREDICT MOLECULAR SUBTYPES
Purrington KS, Visscher DW, Wang C, Yannoukakos D, Hamann U, Nevanlinna H, Cox A, Giles GG, Eckel-Passow JE, Lakis S, Kotoula V, Fountzilas G, Kabisch M, Rüdiger T, Heikkilä P, Blomqvist C, Cross SS, Southey MC, Olson JE, Gilbert J, Deming-Halverson S, Kosma VM, Clarke C, Scott R, Jones JL, Zheng W, Mannermaa A; Jane Carpenter for ABCTC Investigators, Eccles DM, Vachon CM, Couch FJ.
Breast Cancer Res Treat. 2016 May;157(1):117-31. doi: 10.1007/s10549-016-3775-2. Epub 2016 Apr 15.
COMPARISON OF THE ABILITY OF DIFFERENT CLINICAL TREATMENT SCORES TO ESTIMATE PROGNOSIS IN HIGH-RISK EARLY BREAST CANCER PATIENTS: A HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
Flora Stavridi, Konstantine T. Kalogeras, Kyriaki Pliarchopoulou, Ralph M. Wirtz, Zoi Alexopoulou, Flora Zagouri, Elke Veltrup, Eleni Timotheadou, Helen Gogas, Angelos Koutras, Georgios Lazaridis, Christos Christodoulou, George Pentheroudakis, Apostolos Laskarakis, Petroula Arapantoni-Dadioti, Anna Batistatou, Maria Sotiropoulou, Gerasimos Aravantinos, Pavlos Papakostas, Paris Kosmidis, Dimitrios Pectasides, George Fountzilas
PLoS One. 2016 Oct 3;11(10):e0164013. doi: 10.1371/journal.pone.0164013.
MYC COPY GAIN, CHROMOSOMAL INSTABILITY AND PI3K ACTIVATION AS POTENTIAL MARKERS OF UNFAVOURABLE OUTCOME IN TRASTUZUMAB-TREATED PATIENTS WITH METASTATIC BREAST CANCER
Helen Gogas, Vassiliki Kotoula, Zoi Alexopoulou, Christos Christodoulou, Ioannis Kostopoulos, Mattheos Bobos, Georgia Raptou, Elpida Charalambous, Eleftheria Tsolaki, Ioannis Xanthakis, George Pentheroudakis, Angelos Koutras, Dimitrios Bafaloukos, Pavlos Papakostas, Gerasimos Aravantinos, Amanda Psyrri, Kalliopi Petraki, Dimitrios Pectasides, George Fountzilas
J Transl Med. 2016 May 17;14(1):136. doi: 10.1186/s12967-016-0883-z.
TP53 MUTATIONS AND PROTEIN IMMUNOPOSITIVITY MAY PREDICT FOR POOR OUTCOME BUT ALSO FOR TRASTUZUMAB BENEFIT IN PATIENTS WITH EARLY BREAST CANCER TREATED IN THE ADJUVANT SETTING
Fountzilas G, Giannoulatou E, Alexopoulou Z, Zagouri F, Timotheadou E, Papadopoulou K, Lakis S, Bobos M, Poulios C, Sotiropoulou M, Lyberopoulou A, Gogas H, Pentheroudakis G, Pectasides D, Koutras A, Christodoulou C, Papandreou C, Samantas E, Papakostas P, Kosmidis P, Bafaloukos D, Karanikiotis C, Dimopoulos MA, Kotoula V.
Oncotarget. 2016 May 31;7(22):32731-53. doi: 10.18632/oncotarget.9022.
TUMORS WITH HIGH-DENSITY TUMOR INFILTRATING LYMPHOCYTES CONSTITUTE A FAVORABLE ENTITY IN BREAST CANCER: A POOLED ANALYSIS OF FOUR PROSPECTIVE ADJUVANT TRIALS.
Kotoula V, Chatzopoulos K, Lakis S, Alexopoulou Z, Timotheadou E, Zagouri F, Pentheroudakis G, Gogas H, Galani E, Efstratiou I, Zaramboukas T, Koutras A, Aravantinos G, Samantas E, Psyrri A, Kourea H, Bobos M, Papakostas P, Kosmidis P, Pectasides D, Fountzilas G
Oncotarget. 2016 Jan 26;7(4):5074-87. doi: 10.18632/oncotarget.6231.
EFFECTS OF TP53 AND PIK3CA MUTATIONS IN EARLY BREAST CANCER: A MATTER OF CO-MUTATION AND TUMOR INFILTRATING LYMPHOCYTES
Vassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri, George Kouvatseas, Eleni Giannoulatou, Helen Gogas, Sotiris Lakis, George Pentheroudakis, Mattheos Bobos, Kyriaki Papadopoulou, Eleftheria Tsolaki, Dimitrios Pectasides, Georgios Lazaridis, Angelos Koutras, Gerasimos Aravantinos, Christos Christodoulou, Pavlos Papakostas, Christos Markopoulos, George Zografos, Christos Papandreou, George Fountzilas
Breast Cancer Res Treat. 2016 Jul;158(2):307-21. doi: 10.1007/s10549-016-3883-z.
MALE BREAST CANCER IN BRCA1 AND BRCA2 MUTATION CARRIERS: PATHOLOGY DATA FROM THE CONSORTIUM OF INVESTIGATORS OF MODIFIERS OF BRCA1/2.
Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL,….Garber J, Fostira F, Fountzilas G, Chenevix-Trench G, Antoniou AC, Ottini L.
Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y.
Kotoula V, Lakis S, Vlachos IS, Giannoulatou E, Zagouri F, Alexopoulou Z, Gogas H, Pectasides D, Aravantinos G, Efstratiou I, Pentheroudakis G, Papadopoulou K, Chatzopoulos K, Papakostas P, Sotiropoulou M, Nicolaou I, Razis E, Psyrri A, Kosmidis P, Papadimitriou C, Fountzilas G.
PLoS One. 2016 Sep 29;11(9):e0163138. doi: 10.1371/journal.pone.0163138. eCollection 2016.
Apostolou P, Pertesi M, Aleporou-Marinou V, Dimitrakakis C, Papadimitriou C, Razis E, Christodoulou C, Fountzilas G, Yannoukakos D, Konstantopoulou I, Fostira F.
Clin Genet. 2017 Mar;91(3):482-487.doi: 10.1111/cge.12824. Epub 2016 Aug 22.
DISEASE EVOLUTION AND HETEROGENEITY IN BILATERAL BREAST CANCER.
Fountzilas E, Kotoula V, Zagouri F, Giannoulatou E, Kouvatseas G, Pentheroudakis G, Koletsa T, Bobos M, Papadopoulou K, Samantas E, Demiri E, Miliaras S, Christodoulou C, Chrisafi S, Razis E, Fostira F, Pectasides D, Zografos G, Fountzilas G.
Am J Cancer Res. 2016 Nov 1;6(11):2611-2630
HER FAMILY PROTEIN EXPRESSION IN A GREEK POPULATION WITH GASTRIC CANCER. A RETROSPECTIVE HELLENIC COOPERATIVE ONCOLOGY GROUP STUDY
T. Makatsoris, A.C. Tsamandas, A. Strimpakos, Z. Alexopoulou, D. Dionysopoulos, S. Pervana, A. Konstantara, P. Papakostas, E. Samantas, G. Rallis, A. Dimou, G. Pentheroudakis, K. Papaparaskeva, A. Psyrri, K.T. Kalogeras, K. Syrigos, C.D. Scopa, G. Fountzilas
Anticancer Research 36: 1581-1590 (2016)
EVALUATION OF CPG ISLAND METHYLATOR PHENOTYPE AS A BIOMARKER IN COLORECTAL CANCER TREATED WITH ADJUVANT OXALIPLATIN
Cohen SA, Wu C, Yu M, Gourgioti G, Wirtz R, Raptou G, Gkakou C, Kotoula V, Pentheroudakis G, Papaxoinis G, Karavasilis V, Pectasides D, Kalogeras KT, Fountzilas G, Grady WM.
Clin Colorectal Cancer. 2016 Jun;15(2):164-9. doi: 10.1016/j.clcc.2015.10.005.
Pectasides D, Kotoula V, Papaxoinis G, Alexopoulou Z, Dervenis C, Samantas E, Papaparaskeva K, Charalambous E, Gkakou C, Agalianos C, Kalogeras KT, Pentheroudakis G, Fountzilas G.
Anticancer Res. 2016 Dec;36(12):6347-6356.
EVALUATION OF PD-L1 EXPRESSION AND ASSOCIATED TUMOR-INFILTRATING LYMPHOCYTES IN LARYNGEAL SQUAMOUS CELL CARCINOMA
Vassilakopoulou M, Avgeris M, Velcheti V, Kotoula V, Rampias T4, Chatzopoulos K, Perisanidis C, Kontos CK, Giotakis AI, Scorilas A, Rimm D, Sasaki C, Fountzilas G, Psyrri A
Clin Cancer Res. 2016 Feb 1;22(3):704-13. doi: 10.1158/1078-0432.CCR-15-1543.
LESSONS FROM THE PAST: LONG-TERM SAFETY AND SURVIVAL OUTCOMES OF A PREMATURELY TERMINATED RANDOMIZED CONTROLLED TRIAL OF PROPHYLACTIC VERSUS HEMOGLOBIN-BASED ERYTHROPOIETIN ADMINISTRATION IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA.
Giannis Mountzios, Gerasimos Aravantinos, Zoi Alexopoulou, Eleni Timotheadou, Fotini Matsiakou, Christos Christodoulou, Konstantinos Laschos, Eleni Galani, Angelos Koutras, Dimitrios Bafaloukos, Helena Linardou, Dimitrios Pectasides, Ioannis Varthalitis, Pavlos Papakostas, Haralambos P. Kalofonos and George Fountzilas
Mol Clin Oncol. 2016 Feb;4(2):211-220.
NOVEL THERAPIES FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG.
Koutsoukos K, Mountzios G.
Future Oncol. 2016 Mar;12(5):659-67.
THERAPIES IN THE PIPELINE FOR SMALL-CELL LUNG CANCER.
Romanidou O, Imbimbo M, Mountzios G, Abidin A, Morgillo F, Califano R.
Br Med Bull. 2016 Sep;119(1):37-48.
Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
Califano R, Romanidou O, Mountzios G, Landi L, Cappuzzo F, Blackhall F.
Drugs. 2016 May;76(8):831-40.
A POOLED ANALYSIS OF NIVOLUMAB FOR THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER AND THE ROLE OF PD-L1 AS A PREDICTIVE BIOMARKER.
Aguiar PN Jr, Santoro IL, Tadokoro H, de Lima Lopes G, Filardi BA, Tsiatas M, Oliveira P, Castelo-Branco P, Mountzios G, de Mello RA.
Immunotherapy. 2016 Sep;8(9):1011-9. doi: 10.2217/imt-2016-0032
NON-SMALL CELL LUNG CANCER (NSCLC) AND CENTRAL NERVOUS SYSTEM (CNS) METASTASES: ROLE OF TYROSINE KINASE INHIBITORS (TKIS) AND EVIDENCE IN FAVOR OR AGAINST THEIR USE WITH CONCURRENT CRANIAL RADIOTHERAPY
Panagiota Economopoulou, Giannis Mountzios
Transl Lung Cancer Res. 2016 Dec;5(6):588-598. doi: 10.21037/tlcr.2016.12.06.PMID: 28149754
THE IMPACT OF PACLITAXEL AND CARBOPLATIN CHEMOTHERAPY ON THE AUTONOMOUS NERVOUS SYSTEM OF PATIENTS WITH OVARIAN CANCER.
Emmanouil Dermitzakis; Vasilios K. Kimiskidis; George Lazaridis; Zoi Alexopoulou; Eleni Timotheadou; Alexandros Papanikolaou; Ourania Romanidou; George Georgiadis; Konstantine T Kalogeras; Iakovos Tsiptsios; Basil Tarlatzis; George Fountzilas
BMC Neurol. 2016 Oct 1;16(1):190. doi: 10.1186/s12883-016-0710-4.
Trillsch F, Mahner S, Hilpert F, Davies L, García-Martínez E, Kristensen G, Savarese A, Vuylsteke P, Los M, Zagouri F, Gladieff L, Sehouli J, Khoon Lee C, Gebski V, Pujade-Lauraine E.
Ann Oncol. 2016 Sep;27(9):1733-9. doi: 10.1093/annonc/mdw236
Malczewski A, Marshall A, Payne MJ, Mao L, Bafaloukos D, Si L, Pectasides D, Fountzilas G, Guo J, Gogas H, Middleton MR.
Cancer Med. 2016 Jan;5(1):17-23. doi: 10.1002/cam4.563. Epub 2015 Dec 8
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME WITH CONCURRENT NEPHROTIC SYNDROME IN A PATIENT TREATED WITH PAZOPANIB FOR METASTATIC RENAL CELL CARCINOMA: CASE REPORT AND REVIEW OF THE LITERATURE.
Miaris N, Maltezou M, Papaxoinis G, Visvikis A,SamantasE.
Clin Genitourin Cancer. Published online 2016. doi:10.1016/j.clgc.2016.08.005
ATM SPECIAL ISSUE
OVERVIEW OF ADVANCES IN CANCER IMMUNOTHERAPY.
Kotoula V, Fountzilas G.
Ann Transl Med. 2016 jul;4(14):260. doi: 10.21037/atm.2016.07.09
HARNESSING THE IMMUNE SYSTEM TO IMPROVE CANCER THERAPY.
Papaioannou NE, Beniata OV, Vitsos P, Tsitsilonis O, Samara P
Ann Transl Med. 2016 Jul;4(14):261. doi: 10.21037/atm.2016.04.01
Menis J, Litière S, Tryfonidis K, Golfinopoulos V.
Ann Transl Med. 2016 Jul;4(14):267. doi: 10.21037/atm.2016.06.19. Review
OPTIMIZED TUMOR CRYPTIC PEPTIDES: THE BASIS FOR UNIVERSAL NEO-ANTIGEN-LIKE TUMOR VACCINES.
Menez-Jamet J, Gallou C, Rougeot A, Kosmatopoulos K.
Ann Transl Med. 2016 Jul;4(14):266. doi: 10.21037/atm.2016.05.15. Review
MELANOMA IMMUNOTHERAPY DOMINATES THE FIELD.
Diamantopoulos P, Gogas H.
Ann Transl Med. 2016 Jul;4(14):269. doi: 10.21037/atm.2016.06.32. Review
THE DUAL ROLE OF COMPLEMENT IN CANCER AND ITS IMPLICATION IN ANTI-TUMOR THERAPY.
Kourtzelis I, Rafail S.
Ann Transl Med. 2016 Jul;4(14):265. doi: 10.21037/atm.2016.06.26. Review
NEOANTIGEN-BASED CANCER IMMUNOTHERAPY.
Bobisse S, Foukas PG, Coukos G, Harari A.
Ann Transl Med. 2016 Jul;4(14):262. doi: 10.21037/atm.2016.06.17. Review
Nearchou A, Pentheroudakis G.
Ann Transl Med. 2016 Jul;4(14):271. doi: 10.21037/atm.2016.05.54. Review
FUTURE PERSPECTIVES IN CANCER IMMUNOTHERAPY.
Tsiatas M, Mountzios G, Curigliano G.
Ann Transl Med. 2016 Jul;4(14):273. doi: 10.21037/atm.2016.07.14
TOXICITY MANAGEMENT OF IMMUNOTHERAPY FOR PATIENTS WITH METASTATIC MELANOMA.
Linardou H, Gogas H.
Ann Transl Med. 2016 Jul;4(14):272. doi: 10.21037/atm.2016.07.10. Review
DNA DAMAGE, TUMOR MUTATIONAL LOAD AND THEIR IMPACT ON IMMUNE RESPONSES AGAINST CANCER.
Liontos M, Anastasiou I, Bamias A, Dimopoulos MA.
Ann Transl Med. 2016 Jul;4(14):264. doi: 10.21037/atm.2016.07.11. Review
TOWARDS TUMOR IMMUNODIAGNOSTICS.
Kourea H, Kotoula V.
Ann Transl Med. 2016 Jul;4(14):263. doi: 10.21037/atm.2016.07.07. Review
IMMUNOTHERAPY IN NON-SMALL CELL LUNG CANCER: THE CLINICAL IMPACT OF IMMUNE RESPONSE AND TARGETING.
Mountzios G, Linardou H, Kosmidis P.
Ann Transl Med. 2016 Jul;4(14):268. doi: 10.21037/atm.2016.06.24. Review
Δημοσιεύσεις 2017
Apostolou P, Pertesi M, Aleporou-Marinou V, Dimitrakakis C, Papadimitriou C, Razis E, Christodoulou C, Fountzilas G, Yannoukakos D, Konstantopoulou I, Fostira F.
Clin Genet. 2017 Mar;91(3):482-487. doi: 10.1111/cge.12824. Epub 2016 Aug 22.
THE FATE OF BRCA1-RELATED GERMLINE MUTATIONS IN TRIPLE-NEGATIVE BREAST TUMORS.
Kotoula V, Fostira F, Papadopoulou K, Apostolou P, Tsolaki E, Lazaridis G, Manoussou K, Zagouri F, Pectasides D, Vlachos I, Tikas I, Lakis S, Konstantopoulou I, Pentheroudakis G, Gogas H, Papakostas P, Christodoulou C, Bafaloukos D, Razis E, Karavasilis V, Bamias C, Yannoukakos D, Fountzilas G.
Am J Cancer Res. 2017 Jan 1;7(1):98-114. eCollection 2017.
Rotolo F, Pignon JP, Bourhis J, Marguet S, Leclercq J, Tong Ng W, Ma J, Chan AT, Huang PY, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Soong YL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lee AW, Blanchard P, Michiels S; MAC-NPC Collaborative Group.
J Natl Cancer Inst. 2017 Apr;109(4). pii: djw239.
Psyrri A, Kalogeras KT, Wirtz RM, Kouvatseas G, Karayannopoulou G, Goussia A, Zagouri F, Veltrup E, Timotheadou E, Gogas H, Koutras A, Lazaridis G, Christodoulou C, Pentheroudakis G, Economopoulou P, Laskarakis A, Arapantoni-Dadioti P, Batistatou A, Sotiropoulou M, Aravantinos G, Papakostas P, Kosmidis P, Pectasides D, Fountzilas G.
J Transl Med. 2017 Feb 13;15(1):30. doi: 10.1186/s12967-017-1134-7.
Levva S, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Papadopoulou K, Lakis S, Koukoulias K, Karavasilis V, Pentheroudakis G, Balassi E, Zagouri F, Kaklamanos IG, Pectasides D, Razis E, Aravantinos G, Papakostas P, Bafaloukos D, Rallis G, Gogas H, Fountzilas G.
Cancer Genomics Proteomics. 2017 May-Jun;14(3):181-195.
Batistatou A, Kotoula V, Bobos M, Kouvatseas G, Zagouri F, Tsolaki E, Gogas H, Koutras A, Pentheroudakis G, Timotheadou E, Pervana S, Goussia A, Petraki K, Sotiropoulou M, Koletsa T, Razis E, Kosmidis P, Aravantinos G, Papadimitriou C, Pectasides D, Fountzilas G.
Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30138-6. doi: 10.1016/j.clbc.2017.07.004.
PROTEIN EXPRESSION PATTERNS OF CELL CYCLE REGULATORS IN OPERABLE BREAST CANCER.
Zagouri F, Kotoula V, Kouvatseas G, Sotiropoulou M, Koletsa T, Gavressea T, Valavanis C, Trihia H, Bobos M, Lazaridis G, Koutras A, Pentheroudakis G, Skarlos P, Bafaloukos D, Arnogiannaki N, Chrisafi S, Christodoulou C, Papakostas P, Aravantinos G, Kosmidis P, Karanikiotis C, Zografos G, Papadimitriou C, Fountzilas G.
PLoS One. 2017 Aug 10;12(8):e0180489. doi: 10.1371/journal.pone.0180489. eCollection 2017.
Christodoulou C, Kalogera-Fountzila A, Karavasilis V, Kouvatseas G, Papandreou CN, Samantas E, Varaki K, Papadopoulos G, Bobos M, Rallis G, Razis E, Goudopoulou A, Kalogeras KT, Syrigos KN, Fountzilas G.
J Neurooncol. 2017 Sep;134(2):443-451. doi: 10.1007/s11060-017-2548-z
Timotheadou E, Kalogeras KT, Koliou GA, Wirtz RM, Zagouri F, Koutras A, Veltrup E, Christodoulou C, Pentheroudakis G, Tsiftsoglou A, Papakostas P, Aravantinos G, Venizelos V, Pectasides D, Kosmidis P, Karanikiotis C, Markopoulos C, Gogas H, Fountzilas G.
Transl Oncol. 2017 Aug;10(4):589-598. doi: 10.1016/j.tranon.2017.05.006.
Gavressea T, Kalogeras KT, Koliou GA, Zagouri F, Lazaridis G, Gogas H, Tsigaridas K, Koutras A, Petraki K, Markopoulos C, Pazarli E, Aravantinos G, Papadimitriou C, Papakostas P, Koufopoulos N, Karanikiotis C, Chrisafi S, Kalofonos HP, Pectasides D, Fountzilas G, Pavlakis K.
Anticancer Res. 2017 Jun;37(6):2947-2957.
Strati TM, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Lazaridis G, Lakis S, Pentheroudakis G, Pectasides D, Pazarli E, Christodoulou C, Razis E, Pavlakis K, Magkou C, Chrisafi S, Aravantinos G, Bafaloukos D, Papakostas P, Gogas H, Kalogeras KT, Fountzilas G.
Anticancer Res. 2017 May;37(5):2323-2334.
Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, Wirtz RM, Charalambous E, Pentheroudakis G, Kotoula V, Kalogeras KT, Fountzilas G, Grady WM.
Clin Epigenetics. 2017 May 2;9:46. doi: 10.1186/s13148-017-0347-1. eCollection 2017.
Hamdi Y, Soucy P, Kuchenbaeker KB,….G. Fountzilas….
Breast Cancer Res Treat. 2017 Jan;161(1):117-134.
Sorio R, Roemer-Becuwe C, Hilpert F, Gibbs E, García Y, Kaern J, Huizing M, Witteveen P, Zagouri F, Coeffic D, Lück HJ, González-Martín A, Kristensen G, Levaché CB, Lee CK, Gebski V, Pujade-Lauraine E; AURELIA Investigators.
Gynecol Oncol. 2017 Jan;144(1):65-71. doi: 10.1016/j.ygyno.2016.11.006.
BEVACIZUMAB WITH OR AFTER CHEMOTHERAPY FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: EXPLORATORY ANALYSES OF THE AURELIA TRIAL.
Bamias A, Gibbs E, Khoon Lee C, Davies L, Dimopoulos M, Zagouri F, Veillard AS, Kosse J, Santaballa A, Mirza MR, Tabaro G, Vergote I, Bloemendal H, Lykka M, Floquet A, Gebski V, Pujade-Lauraine E
Ann Oncol. 2017 Aug 1;28(8):1842-1848.
Ribassin-Majed L, Marguet S, Lee AWM, Ng WT, Ma J, Chan ATC, Huang PY, Zhu G, Chua DTT, Chen Y, Mai HQ, Kwong DLW, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Bourhis J, Pignon JP, Blanchard P.
J Clin Oncol. 2017 Feb 10;35(5):498-505.
CRIZOTINIB FAILURE IN A TPM4-ALK–REARRANGED INFLAMMATORY MYOFIBROBLASTIC TUMOR WITH AN EMERGING ALK KINASE DOMAIN MUTATION
Kalliopi Tsakiri, Vassiliki Kotoula, Sotirios Lakis, Judith Muller, Florentia Fostira, Mattheos Bobos, Prodromos Hytiroglou, George Fountzilas
JCO Precision Oncology 2017 :1, 1-7
Δημοσιεύσεις 2018
Fountzilas G, Psyrri A, Giannoulatou E, Tikas I, Manousou K, Rontogianni D, Ciuleanu E, Ciuleanu T, Resiga L, Zaramboukas T, Papadopoulou K, Bobos M, Chrisafi S, Tsolaki E, Markou K, Giotakis E, Koutras A, Psoma E, Kalogera-Fountzila A, Skondra M, Bamia C, Pectasides D, Kotoula V.
Int J Cancer. 2018 Jan 1;142(1):66-80.
Papaxoinis G, Kotoula V, Giannoulatou E, Koliou GA, Karavasilis V, Lakis S, Koureas A, Bobos M, Chalaralambous E, Daskalaki E, Chatzopoulos K, Tsironis G, Pazarli E, Chrisafi S, Samantas E, Kaklamanos IG, Varthalitis I, Konstantara A, Syrigos KN, Pentheroudakis G, Pectasides D, Fountzilas G.
Med Oncol. 2018 May 31;35(7):101. doi: 10.1007/s12032-018-1160-1.
AMALTHEA: A PROSPECTIVE, SINGLE-ARM STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG) EVALUATING THE EFFICACY AND SAFETY OF 1ST LINE FOLFIRI+AFLIBERCEPT FOR SIX MONTHS FOLLOWED BY AFLIBERCEPT MAINTENANCE IN PATIENTS WITH METASTATIC COLORECTAL CANCER.
G. Pentheroudakis, V. Kotoula, G.A. Koliou, V. Karavasilis, E. Samantas, G. Aravantinos, L. Kalogeropoulou, I. Souglakos, N. Kentepozidis, G. Koumakis, J. Sgouros, G. Zarkavelis, I. Efstratiou, K. Laschos, C. Petraki, I. Tikas, C. Poulios, A. Voutsina, A. Goudopoulou, D. Bafaloukos, E. Vrettou, A. Kalogera-Fountzila, D. Pectasides, G. Fountzilas
Clin Colorectal Cancer. 2018 Dec;17(4):e631-e637. doi: 10.1016/j.clcc.2018.06.003. Epub 2018 Jun 15.
GENOTYPING AND MRNA PROFILING REVEAL ACTIONABLE MOLECULAR TARGETS IN BILIARY TRACT CANCERS.
Papadopoulou K, Murray S, Manousou K, Tikas I, Dervenis C, Sgouros J, Rontogianni D, Lakis S, Bobos M, Poulios C, Pervana S, Lazaridis G, Fountzilas G, Kotoula V.
Am J Cancer Res. 2018 Jan 1;8(1):2-15. eCollection 2018.
GEMCITABINE COMBINED WITH THE mTOR INHIBITOR TEMSIROLIMUS IN PATIENTS WITH INOPERABLE OR METASTATIC PANCREATIC CANCER. A Hellenic Cooperative Oncology Group phase I/II study.
V. Karavasilis, E. Samantas, G.A. Koliou, A. Kalogera-Fountzila, G. Pentheroudakis, I. Varthalitis, H. Linardou, G. Rallis, M. Skondra, G. Papadopoulos, G. Papatsibas, J. Sgouros, A. Goudopoulou, K. T. Kalogeras, C. Dervenis, D. Pectasides, G. Fountzilas
Target Oncol. 2018 Nov 28. doi: 10.1007/s11523-018-0605-y. [Epub ahead of print]
PROGNOSTIC IMPLICATIONS OF TUMOR GENOTYPES AND CD8+ INFILTRATES IN EARLY-STAGE COLORECTAL CANCER
E. Fountzilas, V. Kotoula, I. Tikas, K. Manousou, K. Papadopoulou, C. Poulios, V. Karavasilis, I. Efstratiou, D. Pectasides, K. Papaparaskeva, I. Varthalitis, C. Christodoulou, G. Papatsibas, S. Chrisafi, G.K. Glantzounis, A. Psyrri, G. Aravantinos, G.A. Koliou, G. K. Koukoulis, G. E. Pentheroudakis, G. Fountzilas
Oncotarget. 2018 Nov 2;9(86):35623-35638. doi: 10.18632/oncotarget.26256.
CHARACTERIZATION AND PREVALENCE OF TWO NOVEL CHEK2 LARGE DELETIONS IN GREEK BREAST CANCER PATIENTS.
Apostolou P, Fostira F, Mollaki V, Delimitsou A, Vlassi M, Pentheroudakis G, Faliakou E, Kollia P, Fountzilas G, Yannoukakos D, Konstantopoulou I.
J Hum Genet. 2018 Jul;63(8):877-886. doi: 10.1038/s10038-018-0466-3.
Zardavas D, Te Marvelde L, Milne RL, Fumagalli D, Fountzilas G, Kotoula V, Razis E, Papaxoinis G, Joensuu H, Moynahan ME, Hennessy BT, Bieche I, Saal LH, Stal O, Iacopetta B, Jensen JD, O’Toole S, Lopez-Knowles E, Barbaraeschi M, Noguchi S, Azim HA Jr, Lerma E, Bachelot T, Wang Q, Perez-Tenorio G, Can de Velde CJH, Rea DW, Sabine V, Bartlett JMS, Sotiriou C, Michiels S, Loi S.
J Clin Oncol. 2018 Apr 1;36(10):981-990. doi: 10.1200/JCO.2017.74.8301.
GERMLINE DELETERIOUS MUTATIONS IN GENES OTHER THAN BRCA2 ARE INFREQUENT IN MALE BREAST CANCER.
Fostira F, Saloustros E, Apostolou P, Vagena A, Kalfakakou D, Mauri D, Tryfonopoulos D, Georgoulias V, Yannoukakos D, Fountzilas G, Konstantopoulou I.
Breast Cancer Res Treat. 2018 May;169(1):105-113. doi: 10.1007/s10549-018-4661-x.
Batistatou A, Kotoula V, Bobos M, Kouvatseas G, Zagouri F, Tsolaki E, Gogas H, Koutras A, Pentheroudakis G, Timotheadou E, Pervana S, Goussia A, Petraki K, Sotiropoulou M, Koletsa T, Razis E, Kosmidis P, Aravantinos G, Papadimitriou C, Pectasides D, Fountzilas G.
Clin Breast Cancer. 2018 Feb;18(1):53-62.e3. doi: 10.1016/j.clbc.2017.07.004.
ASSOCIATIONS OF ANGIOGENESIS-RELATED PROTEINS WITH SPECIFIC PROGNOSTIC FACTORS, BREAST CANCER SUBTYPES AND SURVIVAL OUTCOME IN EARLY-STAGE BREAST CANCER PATIENTS.
A HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG) TRIAL.
A. Goussia, N. Simou, F. Zagouri, K. Manousou, G. Lazaridis, H. Gogas, A. Koutras, M. Sotiropoulou, G. Pentheroudakis, D. Bafaloukos, C. Markopoulos, H. Patsea, C. Christodoulou, P. Papakostas, T. Zaramboukas, E. Samantas, P. Kosmidis, V. Venizelos, C. Karanikiotis, G. Papatsibas, G. Xepapadakis, K.T. Kalogeras, C. Bamia, M.A. Dimopoulos, V. Malamou-Mitsi, G. Fountzilas, A. Batistatou
PLoS One. 2018 Jul 31;13(7):e0200302. doi: 10.1371/journal.pone.0200302.
EVALUATION OF THE PROGNOSTIC VALUE OF CD3, CD8 AND FOXP3 MRNA EXPRESSION IN EARLY BREAST CANCER PATIENTS TREATED WITH ANTHRACYCLINE-BASED ADJUVANT CHEMOTHERAPY
M. Tsiatas, K.T. Kalogeras, K. Manousou, R.M. Wirtz, H. Gogas, E. Veltrup, F. Zagouri, G. Lazaridis, A. Koutras, C. Christodoulou, G. Pentheroudakis, C. Petraki, D. Bafaloukos, D. Pectasides, P. Kosmidis, E. Samantas, C. Karanikiotis, P. Papakostas, M.A. Dimopoulos, G. Fountzilas
Cancer Med. 2018 Oct;7(10):5066-5082. doi: 10.1002/cam4.1730.
EVALUATION OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR PATHWAY IN PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH TRASTUZUMAB
C. Christodoulou, G. Oikonomopoulos, G.A. Koliou, I. Kostopoulos, V. Kotoula, M. Bobos, G. Pentheroudakis, G. Lazaridis, M. Skondra, S. Chrisafi, A. Koutras, D. Bafaloukos, E. Razis, K. Papadopoulou, P. Papakostas, H. P. Kalofonos, D. Pectasides, P. Skarlos, K. T. Kalogeras, G. Fountzilas
Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):461-471. doi: 10.21873/cgp.20105.
TREATING EGFR-MUTATED ONCOGENE-ADDICTED ADVANCED NON-SMALL CELL LUNG CANCER IN THE ERA OF ECONOMIC CRISIS IN GREECE: CHALLENGES AND OPPORTUNITIES
E. Fountzilas, S. Levva, G. Mountzios, G. Polychronidou, N. Maniadakis, V. Kotoula, G. Fountzilas
J Glob Oncol. 2018 Sep;(4):1-12. doi: 10.1200/JGO.18.00115.
BRIDGING CANCER BIOLOGY WITH THE CLINIC COMPREHENDING AND EXPLOITING IDH MUTATIONS IN GLIOMAS
O. Romanidou, V. Kotoula, G. Fountzilas
Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):421-436. doi: 10.21873/cgp.20101. Review.
MISMATCH REPAIR DEFICIENCY AND ABERRATIONS IN THE NOTCH AND HEDGEHOG PATHWAYS ARE OF PROGNOSTIC VALUE IN PATIENTS WITH ENDOMETRIAL CANCER
G. Polychronidou, V. Kotoula, K. Manousou, I. Kostopoulos, G. Karayannopoulou, M. Bobos, I. Efstratiou, D. Dionysopoulos, K. Chatzopoulos, S. Lakis, S. Chrisafi, D. Tsolakidis, A. Papanikolaou; N. Dombros, G. Fountzilas
PLoS One. 2018 Dec 6;13(12):e0208221. doi: 10.1371/journal.pone.0208221.
ANNALS OF TRANSLATIONAL MEDICINE – Special Issue (NSCLC)
Lung cancer: biology and technology foster therapeutic innovation
Giannis Mountzios
The emerging treatment landscape of advanced non-small cell lung cancer
Panagiota Economopoulou, Giannis Mountzios
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?
Panagiotis Baxevanos, Giannis Mountzios
Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)
Giannis Mountzios
Treating ALK-positive non-small cell lung cancer
Dimitrios C. Ziogas, Anna Tsiara, Georgios Tsironis, Maria Lykka, Michalis Liontos, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
Stavros Gkolfinopoulos, Giannis Mountzios
Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?
Georgios Tsironis, Dimitrios C. Ziogas, Anastasios Kyriazoglou, Marita Lykka, Konstantinos Koutsoukos, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
Anna Tsiara, Michalis Liontos, Maria Kaparelou, Roubini Zakopoulou, Aristotelis Bamias, Meletios-Athanasios Dimopoulos
Advanced small cell lung cancer (SCLC): new challenges and new expectations
Nikolaos Tsoukalas, Eleni Aravantinou-Fatorou, Panagiotis Baxevanos, Maria Tolia, Konstantinos Tsapakidis, Michail Galanopoulos, Michail Liontos, George Kyrgias
Advances on systemic treatment for lung neuroendocrine neoplasms
Nikolaos Tsoukalas, Panagiotis Baxevanos, Eleni Aravantinou-Fatorou, Maria Tolia, Michail Galanopoulos, Konstantinos Tsapakidis, George Kyrgias, Christos Toumpanakis, Gregory Kaltsas
Δημοσιεύσεις 2019
Rallis G, Koletsa T, Saridaki Z, Manousou K, Koliou GA, Kostopoulos I, Kotoula V, Makatsoris T, Kourea HP, Raptou G, Chrisafi S, Samantas E, Papaparaskeva K, Pazarli E, Papakostas P, Kafiri G, Mauri D, Papoudou-Bai A, Christodoulou C, Petraki K, Dombros N, Pectasides D, Fountzilas G.
Anticancer Res. 2019 Apr;39(4):2129-2138. doi: 10.21873/anticanres.13326.
PROGNOSTIC IMPLICATIONS OF MISMATCH REPAIR DEFICIENCY IN PATIENTS WITH NON-METASTATIC COLORECTAL AND ENDOMETRIAL CANCER
E Fountzilas, V Kotoula, G Pentheroudakis, K Manousou, G Polychronidou, E Vrettou, C Poulios, I Papadopoulou, G Raptou, E Pectasides, G Karayannopoulou, S Chrisafi, P Papakostas, T Makatsoris, I Varthalitis, A Psyrri, E Samantas, M Bobos, C Christodoulou, C Papadimitriou, G Nasioulas, D Pectasides, G Fountzilas. ESMO Open 2019;4:e000474. doi:10.1136/esmoopen-2018-00047.
GENETIC MAPPING OF PANCREATIC CANCER BY TARGETED NEXT GENERATION SEQUENCING IN A COHORT OF PATIENTS MANAGED WITH NAB-PACLITAXEL-BASED CHEMOTHERAPY OR AGENTS TARGETING THE EGFR AXIS: A RETROSPECTIVE ANALYSIS OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG).
G. Zarkavelis, V. Kotoula, G.A. Koliou, K. Papadopoulou, I. Tikas, V. Karavasilis, E. Samantas, C. Dervenis, I. Efstratiou, I. Nicolaou, D. Apessou, G. Kafiri, T. Koletsa, I. Bompolaki, G. Rallis, A. Batistatou, G. Glantzounis, D. Pectasides, G. Fountzilas, G. Pentheroudakis.
ESMO Open. 2019 Sep 18;4(5):e000525. doi: 10.1136/esmoopen-2019-000525.
ANGIOGENIC AND ANTI-ANGIOGENIC VEGFA SPLICE VARIANTS IN COLORECTAL CANCER: A PROSPECTIVE RETROSPECTIVE COHORT STUDY IN PATIENTS TREATED WITH IRINOTECAN-BASED CHEMOTHERAPY AND BEVACIZUMAB
G Pentheroudakis, L Mavroeidis, K Papadopoulou, G-A Koliou, C Bamia, K Chatzopoulos, E Samantas, D Mauri, I Efstratiou, D Pectasides, T Makatsoris, D Bafaloukos, P Papakostas, G Papatsibas, IBombolaki, S Chrisafi, HP Kourea, K Petraki, G Kafiri, G Fountzilas,VKotoula
Clin Colorectal Cancer. 2019 Jul 15. pii: S1533-0028(18)30554-1. doi: 10.1016/j.clcc.2019.07.007.
Lazaridis G, Kotoula V, Vrettou E, Kostopoulos I, Manousou K, Papadopoulou K, Giannoulatou E, Bobos M, Sotiropoulou M, Pentheroudakis G, Efstratiou I, Papoudou-Bai A, Psyrri A, Christodoulou C, Gogas H, Koutras A, Timotheadou E, Pectasides D, Zagouri F, Fountzilas G.
Cancer Genomics Proteomics. 2019 May-Jun;16(3):195-206. doi: 10.21873/cgp.20125.
Vagena A, Papamentzelopoulou M, Kalfakakou D, Kollia P, Papadimitriou C, Psyrri A, Apostolou P, Fountzilas G, Konstantopoulou I, Yannoukakos D, Fostira F.
J Hum Genet. 2019 May 14. doi: 10.1038/s10038-019-0612-6.
Economopoulou P, Kotoula V, Koliou GA, Papadopoulou K, Christodoulou C, Pentheroudakis G, Lazaridis G, Arapantoni-Dadioti P, Koutras A, Bafaloukos D, Papakostas P, Patsea H, Pavlakis K, Pectasides D, Kotsakis A, Razis E, Aravantinos G, Samantas E, Kalogeras KT, Economopoulos T, Psyrri A, Fountzilas G.
Transl Oncol. 2019 May;12(5):739-748. doi: 10.1016/j.tranon.2019.02.010.
Kotoula V, Tsakiri K, Koliou GA, Lazaridis G, Papadopoulou K, Giannoulatou E, Tikas I, Christodoulou C, Chatzopoulos K, Bobos M, Pentheroudakis G, Tsolaki E, Batistatou A, Kotsakis A, Koutras A, Linardou H, Razis E, Res E, Pectasides D, Fountzilas G.
Clin Breast Cancer. 2019 Apr;19(2):113-125.e4. doi: 10.1016/j.clbc.2018.10.014.
CYCLIN D1 DIFFERENTIAL ACTIVATION AND ITS PROGNOSTIC IMPACT IN ADVANCED BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB
G Mountzios, V Kotoula, G-A Koliou, K Papadopoulou, G Lazaridis, C Christodoulou, G Pentheroudakis, M Skondra, A Koutras, H Linardou, E Razis, P Papakostas, S Chrisafi, G Aravantinos, I Nicolaou, A Goussia, KT Kalogeras, D Pectasides, G Fountzilas
ESMO Open. 2019 May 12;4(2):e000441. doi: 10.1136/esmoopen-2018-000441.
INCREASING THE DOSE INTENSITY OF CHEMOTHERAPY BY MORE FREQUENT ADMINISTRATION OR SEQUENTIAL SCHEDULING: A PATIENT-LEVEL META-ANALYSIS OF 37 298 WOMEN WITH EARLY BREAST CANCER IN 26 RANDOMISED TRIALS.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Gray R, Bradley R, …. Fountzilas G, …. Koliou GA…..
Lancet. 2019 Apr 6;393(10179):1440-1452. doi: 10.1016/S0140-6736(18)33137-4.
Linardou H, Kotoula V, Kouvatseas G, Mountzios G, Karavasilis V, Samantas E, Kalogera-Fountzila A, Televantou D, Papadopoulou K, Mavropoulou X, Daskalaki E, Zaramboukas T, Efstratiou I, Lampaki S, Rallis G, Res E, Syrigos KN, Kosmidis PA, Pectasides D, Fountzilas G.
Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):531-541. doi: 10.21873/cgp.20155.
Kotoula V, Lakis S, Tikas I, Giannoulatou E, Lazaridis G, Papadopoulou K, Manoussou K, Efstratiou I, Papanikolaou A, Fostira F, Vlachos I, Tarlatzis B, Fountzilas G.
Gynecol Oncol. 2019 Feb;152(2):375-386. doi: 10.1016/j.ygyno.2018.11.016.
Bamias A, Karavasilis V, Gavalas N, Tzannis K, Samantas E, Aravantinos G, Koutras A, Gkerzelis I, Kostouros E, Koutsoukos K, Zagouri F, Fountzilas G, Dimopoulos MA.
Int J Clin Oncol. 2019 Apr;24(4):411-419. doi: 10.1007/s10147-018-1361-9.
Papamentzelopoulou M, Apostolou P, Fostira F, Dimitrakakis C, Loutradis D, Fountzilas G, Yannoukakos D, Konstantopoulou I.
Cancer Genet. 2019 Sep;237:90-96. doi: 10.1016/j.cancergen.2019.06.006.
COMPARISON OF SOMATIC VARIANT DETECTION ALGORITHMS USING ION TORRENT TARGETED DEEP SEQUENCING DATA.
Wang Q, Kotoula V, Hsu PC, Papadopoulou K, Ho JWK, Fountzilas G, Giannoulatou E
BMC Med Genomics. 2019 Dec 24;12(Suppl 9):181. doi: 10.1186/s12920-019-0636-y.
Δημοσιεύσεις 2020
PATHOGENIC MUTATIONS AND OVERALL SURVIVAL IN 3,084 PATIENTS WITH CANCER: THE HELLENIC COOPERATIVE ONCOLOGY GROUP PRECISION MEDICINE INITIATIVE
Elena Fountzilas, Vassiliki Kotoula, Georgia-Angeliki Koliou, Eleni Giannoulatou, Helen Gogas, Christos Papadimitriou, Ioannis Tikas, Jianhua Zhang, Kyriaki Papadopoulou, Flora Zagouri, Christos Christodoulou, Angelos Koutras, Thomas Makatsoris, Sofia Chrisafi, Helena Linardou, Ioannis Varthalitis, George Papatsibas, Evangelia Razis, Pavlos Papakostas, Epaminontas Samantas, Gerasimos Aravantinos, Dimitrios Bafaloukos, Paris Kosmidis, Anna Koumarianou, Amanda Psyrri, Georgios Pentheroudakis, Dimitrios Pectasides, Andrew Futreal, George Fountzilasand Apostolia M. Tsimberidou
Oncotarget, 2020, Vol. 11, (No. 1), pp: 1-14
MULTISITE TUMOR SAMPLING REVEALS EXTENSIVE HETEROGENEITY OF TUMOR AND HOST IMMUNE RESPONSE IN OVARIAN CANCER
Sotirios Lakis, Vassiliki Kotoula, Georgia-Angeliki Koliou, Ioannis Efstratiou, Sofia Chrisafi, Alexios Papanikolaou, Pantelis Zebekakis, George Fountzilas
Cancer Genomics Proteomics. Sep-Oct 2020;17(5):529-541.doi: 10.21873/cgp.20209.
Α RARE SOLITARY SPINAL CORD METASTASIS AFTER EPITHELIAL OVARIAN CANCER DIAGNOSIS
Adamantia Nikolaidi, Kyriaki Papadopoulou, Kalliopi Tsakiri, Elisabeth Psoma, Dimitris Zevgaridis, Christos Konstantaras, Ilias Athanasiadis, Florentia Fostira, George Fountzilas
Clinical Oncology: Case Reports. 2020
Koutras A, Zagouri F, Koliou GA, Psoma E, Chryssogonidis I, Lazaridis G, Tryfonopoulos D, Kotsakis A, Res E, Kentepozidis NK, Razis E, Psyrri A, Koumakis G, Kalofonos HP, Dimopoulos MA, Fountzilas G.
Br J Cancer. 2020 Aug;123(3):355-361. doi: 10.1038/s41416-020-0909-4.PMID: 32488135
Koletsa T, Kotoula V, Koliou GA, Manousou K, Chrisafi S, Zagouri F, Sotiropoulou M, Pentheroudakis G, Papoudou-Bai A, Christodoulou C, Xepapadakis G, Zografos G, Petraki K, Pazarli E, Koutras A, Kourea HP, Bafaloukos D, Chatzopoulos K, Iliadis A, Markopoulos C, Venizelos V, Arnogiannaki N, Kalogeras KT, Kostopoulos I, Gogas H, Fountzilas G.
Cancer Immunol Immunother. 2020 Aug;69(8):1549-1564. doi: 10.1007/s00262-020-02557-0.
Nikolaidi A, Kotoula V, Koliou GA, Giannoulatou E, Papadopoulou K, Zagouri F, Pentheroudakis G, Gogas H, Bobos M, Chatzopoulos K, Oikonomopoulos G, Pectasides D, Saloustros E, Arnogiannaki N, Nicolaou I, Papakostas P, Bompolaki I, Aravantinos G, Athanasiadis I, Fountzilas G.
Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):181-193. doi: 10.21873/cgp.20179.PMID: 32108041
THE ROLE OF CXCL13 AND CXCL9 IN EARLY BREAST CANCER
E Razis, KT Kalogeras, I Kotsantis, GA Koliou, K Manousou, R Wirtz, E Veltrup, H Patsea, N Poulakaki, D Dionysopoulos, S Pervana, H Gogas, A Koutras, G Pentheroudakis, C Christodoulou, H Linardou, K Pavlakis, T Koletsa, D Pectasides, F Zagouri, G Fountzilas
Clin Breast Cancer. 2020 Feb;20(1):e36-e53. doi: 10.1016/j.clbc.2019.08.008. PMID: 31699671
Fountzilas E, Koliou GA, Vozikis A, Rapti V, Nikolakopoulos A, Boutis A, Christopoulou A, Kontogiorgos I, Karageorgopoulou S, Lalla E, Tryfonopoulos D, Boukovinas I, Rapti C, Nikolaidi A, Karteri S, Moirogiorgou E, Binas I, Mauri D, Aravantinos G, Zagouri F, Saridaki Z, Psyrri A, Bafaloukos D, Koumarianou A, Res E, Linardou H, Mountzios G, Razis E, Fountzilas G, Koumakis G.
ESMO Open. 2020 Aug;5(4):e000774. doi: 10.1136/esmoopen-2020-000774.PMID: 32817060
Koumarianou A, Pectasides D, Koliou GA, Dionysopoulos D, Kolomodi D, Poulios C, Skondra M, Sgouros J, Pentheroudakis G, Kaltsas G, Fountzilas G.
Biology (Basel). 2020 Mar 9;9(3):51. doi: 10.3390/biology9030051.PMID: 32182791
PROGNOSTIC BIOMARKERS IN EARLY-STAGE GASTRIC ADENOCARCINOMA TREATED WITH ADJUVANT CHEMORADIOTHERAPY.
Pectasides E, Chatzidakis I, Kotoula V, Koliou GA, Papadopoulou K, Giannoulatou E, Giannouzakos VG, Bobos M, Papavasileiou C, Chrisafi S, Florou A, Pectasides D, Fountzilas G.
Cancer Genomics Proteomics. 2020 May-Jun;17(3):277-290. doi: 10.21873/cgp.20188.PMID: 32345669
PATHOLOGY OF BRCA1- AND BRCA2-ASSOCIATED BREAST CANCERS: KNOWN AND LESS KNOWN CONNECTIONS.
Fountzilas E, Konstantopoulou I, Vagena A, Apostolou P, Papadimitriou C, Christodoulou C, Tryfonopoulos D, Manousou K, Delimitsou A, Papamentzelopoulou M, Fountzilas G, Yannoukakos D, Fostira F.
Clin Breast Cancer. 2020 Apr;20(2):152-159. doi: 10.1016/j.clbc.2019.08.003. PMID: 31980407
ONE IN THREE HIGHLY SELECTED GREEK PATIENTS WITH BREAST CANCER CARRIES A LOSS-OF-FUNCTION VARIANT IN A CANCER SUSCEPTIBILITY GENE
Florentia Fostira, Irene Konstantopoulou, Paraskevi Apostolou, Myrto S. Papamentzelopoulou, Christos Papadimitriou, Eleni Faliakou, Christos Christodoulou, Ioannis Boukovinas, Evangelia Razis, Dimitrios Tryfonopoulos, Vasileios Barbounis, Andromachi Vagena, Ioannis S. Vlachos, Despoina Kalfakakou, George Fountzilas, Drakoulis Yannoukakos
J Med Genet. 2020 Jan;57(1):53-61. doi: 10.1136/jmedgenet-2019-106189. Epub 2019 Jul 12.PMID: 31300551
Psoma E, Koliou GA, Dimitrakopoulos FI, Papadopoulou K, Rontogianni D, Bobos M, Visvikis A, Kosmidis PA, Fountzilas G, Constantinidis J, Kalogera-Fountzila A.
Anticancer Res. 2020 Feb;40(2):677-688. doi: 10.21873/anticanres.13997.PMID: 32014908
TUMOR INFILTRATING LYMPHOCYTES AND CD8+ T-CELL SUBSETS AS PROGNOSTIC MARKERS IN PATIENTS WITH OPERABLE LARYNGEAL SQUAMOUS CELL CARCINOMA
K Chatzopoulos, V Kotoula, K Manousou, K Markou, K Vlachtsis, N Angouridakis, A Nikolaou, M Vassilakopoulou, A Psyrri, G Fountzilas
Head Neck Pathol. 2020 Sep;14(3):689-700. doi: 10.1007/s12105-019-01101-6. PMID: 31749124
Mountzios G, Mavropoulou X, Koliou GA, Linardou H, Samantas E, Kosmidis P, Fountzilas G, Charitandi A, Kalogera-Fountzila A.
Anticancer Res. 2020 Apr;40(4):2095-2106. doi: 10.21873/anticanres. 14168. PMID: 3223490
Sgouros J, Aravantinos G, Koliou GA, Pentheroudakis G, Zagouri F, Psyrri A, Lampropoulou DI, Demiri S, Pectasides D, Razis E, Fountzilas G, Samantas E.
Anticancer Res. 2020 Feb;40(2):929-938. doi: 10.21873/anticanres.14026. PMID: 32014937
IS THERE AN INDEPENDENT ROLE OF TERT AND NF1 IN HIGH GRADE GLIOMAS?
Razis E, Kotoula V, Koliou GA, Papadopoulou K, Vrettou E, Giannoulatou E, Tikas I, Labropoulos SV, Rigakos G, Papaemmanoyil S, Romanidou O, Bourkoula E, Nomikos P, Iliadis G, Nasioulas G, Selviaridis P, Polyzoidis K, Fountzilas G.
Transl Oncol. 2020 Feb;13(2):346-354. doi: 10.1016/j.tranon.2019.10.016. PMID: 31891871
Δημοσιεύσεις 2021
GENOTYPE-PHENOTYPE ASSOCIATIONS IN COLORECTAL ADENOCARCINOMAS AND THEIR MATCHED METASTASES.
Chatzopoulos K, Kotoula V, Koliou GA, Giannoulatou E, Papadopoulou K, Karavasilis V, Pazarli E, Pervana S, Kafiri G, Tsoulfas G, Chrisafi S, Sgouramali H, Papakostas P, Pectasides D, Hytiroglou P, Pentheroudakis G, Fountzilas G.
Hum Pathol. 2021 Jan;107:104-116. doi: 10.1016/j.humpath.2020.10.009. PMID: 33161028
CLINICAL SIGNIFICANCE OF GERMLINE CANCER PREDISPOSING VARIANTS IN UNSELECTED EUROPEAN PATIENTS WITH PANCREATIC ADENOCARCINOMA
Cancers (Basel). 2021 Jan 8;13(2):198. doi: 10.3390/cancers13020198. PMID: 33429865
Zarkavelis G, Samantas E, Koliou GA, Papadopoulou K, Mauri D, Aravantinos G, Batistatou A, Pazarli E, Tryfonopoulos D, Tsipoura A, Bobos M, Psyrri A, Makatsoris T, Petraki C, Pectasides D, Fountzilas G, Pentheroudakis G.
Acta Oncol. 2021 May 18:1-9. doi: 10.1080/0284186X.2021.1912822. PMID: 34003074
EVALUATION OF THE ROLE OF P95 HER2 ISOFORM IN TRASTUZUMAB EFFICACY IN METASTATIC BREAST CANCER.
Rigakos G, Razis E, Koliou GA, Oikonomopoulos G, Tsolaki E, Sperinde J, Chrisafi S, Zarkavelis G, Pazarli E, Batistatou A, Kourea HP, Papakostas P, Bafaloukos D, Asimakopoulou NI, Res E, Kotsakis A, Pectasides D, Koutras A, Christodoulou C, Fountzilas G.
Anticancer Res. 2021 Apr;41(4):1793-1802. doi: 10.21873/anticanres. 14945. PMID: 33813384
Ntzifa A, Strati A, Koliou GA, Zagouri F, Pectasides D, Pentheroudakis G, Christodoulou C, Gogas H, Magkou C, Petraki C, Kosmidis P, Aravantinos G, Kotoula V, Fountzilas G, Lianidou E.
Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):147-156. doi: 10.21873/cgp.20249.PMID: 33608311
Apostolou P, Dellatola V, Papadimitriou C, Kalfakakou D, Fountzilas E, Faliakou E, Fountzilas G, Romanidou O, Konstantopoulou I, Fostira F.
Cancers (Basel). 2021 Apr 27;13(9):2106. doi: 10.3390/cancers13092106. PMID: 33925588
FOLLOW-UP OF TISSUE GENOMICS IN BRCA1/2 CARRIERS WHO UNDERWENT PROPHYLACTIC SURGERIES.
Kotoula V, Papadopoulou K, Tikas I, Fostira F, Vrettou E, Chrisafi S, Fountzilas E, Koliou GA, Apostolou P, Papazisis K, Zaramboukas T, Asimaki-Vlachopoulou A, Miliaras S, Ananiadis A, Poulios C, Natsiopoulos I, Tsiftsoglou A, Demiri E, Fountzilas G.
Breast Cancer. 2021 Nov;28(6):1367-1382. doi: 10.1007/s12282-021-01276-3. PMID: 34304347
Dimitrakopoulos FI, Koliou GA, Kotoula V, Papadopoulou K, Markou K, Vlachtsis K, Angouridakis N, Karasmanis I, Nikolaou A, Psyrri A, Visvikis A, Kosmidis P, Fountzilas G, Koutras A.
Cancers (Basel). 2021 Mar 8;13(5):1163. doi: 10.3390/cancers13051163.
PMID: 33800431
GENOTYPING DATA OF ROUTINELY PROCESSED MATCHED PRIMARY/METASTATIC TUMOR SAMPLES
Vassiliki Kotoula, Kyriakos Chatzopoulos, Kyriaki Papadopoulou, Eleni Giannoulatou, Georgia-Angeliki Koliou, Vasilios Karavasilis, Elissavet Pazarli, Stavroula Pervana, Georgia Kafiri, Georgios Tsoulfas, Sofia Chrisafia , Helen Sgouramali , Pavlos Papakostas , Dimitrios Pectasides , Prodromos Hytiroglou , George Pentheroudakis, George Fountzilas
Data in Brief 34 (2021) 106646, DOI: 10.1016/j.humpath.2020.10.009
AN OBSERVATIONAL STUDY TO ASSESS THE MOLECULAR EPIDEMIOLOGY AND DIRECT MEDICAL COSTS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER TREATED WITH AFATINIB IN REAL-WORLD CLINICAL SETTINGS IN GREECE
Giannis Mountzios, Sofia Lampaki, Georgia-Angeliki Koliou, Athanassios Vozikis, Ioannis Kontogiorgos, Panagiotis Papantoniou, Margarita- Ioanna Koufaki, Eleni Res, Anastasios Boutis, Athina Christopoulou, Nicoleta Pastelli, Anastasios Grivas, Gerasimos Aravantinos, Efthalia Lalla, Georgios Oikonomopoulos, Anna Koumarianou, Dionisios Spyratos, Dimitrios Bafaloukos, Georgios Rigakos, Pavlos Papakotoulas, George Fountzilas, Helena Linardou
Lung Cancer: Targets and Therapy, 2021:12 93–102
Fountzilas E, Kotoula V, Koliou GA, Liontos M, Papadopoulou K, Giannoulatou E, Papanikolaou A, Tikas I, Chrisafi S, Mauri D, Chatzopoulos K, Fostira F, Pectasides D, Oikonomopoulos G, Aivazi D, Andrikopoulou A, Visvikis A, Aravantinos G, Zagouri F, Fountzilas G.
Front Oncol. 2021 Jun 1;11:683057. doi: 10.3389/fonc.2021.683057. PMID: 34141624
Linardou H, Spanakis N, Koliou GA, Christopoulou A, Karageorgopoulou S, Alevra N, Vagionas A, Tsoukalas N, Sgourou S, Fountzilas E, Sgouros J, Razis E, Chatzokou D, Lampaki S, Res E, Saridaki Z, Mountzios G, Saroglou G, Fountzilas G.
Cancers (Basel). 2021 Sep 15;13(18):4621. doi: 10.3390/cancers13184621.PMID: 34572848
Apostolou P, Fostira F, Fountzilas G, Razis E, Yannoukakos D, Konstantopoulou I.
Cancer Genet. 2021 Nov;258-259:49-50. doi: 10.1016/j.cancergen.2021.08.003.
Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP; MACH-NC Collaborative Group.
Radiother Oncol. 2021 Mar;156:281-293. doi: 10.1016/j.radonc.2021.01.013. PMID: 33515668
Kourea HP, Dimitrakopoulos FI, Koliou GA, Batistatou A, Papadopoulou K, Bobos M, Asimaki-Vlachopoulou A, Chrisafi S, Pavlakis K, Chatzopoulos K, Galani E, Pentheroudakis G, Pectasides D, Bafaloukos D, Res E, Papakostas P, Koutras A, Kotoula V, Fountzilas G.
Cancer Res Treat. 2021 Nov 17. doi: 10.4143/crt.2021.748. Online ahead of print. PMID: 34793664
META-ANALYSIS OF CHEMOTHERAPY IN NASOPHARYNX CARCINOMA (MAC-NPC): AN UPDATE ON 26 TRIALS AND 7080 PATIENTS
Pierre Blanchard, ….. George Fountzilas…..Jean-Pierre Pignon, on behalf of the MAC-NPC collaborative Group
Clinical and translational radiation oncology, 2021 Nov 26;32:59-68.
doi: 10.1016/j.ctro.2021.11.007. eCollection 2022 Jan.
Δημοσιεύσεις 2022
Rapti V, Moirogiorgou E, Koliou GA, Papadopoulou K, Binas I, Pentheroudakis G, Bafaloukos D, Bobos M, Chatzopoulos K, Chrisafi S, Christodoulou C, Nicolaou I, Sotiropoulou M, Magkou C, Koutras A, Papakostas P, Kotsakis A, Razis E, Psyrri A, Tryfonopoulos D, Pectasides D, Res E, Alexopoulos A, Kotoula V, Fountzilas G.
Oncol Lett. 2022 Jan;23(1):23. doi: 10.3892/ol.2021.13141. PMID: 34868360
Fountzilas E, Lampaki S, Koliou GA, Koumarianou A, Levva S, Vagionas A, Christopoulou A, Laloysis A, Psyrri A, Binas I, Mountzios G, Kentepozidis N, Kotsakis A, Saloustros E, Boutis A, Nikolaidi A, Fountzilas G, Georgoulias V, Chrysanthidis M, Kotteas E, Vo H, Tsiatas M, Res E, Linardou H, Daoussis D, Bompolaki I, Andreadou A, Papaxoinis G, Spyratos D, Gogas H, Syrigos KN, Bafaloukos D.
Cancer Immunol Immunother. 2022 Feb;71(2):327-337. doi: 10.1007/s00262-021-02985-6. PMID: 34164709
CANCER RISKS ASSOCIATED WITH BRCA1 AND BRCA2 PATHOGENIC VARIANTS.
Li S, Silvestri V, Leslie G…Fountzilas G…
J Clin Oncol 2022 May 10;40(14):1529-1541. doi: 10.1200/JCO.21.02112.
Zagouri F, Koliou GA, Dimitrakopoulos F, Papadimitriou C, Binas I, Koutras A, Papakostas P, Markopoulos C, Venizelos V, Xepapadakis G, Andrikopoulou Α, Karanikiotis C, Psyrri A, Bafaloukos D, Kosmidis P, Aravantinos G, Res E, Mauri D, Koumarianou A, Petraki K, Tsipoura A, Pectasides D, Gogas H, Fountzilas G.
Br J Cancer. 2022 Sep;127(4):695-703. doi: 10.1038/s41416-022-01846-y. PMID: 35610366
Papadopoulou K, Koliou GA, Tsimiliotis D, Kotoula V, Foukas P, Goussia A, Tsiatas M, Visvikis A, Chatzopoulos K, Nifora M, Charchanti A, Koumarianou A, Christodoulou C, Pectasides D, Psyrri A, Fostira F, Fountzilas G, Samantas E.
Urol Oncol. 2022, S1078-1439(22)00266-6. doi: 10.1016/j.urolonc.2022.07.007. PMID: 36041976
LUNG CANCER AS A PREDOMINANT FEATURE IN A PATIENT WITH PEUTZ-JEGHERS SYNDROME: CASE REPORT.
Fostira F, Fountzilas E, Papadopoulou K, Karaiskos T, Mpatsi O, Pastelli N, Mountzios G, Konstantopoulou I, Fountzilas G.
Thorac Cancer. 2022 Jun;13(12):1862-1865. doi: 10.1111/1759-7714.14447. PMID: 35543335